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Van der Woude syndrome (VWS) and popliteal pterygium syndrome (PPS) are 
autosomal dominant clefting disorders recently discovered to be caused by mutations in 
the IRF6 (Interferon Regulatory Factor 6) gene.  The IRF gene family consists of nine 
members encoding transcription factors that share a highly conserved helix-turn-helix 
DNA-binding domain and a less conserved protein-binding domain.  Most IRFs regulate 
the expression of interferon-α and -β after viral infection; however, the function of IRF6 
remains unknown.  In this project, a full length zebrafish irf6 cDNA was isolated. It 
encodes a 492 amino acid protein that contains a protein-IRF interaction motif and a 
DNA-binding domain.  The zebrafish irf6 gene was identified to consist of eight exons 
and maps to linkage group 22 closest to marker unp1375.  The in situ hybridization 
analysis of whole mounts and cryosections demonstrates that irf6 was first expressed as a 
maternal transcript. During gastrulation, irf6 expression was concentrated in the 
forerunner cells.  From the bud stage to the 3-somite stage, irf6 expression was observed 
in the Kupffer’s vesicle.  No expression could be detected at the 6-somite and 10-somite 
stages.  At the 14-somite stage, expression was detected in the otic placode.  At the 17-
somite stage, strong expression was also observed in the cloaca.  During the pharyngula, 
hatch and larva periods up to 5 days post-fertilization, irf6 was expressed in the 
pharyngeal arches, olfactory and otic placodes, and in the epithelial cells of endoderm 
derived tissues.  The latter tissues include the mouth, pharynx, esophagus, endodermal 
lining of swim bladder, liver, exocrine pancreas, and associated ducts.  The zebrafish 
expression data are consistent with the observations of lip pits in VWS patients, as well 
 v
as more recent reports of alae nasi, otitis media and sensorineural hearing loss 
documented in some patients. The translation-blocking and splice-modifying 
morpholino-mediated gene knockdown analyses were performed to observe the effect of 
reduction or loss of Irf6 function on organogenesis during zebrafish embryonic 
development.  Additionally, microinjection of capped mRNA carrying an Arg84 to Cys 
(R84C) dominant-negative point mutation was performed. All loss of function treatments 
produced larvae with identical gross morphologies, including bloated abdomen, small 
eyes and head, and delayed yolk resorption.  Major pharyngeal arch deformities were 
observed, including misalignments, degenerations and absent structures.  Furthermore, 
the liver and pancreas were reduced in size compared to wildtype fish.  The intestinal 
lumen was constricted, with absent or reduced folding of the epithelial cell monolayer.  
The epithelial cells of the intestine maintained their cuboidal shape, with the nuclei still 
situated in the center and not the base of the cells.  A milder phenotype showing reddish 
intestine was observed in larvae injected with splice-modifying morpholinos and 
dominant negative perturbation. By the inspiration that both irf6 and sox17 have the 
expression in the forerunner cells and endoderm organs, we propose and test the 
hypothesis that Irf6 is an effector of Nodal signaling pathway, upstream or downstream 
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CHAPTER 1   GENERAL INTRODUCTION 
 
1. Human Genetic Diseases/Inherited disorders 
Diseases are caused by the environmental factors like infectious pathogens, chemicals, 
nutritions, or interactions between genes and environment, or interactions among 
various genes. Inherited disorders occur when abnormalities are present in genome. 
The inherited disorders are categorized into four classes: (1) Monogenic.  When 
mutation occurs in the DNA sequence of single gene, the protein encoded by the gene 
can not perform the normal function, leading to a disorder. This kind of monogenic 
disorders are transmitted to the progenies in a fashion of Mendel’s law, either 
autosomal dominant, autosomal recessive, or sex chromosome-linked (Tamarin, 
1999). (2) Polygenic. This type of disorders is generally caused by the combined 
interactions among the mutations/polymorphisms in multiple genes and 
environmental factors. This multifactorial character makes the diagnosis and the 
mechanism identification hard to be analyzed. Generally, the more cases the diseases 
are present in population, the more factors are involved in the diseases, for instances, 
heart diseases, hypertension, diabetes, arthritis, Parkinson’s disease, autism, 
susceptibility to pathogens, and so on (Badano and Katsanis, 2002). (3)   
Chromosomal. In the nucleus, chromosomes are composed of DNA and proteins. 
Numerous genes are loaded on one chromosome. A disease would happen when the 
number of chromosomes changes (aneuploidy), or when the chromosome structure 
changes, for instance, lost copies, gained copies or translocations. Some chromosomal 
abnormalities can be detected by karotype detection or fluorescence in situ 
hybridization (FISH) using microscope (Pasternak, 2005b). (4) Mitochondrial. 
Mitochondria is an organelle located in the cell cytoplasm, functioning as the 
principal energy source of the cell and containing the cytochrome enzymes of 
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terminal electron transport and the enzymes of the citric acid cycle, fatty acid 
oxidation, and oxidative phosphorylation. This organelle has its own DNA pieces in 
circular, which are separated from chromosomes. The mitochondrial DNA is 
maternally inherited. Some of functional mitochondrial proteins are encoded by 
mitochondrial DNA. Therefore, mutations in the nonchromosomal DNA of 
mitochondria can cause some genetic disorders, generally muscle disorders (Pasternak, 
2005a).  
2. Animal models for interpretation of human genome and genetic diseases 
Human genome is composed of 22 pairs of autosomes and X and Y chromosomes. 
The haploid is long in 3000 Mb. Only 3% of DNA is exon region. The estimated gene 
number is about 35,000 (Ewing and Green, 2000). About 30% of DNA is mobile 
elements, classified into DNA-based transposable elements, autonomous 
retrotransposons, and nonautonomous retrotransposons. The others are composed of 
introns, promoters and enhancers, pseudogenes and repeated sequences (Lander et al., 
2001; Venter et al., 2001). The association of the specific genes with diseases through 
the Mendelian disorders somehow helps define the functions of corresponding genes. 
Some genes when mutated cause lethal effects, or multifactorial disorders. On one 
hand, the functional identification of these genes relies on the direct gene sequencing 
and sequence variations among populations. On the other hand, in the evolutionary 
history, many cell to cell signaling pathways and the regulations of gene expression 
required for embryogenesis are functionally conserved among various organisms, 
especially vertebrates. Thus, animal models are used to study how the disease 
progresses and what factors are associated with the disease process and how the 
disease can be treated. Animal mutagenesis is a powerful way to model the human 
genetic diseases and therefore complement to human sample resources. After the 
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invertebrate models, Drosophila and C.elegans, the large-scale mutageneses using the 
chemical mutagen N-ethyl-N-nitrosourea (ENU), retroviral delivery system and 
transposition system have been carried out in the mouse and zebrafish. In addition, the 
gene expression patterns and disruption of targeted genes in mouse, chick, and 
xenopus establish the association between gene and developmental phenotypes. 
2.1   Zebrafish as a model for Human disorders  
Although physiological differences exist between fish and human, zebrafish has 
advantages to be a disease model to complement to mouse and other animals for 
human monogenic diseases. The transparency of embryos and larvae facilitates the 
pathological phenotypic screening and disease progression examination directly under 
optical microscopes without other complex analysis and equipment. On the other hand, 
forward-genetic screening combined with reverse-genetic transient morpholino 
knockdown allows the investigation about effects by the various dosage of gene 
product. In contrast, in mouse system, only knockout and knockin strategy is available. 
That means that phenotypes caused by only half dosage (heterozygous) or zero dosage 
(homozygous) of normal gene product can be examined. With the unique 
experimental advantages, zebrafish has made major contributions for the 
understanding of human disorders and organogenesis related to: craniofacial 
development (Neuhauss et al., 1996; Piotrowski et al., 1996; Schilling et al., 1996), 
digestive organogenesis (Pack et al., 1996), ear and eye development (Goldsmith and 
Harris, 2003; Whitfield, 2002), hematopoietic and cardiovascular disorders (Dooley 
and Zon, 2000; North and Zon, 2003), neurodevelopment (Tropepe and Sive, 2003), 
hematologic development (Shafizadeh and Paw, 2004), germ cell aneuploidy (Poss, 
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2004), laterality (Peeters and Devriendt, 2006), otoconical development (Hughes et al., 
2006), and nutrient metabolism (Merchant and Sagasti, 2006).  
Zebrafish (Danio rerio) is a species belonging to the family Cyprinidae. It is a tropical 
omnivorous fish inhabiting in the fresh waters of Pakistan, India, Bangladesh and 
Nepal. Zebrafish was first suggested as a system for studies of developmental biology 
in 1981 (Streisinger et al., 1981). It got the increasingly attention to become an 
experimental organism, because the fish is in small size (up to 6 cm), has a short 
generation time (3~4 months), high fecundity (100-200 eggs per mating), external 
fertilization, and transparent embryos. Most of the embryonic methodologies to be 
routinely applied in Xenopus can be also successfully performed on zebrafish. The 
requirement for fish maintenance is far lower than mouse (Detrich, III et al., 1999; 
Eisen, 1996).  
 
The genome of zebrafish is being sequenced and mapped. The databases are available 
on ZFIN, NCBI and ENSEMBL websites, further facilitating the zebrafish research.  
Zebrafish has 25 pairs of chromosomes, very similar to the number of human 
chromosomes (23 pairs) (Sola and Gornung, 2001). The drawback of zebrafish as a 
model to study the human genetic disorder is the duplication event in genome. The 
mapping data indicates that only about 20% of genes keep duplicates, while the 
redundancy in the left 80% of genes is lost. The expression of duplicated genes 
showed some divergent patterns, suggesting specific functions for each duplicate 
(Force et al., 1999; Van de et al., 2002; Taylor et al., 2001). 
 
2.1.1 Forward genetics - Mutagenesis 
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Zebrafish mutants are excellent models for human genetic diseases. Large-scale 
mutagenesis was first performed in zebrafish using ENU. The efficiency of 
mutagenesis is quite high, at a rate of one to three mutations per locus in every 1,000 
haploid genomes (Mullins et al., 1994).   The mutations caused the phenotypes of 
mutants covering every aspect of development (Driever et al., 1996; Haffter et al., 
1996). However, the following identification of the mutations is a major problem, 
because ENU results in point mutations, requiring positional cloning map of the locus 
of the genes, followed by mutation scanning of candidate genes within the mapped 
region. The procedures are highly complex, laborious and time-consuming.  
 
Alternative efficient mutagenesis strategies were developed to simplify the 
identification of disrupted genes.  The integration of exogenous DNA segments serves 
as the marker tags for the subsequent detection of the flanking host sequences by PCR. 
For instance, the high-titer infectious pseudotyped retroviruses were packaged from 
recombinant retroviral vectors and were injected into zebrafish embryos. After the 
infection, the exogenous retroviral DNA sequences were integrated into the host 
genome.  The mutations were transmitted to F1 progeny. The homozygous mutants 
shall be present in F3 generations by cross of F2 generations. Drawback of retroviral-
mediated mutagenesis is that the efficiency of retroviral-mediated mutagenesis is one-
ninth of the frequency by ENU treatment (Amsterdam et al., 1999; Amsterdam and 
Hopkins, 1999; Linney et al., 1999). 
 
2.1.2 Reverse genetics - Perturbation of the gene of interest 
The mutagenesis using mutagens like ethyl nitrosourea (ENU) or pseudotyped 
retrovirus introduces random mutations, belonging to the forward genetic screen. 
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Once the mutants are constructed, the causative genes for the defective phenotypes 
are identified with genetic and molecular methodologies. In contrast to the productive 
forward genetic screens, an alternative strategy is to change a gene of interest and 
then determine the phenotypes. It is called reverse genetics. In mouse, the transgenic 
mouse is constructed by engineering on a particular gene, for instance, deleting the 
gene from the genome. The approach is termed as “gene knockout”. The gene 
knockouts by homologous recombination have not been achieved in zebrafish because 
the culture of embryonic stem cells of zebrafish is not successful at present. To 
understand the gene of interest, the strategy is to perturb the activity of gene product 
and to see how the phenotypes are affected. The perturbation includes gain-of-
function and loss-of-function (Hammerschmidt et al., 1999). 
 
2.1.2.1   Gain of function 
Ectopic expression 
Ectopic expression can be performed by microinjecting the synthetic mRNA or 
expression vector into zebrafish embryos at 1~4 cell stage. The expression vector has 
a ubiquitous promoter to drive the gene product to be present in any cell types from 
early moment. The gene of interest can be expressed as early as midblastula stage. 
 
Entopic expression 
To study the effect of higher dosage of specific gene in its normal place, the entopic 
expression can be performed when the gene-specific promoter is cloned. An 
expression vector with the gene-specific promoter and protein-encoding cDNA can be 
constructed and injected into embryos.   
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2.1.2.2 Loss of function by knockdown 
Repressing gene expression is applied to test the function of a gene in the life of an 
organism. Only mutants carrying the deleted or non-sense mutations can abolish the 
expression of the gene in whole life. An alternative way to mimic the knockout 
animals or mutants is “knockdown”, however, which just transiently inhibits the 
expression of specific genes (Nasevicius and Ekker, 2000).  
 
The knockdown can be mediated by two methods, RNA interference (RNAi) and 
antisense oligonucleotides. RNAi means that the expression of a specific gene in cells 
is interfered through the degradation of mRNA caused by the short homologous 
double-stranded RNA (dsRNA).  This system is highly efficient when applied in plant, 
C. elegans or mammalian cell lines (Chuang and Meyerowitz, 2000; Misquitta and 
Paterson, 1999; Montgomery et al., 1998; Wianny and Zernicka-Goetz, 2000). Three 
research groups independently reported the application of RNAi to zebrafish. 
However, it was found not to produce specific phenotypes in zebrafish by two groups 
(Li et al., 2000; Oates et al., 2000; Zhao et al., 2001). The most advanced system of 
knockdown for zebrafish is the injection of antisense morpholino oligonucleotides. 
Morpholino oligo is composed of 18 to 25 morpholino subunits. Each subunit 
contains a nucleotide base linked to a 6-member morpholine ring. The morpholine 
rings are connected by phosphate and become the backbone similar to the structure 
present in nucleic acid in which the ribose or deoxy-ribose sugar rings are linked 
together by phosphate. The morpholino is stable inside the cells, resistant to the 
nucleases and without the stimulation to the immune system. The injected morpholino 
binds to the complementary sense site and blocks the cell complexes to access the 
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target region (Summerton and Weller, 1997). Two different strategies are utilized for 
the knockdown using morpholino. 
  
ATG-translation blocking is mediated by an antisense 25-base oligo that targets to the 
region from 5’cap to about 25 bases after the start codon. The ribosome complex is 
blocked to initiate the translation from start codon (Summerton, 1999). The protein 
level can not be increased whereas the mRNA is not altered. The efficiency of this 
type of knockdown is evaluated by the presence and amount of proteins, not the level 
of mRNA. 
 
Splice blocking is mediated by morpholinos complementary to the exon-intron or 
intron-exon junctions of the preliminary mRNA (pre-mRNA). The injected 
morpholino binds to pre-mRNA and then prevents the access of spliceosome to the 
targeted site. The splicing site is shifted, leading to variant transcription. The amount 
of normal mRNA is decreased or eliminated. The splicing-modified efficiency can be 
evaluated by the detection of mRNA types with RT-PCR (Draper et al., 2001). 
 
2.1.2.3   Loss of function - dominant negative perturbation 
Dominant negative mutation means a mutation adversely changes the gene product by 
inactivating the functional domain but leaving the protein-protein 
interaction/dimerization domain intact. Because the wildtype protein when dimerized 
with dominant negative protein can not execute the proper function as well, this kind 
of mutation sometimes can give rise to the more deleterious effects than the null 
mutations. The dominant negative effects are usually present in transcription factors, 
signaling proteins, transmembrane receptors and intracellular kinases and 
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phosphatases. In zebrafish, the block of targeted protein activity with dominant 
negative approach can be carried out by the injection of the synthetic mRNA or DNA 
that encode the dominant negative protein (Hammerschmidt et al., 1999). 
 
2.1.3   Developmental studies of digestive organs using zebrafish 
The digestive system is composed of gut, liver, gallbladder and pancreas. The 
developmental program of digestive system is well conserved among vertebrates. The 
program starts from blastula and gastrula periods (Warga and Stainier, 2002), when 
the embryonic cells are divided into three different types of cells for endoderm, 
mesoderm, and ectoderm, from which the digestive system is developed (Bates and 
Deutsch, 2003; Montgomery et al., 1999).  
 
2.1.3.1 Gut 
In mammalians, the endoderm extends and folds laterally, and fuses ventrally to form 
the gut tube with the anterior-posterior polarity. The gut is specified with foregut, 
midgut and hindgut. Lung, thyroid, liver and pancreas are the organs budding off from 
the gut along the anterior-posterior axis. The gut lengthens fast and exceeding the 
length of embryo. The lumen is not able to form temporarily due to the rapid cell 
proliferation. During late embryonic stage, the lumen is present again. The epithelial 
cells of the alimentary canal and the associated organs, liver and pancreas are derived 
from endoderm. Epithelial cells are differentiated into enterocytes, enteroendocrine 
cells, goblet cells and Paneth cells. Surrounding the epithelial cells are the smooth 
muscle, stromal cells and other supporting cells. They are developed from the 
mesoderm. The neurons of enteric nervous system (ENS) are derived from ectoderm 
and neural crest. In addition, lymphocytes are also the cell member of the gut to 
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process mucosal immunity. The gut-associated lymphoid is developed during 
pregnancy period (Bates and Deutsch, 2003). 
 
There are some anatomical and formation differences between zebrafish and 
mammalian guts. Zebrafish gut is composed of mouth, pharynx, pharyngesophageal 
region, esophagus and intestine. Unlike the majority of vertebrates, in between 
esophagus and intestine, there is no stomach in zebrafish. Caudal to the esophagus, is 
an expanded lumen, called the intestinal bulb, for the digestion of lipid and protein. 
Zebrafish does not have the cecum structure to connect the small intestine and large 
intestine. In mammals, endodermal cells adopting the gut fate first rapidly proliferate 
into the multiple-cell layer, which is later converted by the apoptosis into the tubular 
monolayer of polarized epithelial cells. In zebrafish, the lumen is probably developed 
by the apical surface biogenesis when the fish gut is only a thin bilayer of endodermal 
cells. Apoptosis is not involved in the tubular morphogenesis. Enterocytes, goblet 
cells, and enteroendocrine cells are the cell types present in the intestinal epithelium. 
However, similar to xenopus and chick, Paneth cells were not found in the zebrafish 
gut (Ng et al., 2005; Wallace and Pack, 2003). The architecture of zebrafish intestine 
is less complex than that of mammalians. The mammalian intestine is consisted of 
four layers: mucosa (epithelium, lamina propria and muscularis mucosa), submucosa, 
muscularis (circular smooth muscle and longitudinal smooth muscle) and serosa. 
Neuron cell bodies are distributed in the submucosa and muscularis. Zebrafish 
intestine does not have the connective tissue layer, submucosa. The neuron cell bodies 
are present in the muscularis only (Wallace et al., 2005). 
 
2.1.3.2 Liver and pancreas 
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Both hepatic and pancreatic developments go through three courses: competence, 
specification and morphogenesis. The competence means that the primitive gut is 
ready to respond to the inducer to develop into specific organs. The inducers come 
from the adjacent ectoderm and mesoderm. Specification means that with the 
formation of gut tube, the foregut endoderm is specified to bud the liver and pancreas 
by the regulation of various signaling pathways like fibroblast growth factors (FGFs), 
bone morphogenetic proteins (Bmps) and sonic hedgehog (Shh). Morphogenesis is a 
process of cell differentiation and a change of cell behaviour to form the organ (Bates 
and Deutsch, 2003). 
 
Liver development   
When getting the inductive signals from the cardiogenic mesoderm and the repressive 
signals from the trunk mesoderm, a portion of endodermal cells of the primitive gut 
adopt a hepatic fate. In mammals, the hepatic epithelium becomes thick and protrudes 
from the ventral wall of foregut. The outgrowth is anterior besides the yolk sac. The 
outgrowth migrates into the surrounding mesenchyme to form the liver bud. 
Endodermal-derived hepatocytes proliferate to form solid cords. Mesenchyme 
contacted with the liver bud later develops into capsule and connective tissue of the 
liver.  Hepatocytes spread in between the veins and the capillaries to form the 
sinusoids. In the liver bud, the hepatoblasts have the potential to differentiate into 
hepatocytes and biliary epithelium. The development of hepatic venous system 
initiates very early when the primitive liver proliferates and migrates into vitelline 
vein network to form the primitive sinusoidal plexus. The rapidly growing liver is 
incorporated with the lateral placed left and right umbilical veins. When the yolk sac 
is replaced with the placenta, the ductus venous and portal vein migrate into the liver, 
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while the partial left umbilical vein and the total right umbilical vein are regressed. At 
birth, the ductus venosus is closed and the umbilical vein is transformed not to 
transport the blood. The portal vein expands to become the dominant vein to supply 
the whole liver (Portman, 2006). 
 
In zebrafish, the liver budding is similar to that of mammals. However, that the 
adjacent mesenchyme is interstitially invaded by the dissociated hepatocytes observed 
in mammals is not present in zebrafish. Zebrafish hepatocytes assemble together as a 
single patch on the left side of the gut. Following budding, the rapidly growing liver 
spreads to the right side and filling in the abdominal cavity. At this stage, the liver is 
vascularized to be able to carry out the physiological function. The vascularization in 
zebrafish liver is different from mammals, in which the hepatocytes interstitially 
invade into mesenchyme and spread around the vitelline and umbilical veins. 
Zebrafish has the endothelial cells invade into the liver to form its venous system. 
Zebrafish hatchlings are more tolerable to the liver defects and live longer than 
mammals. Mammalian liver is an early hematopoiesis organ, essential to the embryo’ 
survival, while the early hematopoiesis of zebrafish relies on the intermediate cell 
mass and kidney. In addition, zebrafish acquires the oxygen by diffusion not by 
circulation. At this point, zebrafish is a good model to study the liver development 
(Field et al., 2003b). 
 
Pancreas development 
In mammals, the budding of pancreas from foregut has two independent outgrowths, 
located dorsal anterior and ventral posterior to gallbladder. The specification and 
morphogenesis of two outgrowths is regulated by different signaling pathways and 
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transcription factors. Later, with the midgut turning, the ventral primitive pancreas is 
re-oriented to the dorsal side and paralleled with the dorsal one. Both buds enclose the 
portal vein and fuse together to form the pancreas composed of endocrine and 
exocrine cells (Bates and Deutsch, 2003; Slack, 1995). 
 
Zebrafish pancreas also develops from two outgrowths, located ventral anterior and 
dorsal posterior to each other along gut tube. The pancreas fated cells (pdx-1 positive) 
are present as early as at the 10 somite stage (Biemar et al., 2001). Later, this 
population of cells forms the dorsal posterior outgrowth budding out at 14-18 somite 
stage. At 40 hpf, the ventral anterior outgrowth is budding out at the same side with 
posterior anlage.  The anterior bud grows fast and later envelopes and fuses into the 
posterior anlage at 52 hpf. Mouse pancreas develops from two anlagen as well. Each 
anlage gives rise to both endocrine cells and exocrine cell types. However, zebrafish 
posterior anlage of pancreas gives rise to endocrine cells only; while the anterior 
anlage has the exocrine cells and the multipotential precursor cells to develop into the 
endocrine cells. In mammals and xenopus, the endocrine pancreas differentiation 
requires the presence of vascular endothelial cells, while the zebrafish pancreas, 
including endocrine and exocrine cells, develops well in the absence of vascular 
endothelium (Field et al., 2003a). 
 
2.1.3.3   Molecular pathways regulating the development of the digestive system 
Nodal  
Nodals are members of TGFß superfamily. Nodal gene was first reported for its 
essential role in mammalian gastrulation during mouse retroviral mutatgenesis 
(Conlon et al., 1994; Conlon et al., 1991; Zhou et al., 1993). Later studies of more 
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vertebrates revealed that Nodals are inducers of mesendoderm and regulators of left-
right axis asymmetry (Feldman et al., 2000; Jones et al., 1995; Rebagliati et al., 1998; 
Sampath et al., 1998; Sampath et al., 1997). Nodals were only found in chordates but 
not in Drosophila or Caenorhabditis elegans (Schier, 2003). 
 
Squint (Sqt) and Cyclops (Cyc) are two ligands of the Nodal family in zebrafish. They 
bind to and activate the Type I and Type II Activin receptors with the presence of 
facilitator One-eyed pinhead (Oep). The activated receptors catalyze the 
phosphorylation of Smad2, which then associates with Smad4. The heterodimer enters 
the nucleus and collaborates with other transcription factors to activate the targeted 
gene expression. Nodal signaling is required for endoderm and mesoderm formation.  
When either of Sqt, Cyc or Oep is disrupted, both endoderm and most of mesoderm 
are reduced. The misexpression of active Type I receptor (Taram-A) promotes the 
cells to adopt an endodermal fate (Peyrieras et al., 1998). The known effectors of 
Nodal signaling are Casanova (Cas), Bonnie and clyde (Bon), and Faust (Fau/Gata5) 
(Alexander et al., 1999; Kikuchi et al., 2000; Kikuchi et al., 2001; Kikuchi et al., 
2004; Reiter et al., 1999; Stainier, 2002; Warga and Stainier, 2002). Cas represents a 
member of the Sox family of high-mobility group (HMG) domain (Kikuchi et al., 
2001). Bon is a Mix family homeodomain transcription factor (Kikuchi et al., 2000). 
Fau/Gata5 is a zinc-finger transcriptional activator that binds to the consensus 
sequence (A/T)GATA(A/G) (Reiter et al., 1999). The embryonic mutants of the three 
genes have the different levels of endodermal defects. According to the normal 
amount of remaining endodermal cells, the severity order of mutants is cas (no 
endodermal cells left except pharyngeal pouch only) > bon (10% left) > fau (60% left) 
(Reiter et al., 1999). Downstream of these effectors is another member of HMG 
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domain Sox family, sox17 (Kikuchi et al., 2001). Sox17 knock-out mice show absence 
of gut endoderm (Kanai-Azuma et al., 2002). 
 
Notch 
Notch is a single-pass membrane protein. When the membrane-associated ligands 
Delta or Delta-like proteins of adjacent cells bind to Notch receptor, three cleavages 
occur on the Notch receptor, one in the extracellular domain and two in 
transmembrane domain. Cleavages release the intracellular domain of Notch (NICD) 
into cytoplama. NICD then enters into nucleus and binds to transcription factors, 
which regulate the targeted gene expression (Brivanlou and Darnell, Jr., 2002).  
 
Notch signaling inhibits the differentiation of endodermally derived cells into 
intestine and pancreas. In mice, the activation of Notch in intestine cells leads to 
intestinal epithelial cells not to be able to differentiate into the secretory cells like 
goblet cells, enteroendocrine cells and paneth cells (Fre et al., 2005; Stanger et al., 
2005). In zebrafish, the overexpression of Notch signals reduces the number of 
endodermal cells (sox17 and foxA2 positive) (Kikuchi et al., 2004). Ectopic Notch and 
Notch target genes repress the differentiation of pancreas endocrine cells of mouse, 
and acinar cells of mouse and zebrafish, whereas disruption of Notch accelerates the 
differentiation of exocrine pancreas (Apelqvist et al., 1999; Esni et al., 2004; Jensen 
et al., 2000). 
 
Sonic hedgehog (Shh) 
Shh is one of three hedgehog proteins. The other two are desert hedgehog (Dhh) and 
Indian hedgehog (Ihh). Shh is a morphogen. It presents as a lipid-anchored cell 
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surface ligand which binds to a 12-span transmembrane protein, Patched (Ptc) 
receptor. When Shh is absent, Ptc inhibits another 7-span transmembrane receptor 
Smoothened (Smo) When Smo is inhibited, transcription factors Ci/Gli are 
proteolytically cleaved to smaller molecules. The small molecules are in repressor 
form. The targeted genes are not able to be regulated. Presence of Shh releases the 
inhibition of Smo from Ptc. The released Smo prevents Ci/Gli from cleavage. The 
full-length Ci/Gli proteins then activate expression of the Shh responsive genes 
(Ingham and Placzek, 2006; Ingham and McMahon, 2001).  
 
Shh plays versatile and significant roles in gut development of many vertebrates. In 
chick, Shh is expressed in gut epithelium from early developmental stage. The 
inactivation of Shh in the epithelial cells is required for the intestinal gland formation. 
The expression of Shh in the epithelial cells ensures that mesenchymally derived 
smooth muscle and nerve cells locate outside of the epithelium and connective tissue 
layers, not inside of the lumen. In chick and mouse, the budding of pancreas and lung 
from the gastrointestinal tract requires the missing of Shh expression in the area of 
budding (Fukuda and Yasugi, 2002; Kawahira et al., 2005). 
 
Wnt 
Wnt proteins are extracellular morphogenic signals. Their receptors are are 7-span 
transmembrane proteins, belonging to Frizzled family members. When Wnt signals 
are absent, a distruction/proteolytic complex composed of Axin, glycogen synthase 
kinase 3 (GSK-3) and adenomatosis polyposis coli (APC), phosphorylates β-catenin, 
leading to its degradation in cytoplasma. When Wnt ligands bind to Frizzled receptors, 
Disheveled (Dsh) family proteins are activated. The active Dsh molecules dissemble 
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the proteolytic complex. And then β-catenin enters into nucleus to accumulate. β-
catenin is able to interact with TCF/LEF family transciption factors  to drive the target 
gene expression (Brivanlou and Darnell, Jr., 2002).  
 
Wnt signaling pathways were found to be involved in the patterning of the vertebrate 
gut tube. In chick, the genes encoding the Wnt signaling components are expressed 
along the developing gastrointestinal tract in different specific regions, which are 
defined to develop into the functional organs like gizzard, proventriculus, duodenum, 
posterior small intestine, ceca and large intestine. The dominant negative perturbation 
of the transcription factors Tcf4 and Left1 that are downstream in the Wnt signaling 
pathways, results in the absence of microvilli in the gizzard epithelium and the 
expansion of endoderm with the reduced mesoderm in large intestine (Theodosiou 
and Tabin, 2003).  
 
2.1.4   Studies of craniofacial development using zebrafish 
The head is composed of the brain and the organs of sight, hearing, taste, and smell. 
Skull is the bones of the head, composed of two parts: neurocranium and 
viscerocranium. The neurocranium is the braincase containing the brain and olfactory, 
optic and otic organs for sense function, whereas viscerocranium is termed as the 
bones of the face part, including mandible, maxilla, zygoma and nasal, as well as 
palatal, pharyngeal, temporal and auditory bones (Wilkie and Morriss-Kay, 2001).  
 
The skull organogenesis has two different patterns: endochondral osteogenesis and 
intramembranous osteogenesis. In tetrapods and higher vertebrates, the roof of the 
neurocranium, including the frontal, parietal and interparietal bones, develops by 
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intramembranous osteogenesis (ossification in the deep layer of the dermis) at discrete 
centers.  These bones are separated by the sutures and fontenelles, to facilitate the 
molding of the neurocranium at parturition and the brain growth for many years after 
birth.  
 
The remaining neurocranium and the whole viscerocranium are initially developed 
from the cartilages with cranial neural crest origin. The cartilages become ossified by 
calcification. This process is called endochondral ossification. Neural crest is formed 
from two bands of neuroectodermal cells along either side of the line of closure of the 
embryonic neural groove. When the neural tube is formed, the two bands join to 
locate dorsolateral to the developing spinal cord and lateral to the brainstem.  The 
neural crest can migrate and separate into clusters of cells and later develop into 
various cell types, including cartilages of branchial arches, neuroganglion, chromaffin 
cells, Schwann cells, part of the meninges, or integumentary pigment cells, etc. When 
there is no calcified cartilage replacement, the mandible and maxillary growth mainly 
rely on the intramembranous ossification (Lavelle, 2002; Wilkie and Morriss-Kay, 
2001). 
 
Skull development is the most complex but relatively conserved process in vertebrates, 
although the lower vertebrates like fish, amphibians and birds do not have the bony 
palate and cranial sutures. The head skeleton of zebrafish has neurocranium and 
viscerocranium as well. The neurocranium originates from both cranial neural crest 
and mesoderm, and the viscerocranium/pharyngeal skeleton develops from cranial 
neural crest only. The cranial neural crest migrates in three streams (S1, S2 and S3) 
into mesoderm to form the seven pharyngeal arches. The first arch (Meckel’s cartilage 
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and palatoquadrate), equal to mandible, is derived from S1. The second arch, 
composed of basihyal, ceratohyal, hyosymplectic and interhyal, is derived from S2. 
S3 develops into from the third to seventh arches, including ceratobranchials, 
hypobranchials and basibranchials. Similar to human skull, the zebrafish skull has two 
types of cellular bones, dermal bones and cartilage bones, in total 74 bones. The 29 
dermal bones and one membrane bone are formed through intramembranous 
ossification of connective tissue membrane (mesoderm), whereas the 44 cartilage 
bones develop by endochondral and perichondral ossification (neural crest) (Cubbage 
and Mabee, 1996; Kimmel et al., 2001; Yelick and Schilling, 2002). 
 
Due to the similarity of craniofacial development between zebrafish and human, 
zebrafish becomes a model to analyze several human syndromes and their causative 
genes (Boyadjiev et al., 2006; Lang et al., 2006; Matthews et al., 2005; Ernest et al., 
2000; Shin and Fishman, 2002). 
 
2.1.5 Molecular markers for expression analysis of phenotypes 
no tail (ntl) is the homologue of mouse T (Brachyury) gene, which  belongs to T-box 
gene family. Brachyury is required for the formation of mesoderm and body axis. In 
zebrafish, ntl gene is expressed in presumptive mesoderm in gastrulation period and 
notochord, marking the midline of the embryos. 
 
fkd7/foxA1 and nkx2.3 are molecular markers expressed in the developmental intestine 
of zebrafish.  fkd7 belongs to a class of transcription factors that have a highly 
conserved winged helix motif in DNA binding domain, named as fork head domain 
(fkd). This domain was first reported in Drosophila gene fork head. In rodents, this 
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class of genes has another name, HNF3 transcription factors. In zebrafish, fork head 
domain gene family has nine members (fkd1 –fkd9). Among nine members, fkd1, fkd2, 
fkd4 and fkd7 were expressed in the floor plate, the notochord, the hypochord and the 
endoderm. During larvae period, fkd7 is expressed in the epithelial cells of alimentary 
canal (Odenthal and Nusslein-Volhard, 1998). nkx2.3 is one of the vertebrate 
homologs for the Drosophila homeobox gene tinman. Zebrafish nkx2.3 was found to 
be expressed in early endoderm including the developing pharyngeal arches and gut.  
The expression was detected in the pharyngeal pouches and the epithelial cells of 
pharynx and intestine (Lee et al., 1996). 
 
One of the earliest molecular markers for zebrafish liver is prox1.  prox1 is the 
vertebrate homologue of Drosophila prospero, which encodes a divergent 
homeodomain protein (Oliver et al., 1993). In vertebrates, Prox1 is expressed and 
involved in development of eyes, liver, and muscle (Tomarev et al., 1998; Burke and 
Oliver, 2002; Roy et al., 2001). In mouse, Prox1 regulates the migration of 
hepatocytes from endodermal epithelium into septum transversum (Sosa-Pineda et al., 
2000). Liver type fatty acid binding protein (L-fabp) is expressed exclusively in the 
zebrafish liver and used as a marker for the differentiated liver. Fatty acid binding 
proteins (FABPs) locate in cytoplasma and bind to long chain fatty acids in high 
affinity. Their function is to facilitate the intracellular diffusion of the fatty acid, so 
that fatty acids are transported to their metabolic pathways. In zebrafish, besides L-
fabp, there exist another two types, intestinal-type FABP (I-FABP) and brain-type 
FABP (B-FABP) (Her et al., 2003; ovan-Wright et al., 2000). 
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Molecular markers for analysis of pancreas are trypsin and insulin. Trypsin is a 
digestive enzyme expressed in differentiated pancreatic exocrine cells. Endocrine 
cells express insulin, an anabolic polypeptide hormone controlling carbohydrate 
metabolism (Biemar et al., 2001).  
 
Distal-less related homeobox (Dlx) is a family of transcription factors containing a 
homeobox related to that of Drosophila Distalless (Dll). Distalless is expressed in the 
developing head and limbs of Drosophila embryos. Vertebrate Dlxs are expressed in 
and regulate the developmental brain, head skeleton, teeth, sensory organs and limbs. 
In zebrafish, eight dlx genes were isolated: dlx1a, dlx2a, dlx2b, dlx3b, dlx4a, dlx4b, 
dlx5a, and dlx6a (Borday-Birraux et al., 2006). During pharyngula period, dlx3b is 
expressed in the three separate bilateral patches, corresponding to the three streams of 
ventral arch postmigratory neural crest, which are the primordial of pharyngeal arches  
(Miller et al., 2000; Piotrowski and Nusslein-Volhard, 2000). 
 
A family of transcription factors share a domain of double zinc fingers that directly 
binds to a cis-element 5’(A/T)GATA(A/G) on the targeted promoters. Therefore, 
these transcription factors are named as GATA transcription factors. This family has 
six members, GATA-1 to 6. GATA-1, 2 and 3 are crtical regulators of the 
development of hematopoietic cells. GATA-1 and 2 are the markers for the 
hematopoietic primordial cells and intermediate cell mass (ICM) (Heicklen-Klein et 
al., 2005). ICM is a nest of primitive hematopoiesis, located ventral to notochord and 
posterior to cloaca. GATA-4, 5, and 6 play roles in the development of mesoderm and 
endoderm-derived organs including heart, lung, gonad, liver and gut (Molkentin, 2000; 
Molkentin et al., 2000).  
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 β-globin embryonic gene  (βE-globin), encoding an embryonic globin, is expressed 
from 1-somite stage to larval stages (Quinkertz and Campos-Ortega, 1999). 
 
2.2  Mouse  
Mouse and rat, physiologically, immunologically and behaviorally similar to human, 
more accurately reflect human development. The gene sequences between human and 
mouse share higher identity than the other models (Gregory et al., 2002; Mural et al., 
2002). The mouse genome database is well-established. The application of gene 
knockout technique is sophisticated, making the disruption of the targeted gene 
feasible (Gorman and Bullock, 2000; Jiang et al., 2002; Muller, 1999). The short 
generation period, the available inbred strains and the mutant stocks make mouse to 
be the most ideal mammalian model for human diseases (Herman, 2002). However, 
there are manipulation problems for the studies of early development and 
organogenesis of mouse and rat: 1. fertilization is internal and embryos must implant 
and grow inside uterus of mother. The technique for post-implantation is not available. 
The embryo cultured outside the mother uterus can only last for a few hours. Real-
time observation is impossible. 2. To collect the embryos, mothers have to be 
sacrificed.  3. The size of embryos from certain stage is too large to carry out the 
whole mount in situ hybridization analysis for those deeply imbedded organs.  
2.3   Chick  
Chick is one of the most advanced and economical models that more resemble to 
human. Chick is especially suitable for embryological studies, because chick embryos 
grow up outside the mother body, making the accessibility of embryos at desired 
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stages easier (Stern, 2005). Chick embryos are robust to the in vivo electroporation, 
the surgical manipulations and tissue grafting. The transgenic integration mediated by 
pseudotyped retroviral particles is also successfully performed in chick (Ogura, 2002). 
The studies of chick model help establish the knowledge on regulation of 
organogenesis. On the other hand, the maintenance of chick embryos is cheap and 
convenient.  
2.4   Xenopus 
Xenopus laevis is a traditional model system having contributed to reveal the cell, 
molecular and developmental biology. It produces eggs in large number. The eggs are 
externally fertilized.  The fate maps of embryonic cells are available. The embryos are 
suitable for the grafting and surgical manipulation. The approaches for knockdown 
treatment and dominant negative perturbation as well as over-expression of specific 
gene products have been well-employed in frog embryos. However, Xenopus laevis as 
well as most of frog species have the drawbacks to model human genetic diseases. 
Firstly, its genome is tetraploid (Smith, 2005). Secondly, it takes two years to get to 
sexual maturity. Another frog species called Xenopus tropicalis, sexually matures in 
four months, and has a diploid genome. It recently became a new system for genetic 
study of development (Bodart and Duesbery, 2006).   
 
3. Human Van der Woude (VWS) and popliteal pyterygium syndromes (PPS) 
3.1   Orocleft disorders 
Cleft lip and/or palate are common human craniofacial defects. The average incidence 
is 1 in 700 births around the world. Different racial populations have variable 
frequencies, 1 in 500 in Asians and Amerindians and 1 in 2500 in Caucasians and 
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Africans. The complex interactions between genes or gene-environment are the 
etiological factors of the clefts. Clefts have various phenotypes and degrees: unilateral 
and bilateral; cleft lips with cleft palate involving the hard and/or soft palate (CL/P), 
and cleft soft palate only (CPO). Early genetic and embryologic studies suggested that 
the developmental mechanism of CL/P is different from that of CPO. Cleft cases are 
also categorized into nonsyndromic (70% of CL/P and 50% of CPO) and syndromic 
types. Approximately 70% of CL/P and 50% of CPO cases are non-syndromic. The 
individuals with nonsyndromic clefts do not have other physical and developmental 
defects. The syndromic clefts are further categorized into chromosomal syndromes, 
Mendelian inheritance syndromes, teratogens and uncategorized syndromes (Murray 
2002). 
 
3.2   VWS and PPS 
Van der Woude syndrome (VWS) is a dominantly inherited developmental disorder 
with variable expressivity and incomplete penetrance (OMIM no.119300). It is 
characterized by pits and/or sinuses of the lower lip, cleft lip and/or cleft palate (CL/P, 
CP), and hypodontia, and is the most common cleft syndrome (Rizos and Spyropoulos, 
2004; Van Der Woude, 1954).  Popliteal pterygium syndrome (PPS) is a related 
disorder with similar features, but with additional presentations including webbing of 
the lower limbs, bands of mucous membrane between the jaws, syndactyly, and 
genital anomalies (OMIM no.119500; (Froster-Iskenius, 1990)).  More recently, some 
VWS patients have been reported with additional presentations of sensorineural 
hearing loss or otitis media (Kantaputra et al., 2002; Salamone and Myer, 2004).  
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VWS and PPS are allelic disorders caused by a mutated transcription factor gene, 
IRF6 (interferon regulatory factor 6) (Kondo et al., 2002; Lees et al., 1999; Wong 
and Gustafsson, 2000). VWS can be caused by loss of function mutations that result 
in loss of both the DNA-binding and protein-binding functions, or by IRF6 gene 
deletions that result in haploinsufficiency.  In contrast, PPS is caused by dominant-
negative mutations of IRF6 that destroy DNA-binding ability while leaving protein-
binding activity unaffected (Kondo et al., 2002). 
 
4. IRF6 
4.1   IRFs 
Interferon (IFN) regulatory factors are a family of ten transcription factors that share a 
highly conserved helix-turn-helix DNA-binding domain (DBD) and a less conserved 
protein-binding domain. At the amino-terminal region, five tryptophans are 
distributed in the DBD as a motif. Except IRF6, IRF members possess the IRF 
associated domains (IAD) at the carboxyl terminal to mediate hetero- or homo- 
dimerization between the family members. IRFs are named after IRF1 and IRF2, 
which bind to an enhancer element, IFN-stimulated response element (ISRE; core 
sequence is GAAA), in the promoter of the IFN-β gene as response to viral infection. 
IRF2 is the inhibitor of IRF1 (Harada et al., 1989; Harada et al., 1994). The other 
members are defined according to the sequence homology to IRF1 and IRF2. IRFs are 
found to have versatile functions. IRF1 is an activator, to promote apoptosis and TH1 
cell responses when interacting with IRF2 and IRF8 (Taki et al., 1997; Lohoff et al., 
1997; Ogasawara et al., 1998; Elser et al., 2002).  The IRF1 knockout mice have less 
CD8 cells and are susceptible to intracellular pathogens (Matsuyama et al., 1993; 
Salkowski et al., 1999). IRF2 antagonizes IRF1 and IRF9 amd promotes the T helper 
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1 cell (TH1) responses and NK-cell maturation when interacting with IRF1 and IRF8. 
The IRF2 knockout mice are susceptible to virus and parasite and have skin diseases 
(Hida et al., 2000; Lohoff et al., 2000). IRF3 plays as an activator to induce early type 
I IFNs in response to viral infection and Toll-like receptor ligands. It interacts with 
IRF3 itself and IRF7 as well as cyclic-AMP-responsive-element-binding protein 
(CBP) and/or p300 (Doyle et al., 2002; Fitzgerald et al., 2003; Sato et al., 2000; 
Karpova et al., 2002). The IRF3 knockout mice are susceptible to viral infection 
(McWhirter et al., 2004). IRF4 plays as an activator when co-activator is present, to 
promote TH2 responses, to promote apoptosis and generate antibody and CD8α-
dendritic cells. IRF4 interaction partners are IRF8, nuclear factor 1 of activated T 
cells (NFAT1), NFAT2, signal transducer and activator or transcription 6 (STAT6), 
B-cell lymphoma 6 (BCL-6) and PU.1. The IRF4 knockout mice are not able to 
produce antibody and have proper cytolytic and TH2 responses (Lohoff et al., 2004; 
Suzuki et al., 2004; Fanzo et al., 2003; Tominaga et al., 2003; Lohoff et al., 2002; 
Gupta et al., 1999; Mittrucker et al., 1997). IRF5, when interacting with IRF1, IRF3 
and IRF7, is an activator to induce type I IFNs. The IRF5 knockout mice are not able 
to produce enough interleukin 6 (IL-6) and 12 (IL-12) and tumour necrosis factor 
(TNF) (Barnes et al., 2001; Barnes et al., 2003).  IRF7, as an activator when 
interacting with IRF3 and IRF5, induces type I IFNs and promotes macrophage 
differentiation (Lu and Pitha, 2001; Barnes et al., 2003). IRF8 functions either as an 
activator when co-activators are present, or as a repressor when IRF8 is alone by itself. 
It promotes TH1 responses and macrophage and dendritic cell differentiation. IRF8 
co-activators are IRF1, IRF2, IRF4 and PU.1. The IRF8 knockout mice have chronic 
myeloid leukaemia like syndrome. They are defective in antiviral responses and 
susceptible to intracellular pathogens (Fehr et al., 1997; Holtschke et al., 1996; 
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Scharton-Kersten et al., 1997; Giese et al., 1997). IRF9 plays as an activator. Its co-
activators are STAT1 and STAT2. Its function is to induce IRF2 and IRF7 and 
mediate IFN effects. The IRF9 knockout mice are defective in antiviral responses 
(Hida et al., 2000; Harada et al., 1994; Kimura et al., 1996). Phosphorylation 
modifications are required for the regulation functions of IRF1, IRF3, IRF5 and IRF7 
(Lohoff and Mak, 2005; Nguyen et al., 1997; Taniguchi et al., 2001). The functions of 
IRF6 and IRF10 are in investigation. 
 
4.2   IRF6 
The knowledge of IRF6 first came from the analysis of its expression profile in frog. 
In Xenopus embryos, IRF6 is expressed as a maternal transcript and later in the 
posterior somite mesoderm of neural groove stage embryos. In adult frogs, IRF6 
expression has been observed only in the ovary (Hatada et al., 1997). With the finding 
of the association of mutated IRF6 with VWS and PPS, Irf6 expression during palatal 
fusion and palatogenesis has been studied in the mouse and chick (Knight et al., 2006; 
Washbourne and Cox, 2006; Xu et al., 2006).  In mouse, Irf6 expression was detected 
in the eyes, tongue, liver, lung, placenta, skin, and testes by reverse transcription 
polymerase chain reaction (RT-PCR). Whole-mount in situ hybridization analysis 
revealed Irf6 expression in the epithelial cells of the facial processes during the period 
when the upper lip, primary palate and secondary palate in mouse are fusing. In the 
chick, where the primary palate fuses but the secondary palate is naturally cleft, Irf6 
was expressed in the fusing epithelial cells of the primary palate but not in the medial 
edge epithelia of the secondary palate. In addition, Irf6 is expressed in the hair 
follicles of both mouse and chick.  
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The studies on human IRF6 revealed the causative mutations of affected families, the 
association between the IRF6 gene variants and the risk of isolated cleft lip or palate 
(Blanton et al., 2005; Du et al., 2006; Gatta et al., 2004; Ghassibe et al., 2004; 
Ghassibe et al., 2005; Item et al., 2004; Item et al., 2005; Kayano et al., 2003; Kim et 
al., 2003; Kondo et al., 2002; Matsuzawa et al., 2004; Mostowska et al., 2005; 
Peyrard-Janvid et al., 2005; Shanske et al., 2004; Shotelersuk et al., 2003; 
Srichomthong et al., 2005; Wang et al., 2003; Wang et al., 2005; Ye et al., 2005; 
Zucchero et al., 2004). Evidences have shown an association between IRF6 and 
isolated or non-syndromic oral clefting (Scapoli et al., 2005; Zucchero et al., 2004). 
In humans, IRF6 has been shown to associate directly with Maspin (mammary serine 
protease inhibitor), a class II tumor suppressor, and its expression is inversely 
correlated with breast cancer invasiveness (Bailey et al., 2005). These findings 
suggest that IRF6 interacts with maspin to regulate cellular phenotype, and that 
disruption of this interaction could lead to neoplastic transformation. The protein-
binding domain of human IRF6 was considered as a SMAD interaction motif (Kondo 
et al., 2002).  SMAD proteins are transcriptional factors that modulate the activity of 
transforming growth factor β ligands. There are three classes of SMAD. Receptor 
regulated SMAD (R-SMAD) includes SMAD1, SMAD2, SMAD3, SMAD5 and 
SMAD9. SMAD4 is a co-activator (co-SMAD). Inhibitory SMAD (I-SMAD) 
includes SMAD 6 and SMAD7 (Miyazawa, 2002). The relation between Tgfβ3 and 
Irf6 is suggested by the fact that the expression patterns of both genes in oral palatal 
development are very similar. In oral cleft mutant Tgfβ3-/- knockout mice, Irf6 
expression was down-regulated in oral medial edge epithelia (Knight et al., 2006). 
The SMAD members that are interacted with human IRF6 have not been identified. 
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To investigate the function of Irf6, two mouse lines deficient for Irf6 were generatated. 
One line carried null mutation disrupting IRF6. Heterozygous embryos did not show 
defective phenotypes. Homozygous embryos had palate shelves failing to fuse 
together. Instead, they fused with tongue.  The embryos had oral adhesion, esophagus 
adhesion, highly penetrated skin, shorter snouts and jaws, and shorter forelimbs. The 
hindlimbs and tails were joined by epithelial adhesions. The digits in the forelimbs 
and hindlimbs were absent. Irf6-null homozygous embryos do not have the external 
ears (Ingraham et al., 2006). The other line was generated by knock-in of a missense 
mutation, which converted arginine 84 to cysteine. Heterozygous embryos had oral 
adhesion. Most of them can survive and be reproducible. Intercross between them 
produced homozygous embryos. Homozygous embryos had similar defects in skin, 
limbs, oral and esophagus epithelials to defects in null mutants (Richardson et al., 
2006).  Histological and molecular analyses of homozygous Irf6-deficient embryos in 
the two reports revealed that Irf6 determines the proliferation and differentiation of 
keratinocyte.  
 
5. Objectives of characterization of zebrafish irf6 
Oral clefting ranks among the most common of human congenital malformations. To 
date, the genetic basis of oral clefting remains largely unknown. VWS represents the 
most common single gene cause of oral clefting. The function of the causative gene, 
IRF6 is being investigated.  
 
Zebrafish has been selected in this study as the animal model due to its advantages on 
early developmental and cellular studies. Transient gene knockdown and 
overexpression provide a quick strategy to examine the developing pathology and the 
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potential genetic regulations that determine the defective phenotype and severity. 
However, this project is to raise a question: is zebrafish a suitable model to study the 
mechanism of oral cleft disorders? 
 
This project aims to characterize: a) the full-length cDNA, genomic structure, and the 
allele location of irf6; b) to characterize the developmental expression profiles of irf6 
and the tissue morphogenesis affected by irf6; c) the function of Irf6 in the zebrafish, 
especially during early development (Figure 1.1). Zebrafish Irf6 function during 
embryonic development was analyzed by loss of function and over-expression 
analysis. The tissues, organs, and/or structures affected in these embryos were 
examined using a panel of molecular tissue/organ markers. This project provides a 
comprehensive understanding of the role of irf6 during early vertebrate development. 
Understanding the function of zebrafish IRF6 is fundamental to the subsequent 
identification of downstream target genes and interacting proteins.  
 
VWS and PPS are autosomal dominant inherited disorders. Human patients who carry 
the homozygous or compound heterozygous mutations on IRF6 gene have not been 
reported, suggesting a lethal effect when IRF6 function is completely disrupted. 
Therefore, this project aims to generate a zebrafish model for human VWS and PPS 
and to reveal the defective severity that is gene product dosage-dependent. This 
characterization will make contribution to improve clinical counseling and risk 
assessment, and favour for translational research to improve patient management, and 
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Figure 1.1. Flowchart of characterization of irf6 using zebrafish model.
 
CHAPTER 2   MATERIALS AND METHODS 
 
1. Zebrafish strains 
Singapore wild-type and AB strain (Eugene, Oregon) zebrafish were maintained in a 
life support system at 28 °C.  Embryos were staged according to standard criteria as 
described (Kimmel et al., 1995). 
 
2. Isolation of total RNA and genomic DNA 
2.1 Total RNA 
Total RNA was isolated from 24 hpf embryos using the RNAWIZ™ kit (Ambion) and 
TRIzol reagent (Invitrogen). The embryos were placed immediately in liquid nitrogen. 
About 50-100 μl of tissue sample was homogenized in 1 ml of TRIzol reagent 
(Invitrogen) with a plastic pestle. The extraction procedures followed the 
manufacturer’s protocol. RNA pellets were air dried and then dissolved in 20 μl of 
diethylpyrocarbonate (DEPC, Sigma) treated water. To determine the concentration 
and purity, total RNA was diluted in water and pH 7.5 TE (10 mM Tris-Cl, pH 7.5 1 
mM EDTA) buffer, respectively. The absorbencies at 260 nm and 280 nm were 
measured with a UV-visible spectra-photometer (Pharmacia LKB-Ultrospec III or 
Beckman Coulter DU 800). The absorbency 1.0 of RNA in water indicated a 
concentration of 40 μg/ml. The ratio of absorbencies of RNA in pH 7.5 TE buffer at 
260 nm to OD at 280 nm indicated the purity of RNA: 1.8~2.1 for pure RNA; less 
than 1.8 for protein contaminated RNA. 
 
2.2 Genomic DNA 
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Male adult fish were frozen in liquid nitrogen, packaged with aluminum foil and 
hammed to powder. Each fish fresh was homogenized in 10 ml of genomic DNA 
extraction buffer (10 mM Tris.Cl pH 8.0, 100 mM EDTA, 0.5% sodium dodecyl 
sulfate (SDS) and 200 μg/ml proteinase K (Sigma)). The mixture was gently shaken at 
50°C for 4 hours. The solution was extracted with phenol twice, phenol/chloroform 
once by being centrifuged at 3000-5000 g for 10 min. The supernatant was taken out. 
The brown color genomic DNA was precipitated with 200 mM NaCl2 and 2 volumes 
of ethanol. The DNA was washed with 70% ethanol, air-dried and dissolved in 5 ml 
of TE buffer and treated with 100 μg/ml RNAse A (Sigma) at 37°C for 3 hours. The 
solution was extracted with phenol/chloroform once to remove the RNAse A. The 
DNA was precipitated with NaOAc and ethanol. The air-dried pellet was dissolved in 
TE buffer, aliquoted and stored at -20°C. The concentration was measured with 
spectra-photometer. The absorbency 1.0 of DNA in water indicated a concentration of 
50 μg/ml. 
 
3. Full-length cDNA cloning 
3.1. Rapid amplification of completementary DNA ends (RACE)  
A 709 bp 5’ expressed sequence tag (EST) clone containing putative zebrafish irf6 
cDNA sequence (GenBank accession no. AW422721) was identified by BLAST 
(Basic Local Alignment Search Tool) query of GenBank using human IRF6 cDNA 
(GenBank accession no. NM_006147).  Based on the sequence of AW422721, 
primers were designed for the RACE experiments to identify additional 5’ and 3’ 
cDNA sequences.  Both the 5’ and 3’ RACE experiments were performed using the 
SMART™ RACE cDNA amplification kit (BD Biosciences Clontech).  Two non-
overlapping reverse primers complementary to the 5’ region of the EST sequence 
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(5IRFr2: 5’-AGCCAGACCAGCCCAGGAAACGTAG-3’ and 5IRFr1: 5’-
TGAGAGACCAGCCAGGGCTTCAGAC-3’) were designed for nested 5’ RACE.  
Similarly, two non-overlapping forward primers complementary to the 3’ region of 
the EST sequence (3IRFf2: 5’-AACAAGAGTCGCGAGTTCAACCTC-3’ and 
3IRFf1: 5’-CATACGAGACGGATGGAGATGAAGAC-3’) were designed for nested 
3’ RACE.  The PCR conditions for both RACEs were: 5 cycles of 94°C for 10 sec and 
72°C for 3 min, and then 5 cycles of 94°C for 10 sec, 70°C for 20 sec and 72°C for 3 
min, followed by 25 cycles of 94°C for 10 sec, 68°C for 20 sec and 72°C for 3 min. 
PCR products were detected on agarose gel and shown in Figure 2.1. Sequencing was 
carried out using the BigDye™ kit on an ABI 3100 Genetic Analyzer (Applied 
Biosystems). 
AW422721:
    1 GAGGGTGAAA CTCTCGAGCA GAGATTCAGA CACACATGAA ACTCAGTTTC ACACACTTTC 
   61 ACACGGACAC ACGGATATTC TGCGAGTCGT ATCTCTCACC TGTGACTGAC ATACACAGAC 
  121 ATTAAACACG TTTATTCATA AAAACCGTTC GTTTTGGCGG CAAAGGCCTC AGGAGTGCTG 
  181 CCTTTTCCTG CTTTGACGCG AGCGCTTCCT GAAACCCTCA GCCGGTGTGA TGTCGTCTCA 
  241 TCCACGGCGT GTGCGTCTGA AGCCCTGGCT GGTCTCTCAG GTGGACAACG CTACGTTTCC 
                            5’IRFr1                           5’IRFr2 
 
  301 TGGGCTGGTC TGGCTGGATA GAGACGCCAA ACGCTTCCAG ATCCCCTGGA AACACGCAAC 
 
  361 ACGACACACA CCGCAGCAGG AGGAGGAGAA CACCATCTTT AAGGCCTGGG CAGTGGAGAC 
  421 GGGGAAGTAT CAGGAAGGAG TGGATGAACC GGATCCAGCT AAATGGAAAG CGCAGCTCAG 
  481 ATGTGCTTTA AACAAGAGTC GCGAGTTCAA CCTCATCTAC GACGGCACGA AAGAGGTTCC 
                           3’IRFf2 
  541 CATGAACCCG CTGAAGATCT ATGATGTGTG TGACATCCCA CAGACGCCCA GCAACCCTGG 
  601 TTCAGTTCCC ACATACGAGA CGGATGGAGA TGAAGACGAC ATCCCAGACA CTCCTGAACC 
                           3’IRFf1 
  661 TCCTCCACCA TATGCATCAC ATGGCATGAG TGCGTCTCCT CTGGCTGCG  
 
3.2. Assembly of the sequences of 5’RACE cDNA, AW422721 and 3’ RACE cDNA 
with vector NTI.  
5’RACE cDNA: 
    1 ATTCAGAGAA ATGCCCGTGA CGTCATCGCT GTACCTGAGT TTCGGCAGAG GGTGAAACTC 
              FL-IRFf 
   61 TCGAGCAGAG ATTCAGACAC ACATGAAACT CAGTTTCACA CACTTTCACA CGGACACACG 
  121 GATATTCTGC GAGTCGTATC TCTCACCTGT GACTGACATA CACAGACATT AAACACGTTT 
  181 ATTCATAAAA ACCGTTCGTT TTGGCGGCAA AGGCCTCAGG AGTGCTGCCT TTTCCTGCTT 
  241 TGACGCGAGC GCTTCCTGAA ACCCTCAGCC GGTGTGATGT CGTCTCATCC ACGGCGTGTG 
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  301 CGTCTGAAGC CCTGGCTGGT CTCTCA 
           5’IRFr1 
 
3’RACE cDNA: 
    1 CATACGAGAC GGATGGAGAT GAAGACGACA TCCCAGACAC TCCTGAACCT CCTCCACCAT 
     3IRFf1 
   61 ATGCATCACA TGGCATGAGT GCGTCTCCTC TGGCTGCGGT CTGGACTCCT CCAGGCTCCG 
  121 TGTCTCCTCT TCAGCCGTCC AGTTGTGCTC CTCCTCCTGC TCTTCCTCCT CCCCCTGCTC 
  181 TTCCCCCTCC GGCCGCCACC GTTCTTCCGG CCGCCGCCGC TCCTCCTGCT AATGTTTGGC 
  241 CCAAGAAGGA GCCGGAGGAC GTGGAGATGC AGCCGCCCCC CATGGAGATA CAGACGCCCA 
  301 CCGCTCTCGA CAACCTGTTC ATCACGCCGG AGACCTGGAT CAGCTCTCTG CCCATGACGG 
  361 ATCTGGAGGT GCAGTTCTAC TACCGCGGTA AAGAGGTGTG TCCCCCATTG ACGGTCAGTA 
  421 ACCCGCAGGG CTGTCGTCTG TTTTACGGGG ACCTGGGCCC CATAGTGAAC CAAGAGGAGC 
  481 TGTTCGGCCC CGTGAGCCTG GAGCAGGTGC GCTTCCCGCC CACAGAGCAC ATCGCTAACG 
  541 ATAAGCAGCG CGTGTTCACT AGCCGGCTGC TGGACGTGAT GGACCGCGGG CTCATCCTGG 
  601 AGGTCAGCGG GCACGACATC TACGCCGTGC GCCTCTGCCA GTGTAAGGTG TACTGGTCCG 
  661 GTCCCTGCGC CCCCAACCCA AACGCTCCCA ACCTGATCGA GCGCCAGCAA AAGGTCAAGC 
  721 TCTTCTGCCT CGAGTCCTTT CTCAGCGGGG TGATCACTCA TCAGCGTGGT CAGTCTTCTG 
  781 ATGCTCCTCT TTATGATATT CACTTGTGTT TTGGAGAGGA GTGGCCCGAC GGTCGACCCC 
  841 GAGAGCGCAA ACTCATCATG GTGCAGGTGG TTCCAGTAGT GGCTCGTATG ATCAGCGAGA 
  901 TGTTCTCCGG CGACTGCACA CGTTCCTTCG ACAGCGGCAG TGTGCGTCTG CAGATCTCCA 
  961 TCCCGGATAT TAAAGACAAC ATCGTGACGC ACCTGAAGCA GCTGTACCGG CTCCTGCAGA 
 1021 CGCACCAGGG GCCCGAGAAC TGGCCGCTGC CACCCGGGGC CGCCCTGCAG CTCTCCTCCG 
 1081 CCCTGCACAC GCAGTAACGC TCATCACACA CACGCTTTTA TACACACTTC TGTGTGTGTG 
 1141 TGTGTTTAGT AGAGTGTCGG TTTATGTTTG AGTAAGTGTG TGTTTTGTGT ATGCGTTTGT 
 1201 GTGTGTGTGT GTGTTTGTAT GTTTGTTTAT GTGTGTTGGT TTTTGTCTGT GTATGTGTGT 
 1261 GTGTTGTGTA TGCATTTGTG TAAGTTCGTG TTTGTAAATT TGTGTGTGTG TGTTTTGTGT 
 1321 GTGTAAGTTT GTGGGTGTGT TTTGTTTGTG TGTGTTTGTG TGTGTTGGTT TTTGTCTGTT 
 1381 TATGTGTGCA TGTGTGTGTT TTGTGTATGC ATTTGTGTAA GTTTGTAAAT TTGTGTGTGT 
 1441 GTGTGTGTGT GTGTGTGTGT ATGTAAGTTT GATTATGTGT GTGTTTGGTT TTTGTCTGTT 
 1501 TGTTTTGTGC ATGCATTACT TTGTGTGTGT GTGTGTGTCT ATTTGAGTTG TGTGTGTTAC 
 1561 TTTTATACAC GCTTTTGTGT TTTTACTGCA GACGTATGTT ACGCCATTAT TATCCTCCGC 
 1621 CACTTCTGTT TATTCTCCTG CTTCCGCTGT GAAGATCTCG TCGTTCGTTT GTGTTTGTCT 
 1681 TTATTTTATA GCGTGTTCCT GTGTTTGATG TGCTAGTGTG TAGATTTGTC CCGTAATGTA 
                                                  FL-IRFr1 
 1741 TGGATTTATA AATACAAATA AAAAAAAGAA AAACAAAAAA AAAAAAAAAA AAAAA 
 
Full-length cDNA: 
1 ATTCAGAGAA ATGCCCGTGA CGTCATCGCT GTACCTGAGT TTCGGCAGAG GGTGAAACTC 
   FL-IRFf 
   61 TCGAGCAGAG ATTCAGACAC ACATGAAACT CAGTTTCACA CACTTTCACA CGGACACACG 
  121 GATATTCTGC GAGTCGTATC TCTCACCTGT GACTGACATA CACAGACATT AAACACGTTT 
  181 ATTCATAAAA ACCGTTCGTT TTGGCGGCAA AGGCCTCAGG AGTGCTGCCT TTTCCTGCTT 
  241 TGACGCGAGC GCTTCCTGAA ACCCTCAGCC GGTGTGATGT CGTCTCATCC ACGGCGTGTG 
  301 CGTCTGAAGC CCTGGCTGGT CTCTCAGGTG GACAACGCTA CGTTTCCTGG GCTGGTCTGG 
  361 CTGGATAGAG ACGCCAAACG CTTCCAGATC CCCTGGAAAC ACGCAACACG ACACACACCG 
  421 CAGCAGGAGG AGGAGAACAC CATCTTTAAG GCCTGGGCAG TGGAGACGGG GAAGTATCAG 
  481 GAAGGAGTGG ATGAACCGGA TCCAGCTAAA TGGAAAGCGC AGCTCAGATG TGCTTTAAAC 
  541 AAGAGTCGCG AGTTCAACCT CATCTACGAC GGCACGAAAG AGGTTCCCAT GAACCCGCTG 
  601 AAGATCTATG ATGTGTGTGA CATCCCACAG ACGCCCAGCA ACCCTGGTTC AGTTCCCACA 
  661 TACGAGACGG ATGGAGATGA AGACGACATC CCAGACACTC CTGAACCTCC TCCACCATAT 
  721 GCATCACATG GCATGAGTGC GTCTCCTCTG GCTGCGGTCT GGACTCCTCC AGGCTCCGTG 
  781 TCTCCTCTTC AGCCGTCCAG TTGTGCTCCT CCTCCTGCTC TTCCTCCTCC CCCTGCTCTT 
  841 CCCCCTCCGG CCGCCACCGT TCTTCCGGCC GCCGCCGCTC CTCCTGCTAA TGTTTGGCCC 
  901 AAGAAGGAGC CGGAGGACGT GGAGATGCAG CCGCCCCCCA TGGAGATACA GACGCCCACC 
  961 GCTCTCGACA ACCTGTTCAT CACGCCGGAG ACCTGGATCA GCTCTCTGCC CATGACGGAT 
 1021 CTGGAGGTGC AGTTCTACTA CCGCGGTAAA GAGGTGTGTC CCCCATTGAC GGTCAGTAAC 
 1081 CCGCAGGGCT GTCGTCTGTT TTACGGGGAC CTGGGCCCCA TAGTGAACCA AGAGGAGCTG 
 1141 TTCGGCCCCG TGAGCCTGGA GCAGGTGCGC TTCCCGCCCA CAGAGCACAT CGCTAACGAT 
 1201 AAGCAGCGCG TGTTCACTAG CCGGCTGCTG GACGTGATGG ACCGCGGGCT CATCCTGGAG 
 1261 GTCAGCGGGC ACGACATCTA CGCCGTGCGC CTCTGCCAGT GTAAGGTGTA CTGGTCCGGT 
 1321 CCCTGCGCCC CCAACCCAAA CGCTCCCAAC CTGATCGAGC GCCAGCAAAA GGTCAAGCTC 
 1381 TTCTGCCTCG AGTCCTTTCT CAGCGGGGTG ATCACTCATC AGCGTGGTCA GTCTTCTGAT 
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 1441 GCTCCTCTTT ATGATATTCA CTTGTGTTTT GGAGAGGAGT GGCCCGACGG TCGACCCCGA 
                                                              3IRF-pbr1 
 
 1501 GAGCGCAAAC TCATCATGGT GCAGGTGGTT CCAGTAGTGG CTCGTATGAT CAGCGAGATG 
 1561 TTCTCCGGCG ACTGCACACG TTCCTTCGAC AGCGGCAGTG TGCGTCTGCA GATCTCCATC 
 1621 CCGGATATTA AAGACAACAT CGTGACGCAC CTGAAGCAGC TGTACCGGCT CCTGCAGACG 
 1681 CACCAGGGGC CCGAGAACTG GCCGCTGCCA CCCGGGGCCG CCCTGCAGCT CTCCTCCGCC 
 1741 CTGCACACGC AGTAACGCTC ATCACACACA CGCTTTTATA CACACTTCTG TGTGTGTGTG 
 1801 TGTTTAGTAG AGTGTCGGTT TATGTTTGAG TAAGTGTGTG TTTTGTGTAT GCGTTTGTGT 
 1861  GTGTGTGTGT GTTTGTATGT TTGTTTATGT GTGTTGGTTT TTGTCTGTGT ATGTGTGTGT 
 1921 GTTGTGTATG CATTTGTGTA AGTTCGTGTT TGTAAATTTG TGTGTGTGTG TTTTGTGTGT 
 1981 GTAAGTTTGT GGGTGTGTTT TGTTTGTGTG TGTTTGTGTG TGTTGGTTTT TGTCTGTTTA 
 2041 TGTGTGCATG TGTGTGTTTT GTGTATGCAT TTGTGTAAGT TTGTAAATTT GTGTGTGTGT 
 2101 GTGTGTGTGT GTGTGTGTAT GTAAGTTTGA TTATGTGTGT GTTTGGTTTT TGTCTGTTTG 
 2161 TTTTGTGTGT GTGTATGTGT GTGTGTGTGT TTATGTGTCT GCTTGAGTGT GTATGTTTGT 
 2221 GTGTGTGTGT CTGCTTGATT TTTGGTTTGT GTGTATGTTT GTGTGTGCGT GCGTGTGAGT 
 2281 GTCTGTTTTG TTTTGTCTGT GTGTGCGTGT TTTGTGAATG ATTTGTGCTT GTGTATATGT 
 2341 GTGTCTCTGT GTTTGTGTCT GAGTTCATTT GAGTGTTGGT TTGTGTGTGT GTGTGTGTGT 
 2401 TTTGTATGCG TTTGCTTGCT TGTGTGTGTG CGTGTGTGTG TATATACTGT ATGTGTGTGT 
 2461 TTTGTGCATG CATTACTTTG TGTGTGTGTG TGTGTCTATT TGAGTTGTGT GTGTTACTTT 
 2521 TATACACGCT TTTGTGTTTT TACTGCAGAC GTATGTTACG CCATTATTAT CCTCCGCCAC 
 2581 TTCTGTTTAT TCTCCTGCTT CCGCTGTGAA GATCTCGTCG TTCGTTTGTG TTTGTCTTTA 
 2641 TTTTATAGCG TGTTCCTGTG TTTGATGTGC TAGTGTGTAG ATTTGTCCCG TAATGTATGG
                                                   FL-IRFr1 
 2701 ATTTATAAAT ACAAATAAAA AAAAGAAAAA CAAAAAAAAA AAAAAAAAAA AA 
  
 
The primer sites for amplification of the cDNA that was used as the template to 
synthesize RNA probe are in bold letters. 
 
3.3. Full-length cDNA isolation 
Full-length cDNA amplification was carried out using Advantage–HF2 PCR Kit 
(Clontech). The template was 5’-RACE CDS cDNA of 24 hpf embryos. The reaction 
conditions consisted of 25 cycles of 94°C for 30 sec, 62°C for 30 sec and 72°C for 3 
min. After 25 cycles, the reaction was incubated at 72°C for 5 min, and then paused at 
16 °C. The reaction was carried out on a Biometra T3 Thermocycler. PCR product 
was detected on agarose gel (Figure 2.1). PCR products were cloned into pBlueScript 







3.4. irf6 probe synthesis 




Figure 2.1. Amplification of 
irf6 cDNA from AB line 
zebrafish embryos at the age 
of 24 hpf old. The expected 
sizes of bands (kb) are 
indicated with arrows. M: 1 
kb DNA ladder (Fermentus). 
The bands were amplified 
with primers 5’IRFr1 and 
NUP (lane 1),  5’IRFr1 and 
UPM (lane 2), 5’IRFf2 and 
NUP (lane 3), 3’IRFf1 and 
NUP (lane 4), 3’IRFf1 and 
UPM (lane 5), 3’IRFf2 and 
NUP (lane 6), and FL-IRFf 
and FL-IRFr1 (lane 7). 
A 1.5 kb cDNA fragment corresponding to the 5’ UTR and the partial coding region 
of irf6 (nucleotides 1 to 1509) was used as the template for the synthesis of 
digoxigenin-labeled RNA probes.  After amplification with FL-IRFf and 3IRFr1, this 
1.5 kb cDNA sequence was first subcloned into the pBlueScript II KS (+) vector.   
 
4. Phylogenetic analysis 
The open reading frame (ORF) and Translate functions of the Vector NTI (version 7.1) 
software package (Informax) were used to identify the translated amino acid sequence 
of the irf6 cDNA.  Inter-species sequence comparisons and similarity calculations 
were performed using the AlignX function in Vector NTI.  The IRF6 peptide 
sequence was aligned against the known IRF family members of various organisms 
using CLUSTAL X (version 1.81) (Thompson et al., 1997).  Phylogenetic trees were 
created from the Clustal X output using PAUP *4.0b10 (Swofford, 2002).   
 
5. Promoter cloning 
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The genomic segments upstream of the irf6 transcription start site, and containing the 
putative promoter of irf6 gene, were isolated from zebrafish genomic DNA using 
Universal GenomeWalker™ kit (BD Biosciences Clontech). The blunt end restriction 
enzymes applied to construct the GenomeWalker libraries included DraI, EcoRV, 
PvuII, SspI, HinCII, PmaCI, SmaI, SnaBI and StuI. Two non-overlapping reverse 
primers complementary to 5’ UTR (5IRFr5: 5’-
TGTCTGAATCTCTGCTCGAGAGTTTCAC-3’ and 5IRFr7: 5’-
CAGCGATGACGTCACGGGCATTTCTCTG-3’) were designed for the upstream 
genome walking experiment. The most upstream of genomic DNA, was amplified 
from the GenomeWalker library by SnaBI digestion (Figure 2.2). The sequence of this 

















   
   
   
































   
   
   


















Figure 2.2. Amplification of the putative irf6 promoter fragments using Universal 
GenomeWalker™ kit.  The blunt-end restriction enzymes marked above the gel bands 
were used to digest the genomic DNA.  
 
 6. Identification of genomic structure 
The zebrafish irf6 cDNA sequence was used in a BLAST query of the Ensembl 
database for Danio rerio (version14.2.1; www.ensembl.org). The genomic contigs 
that cover irf6 gene were NA7065.1 (exon 2), ctg24987.2 (exons 3 and 4), NA5667.1 
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(exons 5 to 8), and NA14600.1 (exon 8).  The genomic DNA sequences of these 
subcontigs were aligned against the irf6 cDNA sequence. Putative exon/intron 
junctions were identified by observing genomic sequence divergence from cDNA 
beginning with a GT dinucleotide (splice acceptor sites) or ending with an AG 
dinucleotide (splice donor sites) (Figure 2.3A).   
 




   
   
   
   
   
   
   














































































   
   
   
   
   
   
   




































   
   
   
   
   
   
   









































































































Figure 2.3.  Diagram of the putative genomic structure and the PCR detection of 
exon-intron junction using primers. (A) The exons are shown in rectangle. The introns 
are marked with line. The coding region is in grey color. The paired primers and 
targeted regions are highlighted in grey blocks. The primers failed to amplify the 
genomic fragments are crossed. (B) PCR of genomic DNA using exon-exon or exon-
intron or intron-exon primers. 
 
The putative introns 1, 2, 3, 4, 5, 6, 7 and 8 were cloned by PCR of genomic DNA 
using exon-to-exon primers using Hot Start Taq polymerase (Qiagen). The reactions 
were set with 95°C for 15 min, 35 cycles of 94°C for 30 sec, annealing temperature 
for 30 sec and 72°C for 5 min. After 35 cycles, the reaction was incubated at 72°C for 
5 min, and then paused at 16°C. For every reaction, 100 ng of genomic DNA was 
used as the template. The annealing temperatures were set according to the Tm of 
primers. The PCR products were detected on agarose gel (Figure 2.3B). The bands 
were extracted with GFX PCR, DNA and Gel Band Purification Kit (Amersham). The 
extracted DNA samples were sequenced using the BigDye™ kit on an ABI 3100 
Genetic Analyzer (Applied Biosystems). 
 
Table 2.1. Primer pairs for PCR detection of introns. 
Amplicons Primer sequences 5’ to 3’ Annealing temperature 
and PCR band sizes 
E1f CAA-AGG-CCT-CAG-GAG-TGC-TGC 
E2r CAG-GAA-ACG-TAG-CGT-TGT-CCA-CC 





60/65°C, a band 
between 1.1 kb 
E3f CAC-GAA-AGA-GGT-TCC-CAT-GAA-CC 
E4r GTT-CAG-GAG-TGT-CTG-GGA-TGT-CG 




















63°C, a band at 1.0 kb 
E4f5’ GTT-CAG-TTC-CCA-CAT-ACG-AGA-CG 
Int4r GGA-CCA-ATG-AGA-GTT-TGA-CCA-TG 
63°C, a band at 0.1 kb 
I4f3up TGA-CCG-GTA-GTT-TAG-TTA-GCT-ATG 
E5r3’ GCG-TGA-TGA-ACA-GGT-TGT-CG 
63°C, a band between 
0.3 and 0.4 kb 
E7f5’ GTG-ATC-ACT-CAT-CAG-CGT-GGT-CAG 
Int7r TCG-CTA-CTG-ACT-TCA-GTA-ATC-G 




60°C, a band of 1.2 kb 
 
7. Chromosome mapping 
The sequence of the 5’UTR and its adjoining upstream genomic region were 
submitted to http://zfrhmaps.tch.harvard.edu/ZonRHmapper/ for locus mapping on the 
Goodfellow T51 radiation hydrid panel.  A pair of primers, 5IRFf1: 5’-
GTACCTGAGTTTCGGCAGAGGGTGAAAC-3’ and 5IRFr8:  5’-
CTGAGGGTTTCAGGAAGCGCTC-3’, was used to amplify a fragment from 
nucleotides +31 to +268 of the 5’UTR (transcription start site = nucleotide +1).  
Mapping was also performed with a second pair of primers, 447U24 (forward): 5’-
CGTGCCTGTTTGTGTGCGCGTGAT-3’ and 578L24 (reverse): 5’-
CTCGCAGAATATCCGTGTGTCCGT-3’, which was used to amplify an 
overlapping genomic fragment from nucleotides -22 to +133. 
 
8. Synthesis of RNA probes for in situ hybridization analysis 
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8.1. Linearization of plasmids 
Plasmid DNA was digested with the restriction enzyme. The digested products were 
checked with agarose gel electrophoresis. The linearized plasmids were purified using  
phenol/chloroform/isoamyl (25:24:1) extraction and chloroform/isoamyl (24:1) 
extraction, respectively. In the following steps, all reagents, tips and tubes were 
RNase free. The upper phase was transferred to a fresh tube. The nucleic acid in the 
aqueous phase was mixed with 0.1 volume of 3M sodium acetate (pH5.2), 2.5 
volumes of cold absolute ethanol and 20 μg glycogen (Invitrogen) and stored at -20 
°C for 20 min. The solution was centrifuged at 13,000 rpm for 20 min. The 
supernatant was decanted. The pellet was washed with 250 μl of cold 70% ethanol 
and centrifuged at 13,000 rpm for 10 min. The supernatant was decanted. The pellet 
was air-dried and resuspended in 0.1% DEPC water. 
 
8.2. RNA labeling with DIG RNA labeling kits (SP6/T7/T3; Roche)  
One μg of linearized plasmid was mixed with 2 μl of 10XNTP Digoxenin or 
Fluorescein-labeling mixture, 2 μl of 10X transcription buffer, 1 μl of RNase inhibitor 
and 2 μl of RNA polymerase. The final volume was 20 μl. The reaction was incubated 
at 37°C for 2 hours. DNA plasmid was degraded by adding 2 μl of DNase I (Roche) 
at 37°C for 1 hour.  
 
8.3. Purification of RNA probe 
The RNA was precipitated with 10 μl of 10M ammonium acetate and 60 μl of 
absolute ethanol at -85°C for 30 min. The mixture was centrifuged at 13,000 rpm and 
4°C for 30 min. The pellet was washed with 300 μl of cold 70% ethanol, air-dried and 
re-suspended in 70 μl of DEPC water. The RNA probe was further purified using 
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Chroma Spin-100 column (Clontech). The procedure followed the manufacturer’s 
protocol. The 3 μl of RNA probe was checked with a gel electrophoresis. The RNA 
probe was kept at -85°C.  
 
9.  Whole mount RNA in situ hybridization 
Paraformaldehyde (Sigma) was dissolved at 70°C in PBST (8 g of NaCl, 0.2 g of KCl, 
1.44 g of Na2HPO4 and 0.24 g of KH2PO4, at pH7.4; 0.1% of Tween 20) at the 
concentration of 4%. Embryos at no later than 26-somite stage were fixed in their 
chorions in 4% paraformaldehyde for overnight at 4°C. The fixed embryos were 
washed with PBST twice for 5 min each at room temperature followed by 
dechorionation. The embryos from pharyngula period (prim-5) were fixed after 
dechorionation.  After washes with PBST, the embryos were dehydrated three times 
for 5 min each in absolute methanol. The dehydrated embryos were stored in 
methanol at -20 °C. 
 
The embryos were subsequently rehydrated in 75% methanol/25% PBST, 50% 
methanol/50% PBST, 25% methanol/75% PBST, and 4 times of 100% PBST, each 
for 5 min. 
 
Protein digestion with proteinase K was to facilitate the penetration of RNA probe 
into tissue and cells. The embryos younger than somite stage were not treated with the 
proteinase K digestion. The embryos after somite stage were digested with proteinase 
K in PBST at 5 or 20 μg/ml. The digestion periods were according to their stage at 
room temperature: embryos at 1 dpf old were treated with proteinase K at 5 μg/ml 
concentration for 12 min; embryos at 2 dpf old were treated at 5 μg/ml for 23 min; 
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embryos at 3 dpf old were treated at 20 μg/ml concentration for 20 min; and embryos 
at 5 dpf old were treated at 20 μg/ml for 30 min. The digestion was terminated with 
4% paraformaldehyde for 20 min. The embryos were then washed with PBST five 
times for 5 min each. 
 
Prehybridization was performed by soaking the embryos into hybridization buffer 
(50-65% formamide (Merck), 5X SSC (150 mM NaCl and 15 mM sodium citrate), 
500μg/ml yeast RNA (Sigma), 50μg/ml heparin (Sigma), and 0.1% Tween 20, adjust 
to pH7.0 with 1M citric acid) for 2 hours at 55-70°C. Hybridization was performed by 
transferring the prehybridized embryos into hybridization buffer containing 500 ng/ml 
labeled RNA probe. The embryos were shaken overnight at the same temperature as 
prehybridization. The formamide concentration and the hybridization temperature 
were set according to the probe length and the specificity. 
 
After hybridization, embryos were subsequently washed at hybridization temperature 
with 50 or 60 % formamide/ 2XSSC, 37.5 or 45% formamide/2XSSC, 25 or 30% 
formamide /2XSSC, 12.5 or 15% formamide/2XSSC, 2XSSC for 10 mins each; and 
0.2XSSC/0.1% Tween 20 twice for 30 min each. Embryos were then washed at room 
temperature with 0.15XSSC/PBST, 0.1XSSC/PBST and 0.05XSSC/PBST for 10 min 
each. 
 
The hybridized embryos were blocked with a buffer containing 2% of Boehringer 
Blocking Reagent and 150 mM NaCl for at least 1 hour. Then the embryos were 
incubated in 1:4000 dilution of anti-Digoxenin (Roche) or 1:2500 dilution of anti-
Fluorescein Fab (Roche) in blocking reagent overnight at 4°C. The embryos were 
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washed four times with maleic acid buffer (150 mM maleic acid (Sigma) and 100 mM 
NaCl) for 20 min each.  
 
The embryos were washed in alkaline phosphatase buffer (100 mM Tris.HCl at pH9.5 
or pH8.2, 50 mM MgCl2, 100 mM NaCl and 0.1% Tween 20) three times for 5 min 
each. The embryos were incubated in the substrate solution to develop the color 
signals in the dark at room temperature. Three types of substrates were applied in the 
analyses NBT/BCIP substrate was used for the detection of anti-Dig-AP Fab 
fragments. 4.5 μl of NBT (4-Nitroblue tetrazolium chloride at 100 mg/ml in 
dimethylformamide; Roche), and 3.5 μl of BCIP (5-Bromo-4-chloro-3-indolyl-
phosphate at 50 mg/ml in dimethylformamide; Roche) were added in 1 ml of alkaline 
phosphatase buffer. The staining buffer was replaced with fresh-made substrate 
solution when turning purple. The second substrate was BM-purple (Roche), also for 
the detection of anti-Dig-AP Fab fragments. The commercial product was directly 
applied to stain the embryo. The third substrate was Fast Red (Roche), to detect anti-
Fluorescein-AP Fab fragments. One tablet of Fast-red was dissolved in 4 ml of 
alkaline phosphatase buffer (100 mM Tris.HCl at pH8.2, 50 mM MgCl2, 100 mM 
NaCl and 0.1% Tween 20). The Fast Red solution was centrifuged to remove the 
particles. In another tube, 40 µl of NAMP stock (naphthol-AS-MX-phosphate, Sigma; 
dissolved in dimethyl sulfoxide at a concentration of 50 ng/ml) were added in 4ml of 
Alkaline Phosphatase buffer (pH8.2). The Fast Red solution was prepared by mixing 
the two solutions together. The embryos were stained at room temperature until the 
desired signal was developed. The staining did not exceed 48 hours.  
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For double-color in situ hybridization, both RNA probes (Dig-labeled and 
Fluorescein-labeled) were added into the hybridization buffer to soak the embryos 
overnight. After washing and blocking step, the embryos were incubated with the first 
antibody, either anti-Fluorescein Fab or anti-Dig Fab. When the first color detection 
was completed, the staining was stopped by rinsing the embryos five times in PBST 
for 5 min each. The embryos were incubated in 0.1 M Glycine (pH2.2, Sigma) to 
inactivate the first antibody. The embryos were washed with maleic acid buffer three 
times for 5 min each. Embryos were blocked with the blocking reagent again, 
following by the incubation with the second antibody, washing and color detection. 
 
When coloration was developed, the staining was stopped by rinsing the embryos 
twice in PBST for 5 min each and the embryos were re-fixed in 4% paraformaldehyde. 
The stained embryos were stored in 4% paraformaldehyde. 
 
Table 2.2. Syntheses of RNA probes and in situ hybridization conditions. 
Plasmids for RNA probe 
preparation 
RNA polymerase and 
restriction enzyme for 
linearization 
In situ hybridization 
conditions 
irf6 Antisense: T3 and PstI 
Sense: T7 and Hind III 
65% formamide, 68 ºC 
dlx3 T7 and Sal I 60% formamide, 68ºC 
foxA1 T3 and EcoRI 50% formamide, 68ºC 
nkx2.3 T7 and Xba I 50% formamide, 68ºC 
L-fabp T3 and EcoRI 50% formamide, 68ºC 
trypsin T3 and EcoRI 50% formamide, 68ºC 
insulin SP6 and Nco I 50% formamide, 68ºC 
gata-1 T7 and Xba I 50% formamide, 68ºC 
βE-globin T7 and Xba I 50% formamide, 68ºC 
prox1 Sp6 and SmaI 65% formamide, 68ºC 
ntl T7 and BamHI 65% formamide, 68ºC 
 
 
11. Cryosection  
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Analysis of tissue sections was carried out by embedding each fixed and stained 
embryo in an agar block which was trimmed into a “pyramid” shape and immersed in 
30% sucrose solution for overnight incubation at 4°C.  The blocks were cryosectioned 
at 10-20 μm thickness using a cryostat (Leica or Zeiss).  The sections were overlaid 
onto poly-lysine coated slides and air-dried overnight.   
 
For the specimens ready for direct detection under microscope, the air-dried slides 
were then washed in 1X PBS solution for three times at 5 min each wash.  One to two 
drops of 50% glycerol/1X PBS solution were added to each washed slide and the 
sections were then covered by a large coverslip. 
 
Alternatively the air-dried slides were kept for later hematoxylin and eosin staining. 
 
12. Paraffin section 
The embryos were fixed with 4% PFA/PBS and dehydrated with increasing 
concentrations of ethanol (50%, 70% and 90%) for 30 min each, and 100% ethanol 
three times for 20 min each. The embryos were put in Xylene twice for 5 min each, 
followed by soaking in paraffin (Sigma) three times for 5 min each. Then, the 
embryos were embedded in paraffin and sectioned at the thickness of 5 μm.  
 
13. H and E staining 
Hematoxylin (H) is a blue-purple basophilic dye to stain nucleic acids. In cells, this 
dye binds to ribosomes, chromatin-rich nucleus and RNA. Eosin is an alcohol-based 
pink-orange acidic dye to stain the intracellular and extracellular proteins. 
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After cryosection, the section slides were soaked into 95% ethanol/5% glacial acetic 
acid solution for 1 min for fixation. The slides were put into hematoxylin (Merck) for 
1 to 1.5 min, and rinsed with Tap water. The nuclear staining with hematoxylin was 
differentiated with 1% HCl (1 ml of concentrated HCl + 99 ml 75% ethanol) for a few 
sec. The slides were rinsed with Tap water and neutralized in ammonia water for less 
than 30 sec, and rinsed with Tap water again. The slides were stained with Eosin  
(Merck) for 30 sec to 5 min, and then soaked in 90% ethanol until the red color was 
suitable. The slides were dehydrated with 100% ethanol twice for 2 min each. The 
dehydrated slides were put into xylene solution for 2 min, and then transferred into 
another xylene solution for 2 min or longer. The slides were applied with coverslips, 
sealed and air-dried in chemical hood. 
 
For paraffin section, the section slides were de-waxed with xylene twice for 10 min 
each. The xylenes on sections were washed with 100% ethanol twice for 1 min each. 
The slides were rehydrated with 95%, 80%, 70%, 50% ethanol and water for 1 min 
each. Then the sildes were stained with the hematoxylin and eosin as the procedures 
for cryosection slides. 
 
 
For paraffin sections, the section slides were de-waxed with xylene twice for 10 min 
each. The xylenes on sections were washed with 100% ethanol twice for 1 min each. 
The slides were rehydrated with 95%, 80%, 70%, 50% ethanol and water for 1 min 
each. Then the sildes were stained with the hematoxylin and eosin. The procedures 
were the same as those for cryosection slides. 
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14. Head Cartilage Detection with Alcian blue staining 
Alcian blue (Sigma) is a polyvalent-basic dye to stain both sulfated and carboxylated 
acid mucopolysaccharides and sulfated and carboxylated sialomucins (glycoproteins) 
by forming salt linkages with the acid groups of cartilage proteoglycan. The larvae 
were anaesthetized in tricaine solution (0.016% tricaine at pH 7) and transferred into a 
1.5 ml eppendorf tube. The tricaine solution was removed. The larvae were fixed with 
1 ml of 5% trichloroacetic acid (TCA; BDH) for at least 6 hours at room temperature. 
The TCA solution was removed. One ml of 0.1% alcian blue solution (alcian blue in 
70% ethanol/1% HCl) was added for staining overnight. The stained larvae were 
rehydrated in 100% ethanol, 60% ethanol/0.4XPBS, 40% ethanol/0.6XPBS, 20% 
ethanol/0.8XPBS and PBS for 5 min each. The larvae were bleached with 3% 
H2O2/1% KOH for no more than 20 min. The larvae were washed with 0.4% 
KOH/50% glycerol for 1 hour and 0.25% KOH/50% glycerol for overnight.  
 
15. Staining of red blood cells 
15.1 O-dianisidine  
Red blood cells have hemoglobin proteins. When oxygen is present, hemoglobin 
functions a pseudo-peroxidase to oxidize the colorless o-dianisidine to become 
brownish. Embryos were stained for about 15 mins in the dark in the staining solution 
containing o-dianisidine (Sigma) (0.6 mg/ml), 0.01 M sodium acetate, 0.65% H2O2, 
40% (vol/vol) ethanol. Stop staining by washing with PBST. The brownish cells or 
organs indicate the presence of red blood cells.  
 
15.2 Wright’s staining  
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Wright’s stain is used to examine peripheral blood smear and bone marrow aspirate in 
clinlical diagnosis. Stained red blood cells and various white blood cells are visible 
for light microscopy. 
 
0.6 g of Wright’s staining powder (Sigma) was dissolved in 100 ml of methanol and 
stirred overnight and filtered before use. Wright’s staining reagent was prepared by 
mixing the Wright’s solution and one tenth volume of Giemsa’s azure eosin 
methylene blue solution (Merck). Transverse cryosection was performed on the 
zebrafish larvae. The slides were fixed in methanol for 15 min. Slides were stained in 
a closed coplin jar of Wright's staining reagent for 5 min. The slides were placed on a 
rack, rinsed and treated with pH7.2 buffer primed with 1 ml Wright's stain per 400 ml 
for 3 min, followed by being rinsed with pH7.2 buffer for 20 sec. The slides were then 
blot dried, cleared and mounted. Red blood cells were supposed to be stained in red to 
pink. 
 
16. Image processing 
All images were digitally taken using either a DP50 digital camera (Olympus) and 
processed using Adobe Photoshop version 7 software, or a MicroPublisherTM color 




Microinjection was carried out under a dissection microscope (MZ125 or MZ FLIII , 
Leica) by using a FemtoJet  Microinjector (Eppendorf). ®
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18. Knockdown analysis 
18.1  Morpholino injection 
Morpholinos were purchased from Gene Tools LLC (Philomath, OR) and Open 
Biosystems (USA). They were injected into one- to four-cell stage embryos and the 
effectiveness and specificity were titrated at the concentrations of 0.5, 0.65, 0.75, 1.0 
and 2.0 mM in 1X Danieau’s buffer (58 mM NaCl; 0.7 mM KCl; 0.4 mM MgSO4; 
0.6 mM Ca(NO3)2 and 5.0 mM Hepes, pH 7.6). Approximately 2 nl of morpholino 
was injected into one embryo. Three morpholinos were designed to block the 
translation:  
irf6-X, 5’ATGAGACGACATCACACCGGCTGAG (target to from -13 to +12 of 
cDNA, site for start codon ATG is underlined);  
irf6-Y, 5’CGCTCGCGTCAAAGCAGGAAAAGGC (target to from -50 to -26 of 
cDNA);  
irf6-Z, 5’GCACACGCCGTGGATGAGACGACAT (target to from +1 to +25 of 
cDNA). 
For rigorous specificity studies, a 4-base mismatch (indicated in small letters) 
morpholino irf6-Xi in contrast to X was used as the internal negative control:  5’ 
ATGAGgCGACAcCACACtGGCTaAG.  
Two morpholinos were designed to block the nuclear processing-pre-mRNA splicing:
E4I4, 5’gcctattaatctcccatacCATGTG (Exon is indicated in capital letter while intron 
in small letter); E3I3, 5’ctgtgtgtgtgttacCAGGGTTGCT. 
A general morpholino oligo was used as the morpholino toxicity control: STD, 
5’CCTCTTACCTCAGTTACAATTTATA. Another two morpholinos to knockdown 
the dlx3 and sox17 genes are: MO-dlx3, 5’ TGTCGGTCCACTCATCCTTAATAAG; 
MO-sox17, 5’ CGCATCGGGACTGCTCATCTCAAAC.  
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 18.2. Effectiveness and specificity of morpholinos 
The strategy for effectiveness analysis was according to the past report (Zhang et al., 
2004). A plasmid was constructed by inserting the first 502 bp region of irf6, which 
covers the 267-bp 5’UTR and 5’ coding region of irf6, in frame into the pCMV-EGFP 
vector (Clontech). A fused protein 5’irf6-EGFP was supposed to be expressed under 
the CMV promoter. The analyses of the effectiveness of the three ATG-translation 
blocking morpholinos and controls were performed by the co-injection of pCMV-
5’irf6-EGFP at 1 μg/μl and each morpholinos at 0.25 mM, 0.5 mM and 1 mM. The 
brightness of EGFP indicated the knockdown efficiencies.  
 
The specificity was at the beginning determined by rescue experiment. X and Y are 
anti-sense morpholinos to block ATG translation. X is targeted to junction of irf6 5’ 
UTR and coding region, while Y is targeted to 5’ UTR region. A dosage of 6-8 ng of 
either X or Y morpholino resulted in a phenotype with reduced eyes and head and 
bubble-like abdomen. To determine the specificity of knockdown effects, around 6 ng 
of either morpholino was injected into 1 to 2 cell embryos. The 2-4 embryos injected 
with equal amount of morpholino were considered as one group and were divided into 
two subgroups. One subgroup was followed by injection of the 500 pg of irf6 capped 
mRNA transcripts. Each subgroup was transferred into 96-well plate. After 3 dpf, the 
severities of two subgroups in every group were compared and recorded. After 
injection of mRNA, the severity that became milder was considered as rescued, while   




Injection of exogenous mRNA is not able to rescue the knockdown phenotype. The 
time points of endogenous translation of some genes are significant to normal 
development. In this case, exogenous mRNA may disturb the embryonic development. 
Or, when the gene product functions in later embryonic stage, the injected mRNA is 
degraded before the protein initiates its biological function. In these cases, the 
specificity was further judged by the common phenotypes caused by morpholinos X, 
Y and Z, but less present in Xi, and not present in STD. 
 
The knockdown effectiveness of splicing-modified morpholinos was detected by RT-
PCR using exon primers E2f (5’GCTTCCAGATCCCCTGGAAAC) and E5r 
(5’ACTGGACGGCTGAAGAGGAGA). Those phenotypes that were commonly 
present in other irf6 loss of function treatments were considered as specific. 
 
19. Dominant negative perturbation and ectopic expression 
19.1 mRNA preparation and injection 
Point mutations were introduced into the 84th codon of cDNA to convert AGA (Arg) 
to TGT (Cys) by PCR primers. To prepare the capped mRNAs of mutated R84CIrf6 
and wildtype Irf6, the plasmids pT7TS-R84Cirf6 and pT7TS-irf6 were linearized with 
XbaI, and in vitro transcribed using T7 mMessage mMachine Kit (Ambion). Their 
corresponding non-capped mRNA and capped mRNA of EGFP were applied as the 
negative controls. The injected RNA amount was at the dosage of 500 pg. 
 
19.2 Effectiveness 
To detect the effectiveness of translation of capped mRNA, encoded proteins were 
labeled with the TNT® Quick Coupled Transcription/Translation System and 
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FluoroTect. GreenLys in vitro Translation Labeling System (Promega) and detected on 
a 15% SDS PAGE gel with Typhoon 9200 at the 488 nm excitation.  
 
20. Western Blot to detect Irf6 protein 
Western blot analysis was performed to detect the effectiveness of knockdown. 
Embryos were dechoriated with two forceps and rinsed three times in cold Ringer's 
solution (116 mM NaCl, 2.9 mM KCl, 1.8 mM CaCl2, 5 mM HEPES at pH7.2, 1 mM 
EDTA and 0.3 mM phenyl-methyl-sulfonylfluoride (PMSF, Sigma)). Yolks were 
removed by triturating with a glass pipette that has been drawn out to have a tip 
diameter approximately the size of the yolk. The dechorionated and deyolked 
embryos were rinsed with cold Ringer’s solution twice. The solution was removed as 
much as possible from the embryos.  
 
The embryos were frozen in liquid nitrogen and stored at -70°C. Embryos were 
homogenized with ice-cold cell disruption buffer (Protein and RNA Isolation System 
- PARIS, Ambion). The lysates were centrifuged at 16,000 g at 4°C twice for 5 min 
each to remove the cell debris. The clear supernatant was collected and kept on ice for 
Bio-Rad Protein Assay and SDS-PAGE gel electrophoresis.  
 
SDS-PAGE gel was prepared and assembled. The samples of morphant and wildtype 
were loaded into the wells in the amount of 70 μg of protein per lane. The proteins 
were separated in 15% resolving gel. Precision plus protein dual colored standard 
(BioRad) was used as the marker.  After running SDS-PAGE electrophoresis, the 
proteins were transferred from gel to Immuno-Blot PVDF membrane (BioRad) by 
semi-dry transfer cell (TRANS-BLOT SD, BioRad). 
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 The transferred membrane was used for immunoblotting. The primary antibodies 
were: Rabbit polyclonal antibody for epitope Irf6 peptide, 
G124SVPTYETDGDEDDI138 (IMGENEX) and goat polyclonal antibody for actin (I-
19) (SC-1616) (Santa Cruz Biotechnology).  The secondary antibodies were: HRP-
GAR and HRP-RAG (Pierce). The detection was performed with ECL advanced 
Western blotting detection reagent (Amersham Biosciences). The membranes were 
exposed to X-ray film (Kodak, USA) for 7 to 15 sec. 
 
21. Detection of putative promoter 
By using the GenomeWalker kit (Clontech), a 1.5 kb fragment representing the irf6 
promoter was cloned. To detect the cis-acting elements of irf6 gene in the DNA 
upstream of the irf6 coding region, a 4.0 kb consisting of the 1.5 kb promoter, exon 1 
and intron 1 was amplified from male fish genomic DNA using the primers, PaeI-
IRF-Pf4 (5’gactagcatgcGAACTGCGATCTTAAGTTGTTG) and BamHI-5’E2r (5’ 
gaaggatccCGTGGATGAGACGACATCAC) as well as the Expand high fidelity PCR 
system (Roche). The PCR condition was: 94°C for 2 min, 35 cycles of 94°C for 30 
sec, 60°C for 30 sec and 68°C for 3 min, followed by 68°C for 7 min. PCR product 
was detected on agarose gel (Figure 2.4A). This fragment was subcloned into an 
expression vector to drive a reporter gene, EGFP. This expression vector contained a 
Xenopus EF-1α enhancer upstream of putative promoter and a zebrafish EF-1α 
3’UTR with polyadenylation sequence downstream of EGFP coding region (Figure 
2.4B).  The plasmid was injected into 1-4 cell stage embryos to determine the 
promoter specificity.  
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Figure 2.4.  (A) PCR fragment amplified from genomic DNA using PaeI-IRF-Pf4 and 
BamHI-5’E2r primers. (B) Expression plasmid to detect the cis-elements upstream of 

























CHAPTER 3   RESULTS 
 
1. Characterization of the full-length zebrafish irf6 cDNA 
Characterization of zebrafish irf6 initiated from the cloning of cDNA. Using the 
sequence of human IRF6 cDNA as query in a search of the GenBank database, a 709 
bp zebrafish 5’ EST (expressed sequence tag) sequence with high similarity was 
identified (AW422721). Using 5’ and 3’ RACE (rapid amplification of cDNA ends) 
experiments to identify additional 5’ and 3’ sequences, the complete nucleotide 
sequence of zebrafish irf6 cDNA was determined (AY725802).  It comprises a 276 bp 
5’ UTR (untranslated region), a 1479 bp ORF (open reading frame) encoding a 492 
amino acid protein, and a 997 bp GT-rich 3’ UTR (Fig. 3.1).  The deduced amino acid 
sequence has a winged-helix DNA-binding domain (Trp13 to Val113) and a protein-
interaction domain (Leu249 to Val417).  Also present in the DNA-binding domain are 
five tryptophan residues (Trp13, 28, 40, 60, 79) that are highly conserved amongst the 
IRF family members (Eroshkin and Mushegian, 1999). 
 
    1 attcagagaaatgcccgtgacgtcatcgctgtacctgagtttcggcagagggtgaaactc 
   61 tcgagcagagattcagacacacatgaaactcagtttcacacactttcacacggacacacg 
  121 gatattctgcgagtcgtatctctcacctgtgactgacatacacagacattaaacacgttt Exon1  181 attcataaaaaccgttcgttttggcggcaaaggcctcaggagtgctgccttttcctgctt 
    1                                        M  S  S  H  P  R  R  V 
  241 tgacgcgagcgcttcctgaaaccctcagccggtgtgatgtcgtctcatccacggcgtgtg 
    9    R  L  K  P  W  L  V  S  Q  V  D  N  A  T  F  P  G  L  V  W 
  301 cgtctgaagccctggctggtctctcaggtggacaacgctacgtttcctgggctggtctgg 
   29    L  D  R  D  A  K  R  F  Q  I  P  W  K  H  A  T  R  H  T  P 
  361 ctggatagagacgccaaacgcttccagatcccctggaaacacgcaacacgacacacaccg 
   49    Q  Q  E  E  E  N  T  I  F  K  A  W  A  V  E  T  G  K  Y  Q 
  421 cagcaggaggaggagaacaccatctttaaggcctgggcagtggagacggggaagtatcag 
   69  E  G  V  D  E  P  D  P  A  K  W  K  A  Q  L  R  C  A  L  N 
  481 gaaggagtggatgaaccggatccagctaaatggaaagcgcagctcagatgtgctttaaac 
   89  K  S  R  E  F  N  L  I  Y  D  G  T  K  E  V  P  M  N  P  L 
  541 aagagtcgcgagttcaacctcatctacgacggcacgaaagaggttcccatgaacccgctg 
  109  K  I  Y  D  V  C  D  I  P  Q  T  P  S  N  P  G  S  V  P  T 
  601 aagatctatgatgtgtgtgacatcccacagacgcccagcaaccctggttcagttcccaca 
  129  Y  E  T  D  G  D  E  D  D  I  P  D  T  P  E  P  P  P  P  Y 
  661 tacgagacggatggagatgaagacgacatcccagacactcctgaacctcctccaccatat 
  149  A  S  H  G  M  S  A  S  P  L  A  A  V  W  T  P  P  G  S  V 





  169  S  P  L  Q  P  S  S  C  A  P  P  P  A  L  P  P  P  P  A  L 
  781 tctcctcttcagccgtccagttgtgctcctcctcctgctcttcctcctccccctgctctt Exon5  189  P  P  P  A  A  T  V  L  P  A  A  A  A  P  P  A  N  V  W  P 
  841 ccccctccggccgccaccgttcttccggccgccgccgctcctcctgctaatgtttggccc 
  209  K  K  E  P  E  D  V  E  M  Q  P  P  P  M  E  I  Q  T  P  T 
  901 aagaaggagccggaggacgtggagatgcagccgccccccatggagatacagacgcccacc 
  229  A  L  D  N  L  F  I  T  P  E  T  W  I  S  S  L  P  M  T  D 
  961 gctctcgacaacctgttcatcacgccggagacctggatcagctctctgcccatgacggat 
  249  L  E  V  Q  F  Y  Y  R  G  K  E  V  C  P  P  L  T  V  S  N 
 1021 ctggaggtgcagttctactaccgcggtaaagaggtgtgtcccccattgacggtcagtaac 
  269  P  Q  G  C  R  L  F  Y  G  D  L  G  P  I  V  N  Q  E  E  L 
 1081 ccgcagggctgtcgtctgttttacggggacctgggccccatagtgaaccaagaggagctg 
  289  F  G  P  V  S  L  E  Q  V  R  F  P  P  T  E  H  I  A  N  D 
 1141 ttcggccccgtgagcctggagcaggtgcgcttcccgcccacagagcacatcgctaacgat 
  309  K  Q  R  V  F  T  S  R  L  L  D  V  M  D  R  G  L  I  L  E 
 1201 aagcagcgcgtgttcactagccggctgctggacgtgatggaccgcgggctcatcctggag 
  329  V  S  G  H  D  I  Y  A  V  R  L  C  Q  C  K  V  Y  W  S  G 
 1261 gtcagcgggcacgacatctacgccgtgcgcctctgccagtgtaaggtgtactggtccggt 
  349  P  C  A  P  N  P  N  A  P  N  L  I  E  R  Q  Q  K  V  K  L 
 1321 ccctgcgcccccaacccaaacgctcccaacctgatcgagcgccagcaaaaggtcaagctc 
  369  F  C  L  E  S  F  L  S  G  V  I  T  H  Q  R  G  Q  S  S  D 
 1381 ttctgcctcgagtcctttctcagcggggtgatcactcatcagcgtggtcagtcttctgat 
  389  A  P  L  Y  D  I  H  L  C  F  G  E  E  W  P  D  G  R  P  R 
Exon6
Exon7
 1441 gctcctctttatgatattcacttgtgttttggagaggagtggcccgacggtcgaccccga 
  409  E  R  K  L  I  M  V  Q  V  V  P  V  V  A  R  M  I  S  E  M 
 1501 gagcgcaaactcatcatggtgcaggtggttccagtagtggctcgtatgatcagcgagatg 
  429  F  S  G  D  C  T  R  S  F  D  S  G  S  V  R  L  Q  I  S  I 
 1561 ttctccggcgactgcacacgttccttcgacagcggcagtgtgcgtctgcagatctccatc 
  449  P  D  I  K  D  N  I  V  T  H  L  K  Q  L  Y  R  L  L  Q  T 
 1621 ccggatattaaagacaacatcgtgacgcacctgaagcagctgtaccggctcctgcagacg 
Exon8  469  H  Q  G  P  E  N  W  P  L  P  P  G  A  A  L  Q  L  S  S  A 
 1681 caccaggggcccgagaactggccgctgccacccggggccgccctgcagctctcctccgcc 
  489  L  H  T  Q  * 
 1741 ctgcacacgcagtaacgctcatcacacacacgcttttatacacacttctgtgtgtgtgtg 
 1801 tgtttagtagagtgtcggtttatgtttgagtaagtgtgtgttttgtgtatgcgtttgtgt 
 1861 gtgtgtgtgtgtttgtatgtttgtttatgtgtgttggtttttgtctgtgtatgtgtgtgt 
 1921 gttgtgtatgcatttgtgtaagttcgtgtttgtaaatttgtgtgtgtgtgttttgtgtgt 
 1981 gtaagtttgtgggtgtgttttgtttgtgtgtgtttgtgtgtgttggtttttgtctgttta 
 2041 tgtgtgcatgtgtgtgttttgtgtatgcatttgtgtaagtttgtaaatttgtgtgtgtgt 
 2101 gtgtgtgtgtgtgtgtgtatgtaagtttgattatgtgtgtgtttggtttttgtctgtttg 
 2161 ttttgtgtgtgtgtatgtgtgtgtgtgtgtttatgtgtctgcttgagtgtgtatgtttgt 
 2221 gtgtgtgtgtctgcttgatttttggtttgtgtgtatgtttgtgtgtgcgtgcgtgtgagt 
 2281 gtctgttttgttttgtctgtgtgtgcgtgttttgtgaatgatttgtgcttgtgtatatgt 
 2341 gtgtctctgtgtttgtgtctgagttcatttgagtgttggtttgtgtgtgtgtgtgtgtgt 
 2401 tttgtatgcgtttgcttgcttgtgtgtgtgcgtgtgtgtgtatatactgtatgtgtgtgt 
 2461 tttgtgcatgcattactttgtgtgtgtgtgtgtgtctatttgagttgtgtgtgttacttt 
 2521 tatacacgcttttgtgtttttactgcagacgtatgttacgccattattatcctccgccac 
 2581 ttctgtttattctcctgcttccgctgtgaagatctcgtcgttcgtttgtgtttgtcttta 
 2641 ttttatagcgtgttcctgtgtttgatgtgctagtgtgtagatttgtcccgtaatgtatgg 
 2701 atttataaatacaaataaaaaaaagaaaaacaaaaaaaaaaaaaaaaaaaaa 
 
 
Figure 3.1.  Full-length nucleotide sequence of zebrafish irf6 cDNA (in lowercase) 
and its deduced amino acid sequence (in UPPERCASE single letter code).  The start 
and stop codons are underlined, while the polyadenylation signal is double-underlined.  
Exon-exon junctions are demarcated by vertical lines.  The winged-helix DNA-
binding domain (W13 to V113) is in BOLD and its five conserved tryptophans are 
shaded.  The protein-interaction domain (L249 to V417) is in BOLD ITALICS.   
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To examine the relationship between this gene and members of the IRF gene family in other 
species, a phylogenetic tree was constructed using multiple alignments of homologous 
proteins.  Maximum parsimony analysis indicates that our isolated gene is clustered with the 
IRF6 proteins of other organisms such as Fugu, Xenopus, pig, mouse and human, thus 
confirming its identity (Fig. 3.2). 
 

























Figure 3.2. Phylogenetic analysis of the IRF gene family.  An unrooted MP phylogenetic tree 
is generated using amino acid sequences.  The branch length is proportional to the number of 
minimum changes.  GenBank accession numbers are: P10914 (human IRF1); P14316 
(human IRF2); Q14653 (human IRF3); Q15306 (human IRF4); Q13568 (human IRF5); 
O14896 (human IRF6/hIRF6); Q92985 (human IRF7); Q02556 (human IRF8/ICSBP); 
Q00978 (human IRF9/ISGF3γ); P15314 (mouse IRF1); P23906 (mouse IRF2); P70671 
(mouse IRF3); Q64287 (mouse IRF4); P56477 (mouse IRF5); NP_058547 (mouse 
IRF6/mIRF6); P70434 (mouse IRF7); AAH05450 (mouse IRF8/ICSBP1); BAA24349.1 
(Xenopus IRF6/xIRF6); AAL37429.1 (pig IRF6); AAF34782.1 (sheep IRF6).  Proteins 
inferred from Ensembl transcripts with identification numbers are: SINFRUT00000151792 
(Fugu Irf5); SINFRUT00000136824 (Fugu Irf6/fIRF6); GENSCAN00000015076 (zebrafish 
Irf5). 
 60
A comparison of the translated peptide sequences of IRF6 in human, mouse, Xenopus, 
zebrafish and Fugu reveals that both the winged-helix DNA binding motif and the SMAD 
protein-interaction motif are identical in size among all five species and highly conserved in 
amino acid content (Fig. 3.3).  The overall similarity of zebrafish IRF6 to human, mouse, 
Xenopus, and Fugu peptides was 63%, 63%, 62% and 71%, respectively.  When only the 
DNA-binding motifs were compared, the similarities increased to 87%, 87%, 85% and 85%, 
respectively, whereas the corresponding protein-binding motif similarities were intermediate 
at 75%, 75%, 73% and 88%, respectively (Table 3.1). 
 
Table 3.1.  Percentage amino acid similarity of zebrafish IRF6 compared with other species. 
 
 IRF6 protein Winged helix DNA-
binding motif 
protein-binding motif 
Human IRF6 63 87 75 
Mouse IRF6 63 87 75 
Xenopus IRF6 62 85 73 








































                 1           *              *           *                   *        70 
    hIRF6    (1) MALHPRRVRLKPWLVAQVDSGLYPGLIWLHRDSKRFQIPWKHATRHSPQQEEENTIFKAWAVETGKYQEG 
    mIRF6    (1) MALHPRRVRLKPWLVAQVDSGLYPGLIWLHRDSKRFQIPWKHATRHSPQQEEENTIFKAWAVETGKYQEG 
    zIRF6    (1) MSSHPRRVRLKPWLVSQVDNATFPGLVWLDRDAKRFQIPWKHATRHTPQQEEENTIFKAWAVETGKYQEG 
    fIRF6    (1) MSVTPRRVRLKPWLVAQVDSGRYPGLVWIDREAMRFRIPWKHATRHTPQHEDEDTIFKAWAVETGKFQEG 
    xIRF6    (1) MAMHPRRVRLKPWLVAQVDSGMYPGLIWLNREAKRFQIPWKHATRHSPRQEEENTIFKAWAVETGKYQEG 
Consensus    (1) MALHPRRVRLKPWLVAQVDSGLYPGLIWL RDAKRFQIPWKHATRHSPQQEEENTIFKAWAVETGKYQEG 
 
                 71      *                                                          140 
    hIRF6   (71) VDDPDPAKWKAQLRCALNKSREFNLMYDGTKEVPMNPVKIYQVCDIPQPQGSIINPGS--TGSAPWDEKD 
    mIRF6   (71) VDDPDPAKWKAQLRCALNKSREFNLMYDGTKEVPMNPVKIYQVCDIPQTQGSVINPGS--TGSAPWDEKD 
    zIRF6   (71) VDEPDPAKWKAQLRCALNKSREFNLIYDGTKEVPMNPLKIYDVCDIPQTPS---NPGS-----VPTYETD 
    fIRF6   (71) MDEPDPAKWKAQLRCALNKSREFNLVYDGTKEVPMNPLKIYDVCEIPQPSS---NQGSSDAGSWTPHDDD 
    xIRF6   (71) ADEPDPAKWKAQLRCALNKSREFKLMYDGTKEVPMNPVKIYEVCDIPQSQGSIINPGS--TGSVPWDDDD 
Consensus   (71) VDEPDPAKWKAQLRCALNKSREFNLMYDGTKEVPMNPVKIYDVCDIPQTQGSIINPGS  TGS PWDE D 
 
                 141                                                                210 
    hIRF6  (139) NDVDEEDEEDELDQSQHHVPIQDTFPFLNINGSPMAP-ASVGNCSVGNCSPE------------------ 
    mIRF6  (139) NDVDEDEEEDELEQSQHHVPIQDTFPFLNINGSPMAP-ASVGNCSVGNCSPE------------------ 
    zIRF6  (133) GD-----EDDIPDTPEPPPPYASHGMSASPLAAVWTPPGSVSPLQPSSCAPPPALPPPPALPPPAATVLP 
    fIRF6  (138) GG-----EEDIPDTPESLPPYPSN---ES-------------SMQPSSCPPSNEGWP------------- 
    xIRF6  (139) ------FEADELNQSQNHVPISEPFNCLNINDSPIG------SSSTGSCTPE------------------ 
Consensus  (141)  D     EEDELDQSQ HVPI D F  LNINGSPMAP ASV   S GSCSPE                   
 
                 211                                                                280 
    hIRF6  (190) -------AVWPKTEPLEMEVPQAP-------------------IQPFYSSPELWISSLPMTDLDIKFQYR 
    mIRF6  (190) -------SVWPKTEPLEMEVPQAP-------------------IQPFYSSPELWISSLPMTDLDIKFQYR 
    zIRF6  (198) AAAAPPANVWPKKEPEDVEMQP-----------PPMEIQTPTALDNLFITPETWISSLPMTDLEVQFYYR 
    fIRF6  (174) --KEESVKIWPKEEPVDVEMHPTLMADMPPANLPDHPMQPPPLPDTLFATPEHWSS-LPMTDLEVQFLYR 
    xIRF6  (179) -------QTWPKTEPQEMEVPPTSG------------------PADFFSSPEMWISSLPMTDLEIQFYYR 
Consensus  (211)         VWPKTEPLEMEVPP                     I  FFSSPELWISSLPMTDLEIQF YR 
 
                 281                                                                350 
    hIRF6  (234) GKEYGQTMTVSNPQGCRLFYGDLGPMPDQEELFGPVSLEQVKFPGPEHITNEKQKLFTSKLLDVMDRGLI 
    mIRF6  (234) GKEYGQTMTVSNPQGCRLFYGDLGPMPDQEELFGPVSLEQVKFPGPEHITNEKQKLFTSKLLDVMDRGLI 
    zIRF6  (257) GKEVCPPLTVSNPQGCRLFYGDLGPIVNQEELFGPVSLEQVRFPPTEHIANDKQRVFTSRLLDVMDRGLI 
    fIRF6  (241) GKEMCPTVTVSNPQGCRLFYGDLGPMVNQEELFGPVSLEQLRFPTAEHITNDKQRVFTSRLLDVMDRGLI 
    xIRF6  (224) GKEMGQTMTVSNPQGCRLFYGDLGPMPNQEELFGPITLEQVRFPGTEQIVNEKQKLFTSRLLDVMDRGLI 
Consensus  (281) GKEMGQTMTVSNPQGCRLFYGDLGPMPNQEELFGPVSLEQVRFPG EHITNEKQKLFTSRLLDVMDRGLI 
 
                 351                                                                420 
    hIRF6  (304) LEVSGHAIYAIRLCQCKVYWSGPCAPSLVAPNLIERQKKVKLFCLETFLSDLIAHQKGQIEKQPPFEIYL 
    mIRF6  (304) LEVSGHAIYAIRLCQCKVYWSGPCAPSLAAPNLIERQKKVKLFCLETFLSELIAHQKGQIEKQPPFEIYL 
    zIRF6  (327) LEVSGHDIYAVRLCQCKVYWSGPCAPNPNAPNLIERQQKVKLFCLESFLSGVITHQRGQSSDAPLYDIHL 
    fIRF6  (311) LEVSGHDIYAVRLCQCKVYWSGPCAPNQAAPNLIERQKKVKLFCLESFLSGVIAHQRGQTPTLPAFDISL 
    xIRF6  (294) LEVSGHAIYAIRLCQCKVYWSGPCSPSPITPNFIERQKRVKLFCVETFLSDLISHQKGIITKQPPYEIYL 
Consensus  (351) LEVSGHAIYAIRLCQCKVYWSGPCAPS  APNLIERQKKVKLFCLETFLSDLIAHQKGQI KQPPFEIYL 
 
                 421                                                                490 
    hIRF6  (374) CFGEEWPDGKPLERKLILVQVIPVVARMIYEMFSGDFTRSFDSGSVRLQISTPDIKDNIVAQLKQLYRIL 
    mIRF6  (374) CFGEEWPDGKPLERKLILVQVIPVVARMIYEMFSGDFTRSFDSGSVRLQISTPDIKDNIVAQLKQLYRIL 
    zIRF6  (397) CFGEEWPDGRPRERKLIMVQVVPVVARMISEMFSGDCTRSFDSGSVRLQISIPDIKDNIVTHLKQLYRLL 
    fIRF6  (381) CFGEEWPDGRPRERKLIMVQVIPVVARMITEMFSGDNTRSFDSGSVRLQISVPDIKDNIVSHLKHLYCLL 
    xIRF6  (364) GFGEEWPDGKYKERKLIIVQIIPIVARMIIEMFTGDSTRSFDSGSIRLQISIPDIKDNIVSHLKHLYRLL 
Consensus  (421) CFGEEWPDGKPRERKLILVQVIPVVARMI EMFSGD TRSFDSGSVRLQISIPDIKDNIVAHLKQLYRLL 
 
                 491                     517 
    hIRF6  (444) QTQES---WQPMQPTPSMQLPPALPPQ 
    mIRF6  (444) QTQES---WQPMQPAPSMQLPQALPAQ 
    zIRF6  (467) QTHQGPE-NWPLPPGAALQLSSALHTQ 
    fIRF6  (451) QTHQGQE-GWALPPGAGLNIDQALQAQ 
    xIRF6  (434) QNHQGPDAWPLMQPQ-NMHLAQMLQAQ 
Consensus  (491) QTHQG E W PMQPG SMQL QAL AQ 
 
 
Figure 3.3.  Alignment of the predicted IRF6 proteins from five species. The five conserved 
tryptophans in the DNA binding domain are indicated with “*”.  The winged-helix DNA-




2. Genomic organization and map location of zebrafish irf6 
The understanding of genomic structure is necessary for promoter analysis and the 
next application of splice-modified morpholino in knockdown experiment.  The 
understanding of gene locus is important for the orthologous identification.  
 
By alignment of the full length irf6 cDNA against available genomic sequences in the 
Ensembl zebrafish database version 14.2.1, and experimental confirmation using 
exon-exon PCR across predicted introns or exon-intron PCR, we determined the irf6 
gene to consist of eight exons (Fig. 3.4).  Exon 1 is non-coding, with initiation of 
translation beginning in exon 2 (Fig 3.1 and 3.2).  The DNA-binding domain of the 
IRF6 protein is encoded within exons 2 and 3, while the protein interaction domain is 
encoded primarily within exons 6 and 7, with the last amino acid of this domain 
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Figure 3.4.  Genomic organization of the IRF6 orthologs in human, mouse, Fugu, and 
zebrafish.  Exons (rectangles) are drawn to scale, except for exons 9 and 10 in human, 
and exon 8 in mouse.  Empty rectangles represent untranslated regions.  Filled and 
shaded rectangles represent coding regions.  The deduced IRF6 proteins contain the 
winged-helix DNA-binding domain (stripped) and the protein-interaction domain 
(grey).  Conserved exon-intron junctions are indicated by arrows and dotted lines.  
GenBank accession numbers of the human and mouse IRF6s are AL022398 and 
NW_000164, respectively.  The Ensembl identification number for Fugu IRF6 is 
scaffold_108. N.d.: not determined.  
 
(A)  Promoter to 5’ of intron 4  
    1 ATATTTTTTT TTTTGTTGTT TATTTGAATT TTTCTCCCTT ATTAAATTTT TAATAATATT 
   61 TTTCTCCAAA TTTAGTGGGT GTTTTCATTT TTGAACTGCG ATCTTAAGTT GTTGTTAGAG 
  121 TAGTTCACTT TTGTGATTAA ACTAACTAAT CTAATATATG CACAAATATA TTACTGTAAA 
  181 GCATCCTGTG GAAATATCTT TAAGGGGTGA ACTCATTTGT GCTTAGCACT TTATAAAGCT 
  241 GTTCTTGAAA GCATTGTGAG GTATGGTATC ACATTGTGGT TTGGCAGCCT ATCTGTACAT 
  301 TCATTCATTC ATTCATTTTC TTTTCAGCTT AGTCCCTTTA TTAATTAGGG GTTGCCACAG 
  361 CGGAATGAGC CGCCAATTTA TCCAGCATAC GTTTTACACA GCGGATGCCC TTCCAGCTGC 
  421 AACCCAACAC TGGGAAACAC CCATACATTC TTGCATTTAC ACTCATACAG CCAATTTAGT 
  481 TCATCAATTC CCCTATAGGG CATGTGTTTT GACTCAAATC AGCGACCTTC TTGCTATGAG 
  541 GCGATCGTGC TACTCACTGC GCCACTGTGA CGCTCCCTAT CTGTACACTG TAAGTCTGTA 
  601 CAGTATGATA AAATGTTTGG CATGATGAAT ATTTTAATTC TCAAGTTTTA TATGAGAATT 
  661 GTGTCCTTAA TCAGGTGGCA AAGATTCTGA ATGATCCAAC TCATTTTTTG TATTCACACT 
  721 YCCCTCTGGT GGTAGGGGAT ATGGAGTGTA GGTTGAACCG TTATAAGAAA CCTTTGTAGC 
  781 CATTAAAGTA GGTTTATTTA ACAAGAGTTT ATCTTAATTA GCATTATAAT TATTGTAACT 
  841 ACTGTATTTT GTATTGTTTG TATTTATGGA ATGTCTGCAG CAATATGGTG ATGCCAATAA 
  901 CAAATTTTCT GTCATGGACA ATAAAGTGTT CTACTACTAC CCTGTATGTC CAATCATTTA 
  961 TAATTTGGTC TGTGTGCTAC TCATGATGGA AACAAATCTG CAATTAGCTT ATAAAATGTA 
 1021 AAATTGTTAA TTAAACAAAG ATATATATTG AATGAGTGAG TGGTTGAAAA AGGCAGTAAG 
 1081 GAATGTGTGT GAGAAACTGA AAAACTTACA GAAAATTATT TCAGAATTTA GAGAATTTAT 
 1141 TTTAGTCAGT TGTCATTAAC ATTTCTAATT TAAGTAAATA TGCTACATTA GCATATTTAG 
 1201 CTATTTTAAA TGTTATTGAA ATTAGTTTAA ATAATATATA CGTTTTAACA ATTAAATCTT 
 1261 GTAGAAATAA AAAAAAACTT AAAATCATTT TACATTTTAA TTAAACGTTT AGTGTTGGAT 
 1321 TCTTTCATTA CATATAGGCT GCAGGGTTTG ATTAACCCTG CAAACAATAT AATCAGCTTA 
 1381 TGAAATTGGA CATGAATGTG TAGCATGACC TAATTGTATT TAACCGAGTA GCATTGCTAA 
 1441 AAAGAGAATG TATATATATT TCATACTTGA GGGCCCGTGA GTGTGCGCGC GCCCGTGCCT 
 
 1501 GTTTGTGTGC GCGTGATTCA GAGAAATGCC CGTGACGTCA TCGCTGTACC TGAGTTTCGG 
          447U24               5IRFr7                          5IRFf1 
 1561 CAGAGGGTGA AACTCTCGAG CAGAGATTCA GACACACATG AAACTCAGTT TCACACACTT 
                         5IRFr5  
            
 1621 TCACACGGAC ACACGGATAT TCTGCGAGTC GTATCTCTCA CCTGTGACTG ACATACACAG 
                578L24 
 1681 ACATTAAACA CGTTTATTCA TAAAAACCGT TCGTTTTGGC GGCAAAGGCC TCAGGAGTGC 
                                                         E1f 
 1741 TGCCTTTTCC TGCTTTGACG CGAGCGCTTC CTGAAACCCT CAGGTGAGAC TCATTAATAT 
                                   5IRFr8 
 1801 TTATATCGCG TTTATATTTA ATGTTTATAG TCTTTTACAA TCATTCCAGC AGTATAAAAC 
 1861 GCTTTCATGT GATTTAGTGT CGGATTTTCA GCGTTTTAAT CGACGACGAG GATATTTTCT 
 1921 TGCTTTAGAA TCAAATATCA AAGTCAGGCT CTTTATTTAC CCTTTATTTA CTGTATTATG 
 1981 TGGCTTTTTC TTTTCAAACT ACCCATTGAA TCAATGTTTT GACCATACAT GAGCTTTTTC 
 2041 TGTGTTGTAC ATTTAGTCAA TTTGTTTATA ATCAATGGAA ACTTAAATGT TCAATAAAGT 
 2101 TGCTGTTTCA GAATTGTTTA TATTTTGTAA TATTGCAATA TTTGCGCATT TTAATGTTAG 
 2161 AGCGGTTGTT ATCAGTTTGT TTATTGTGTT AAATAAAGTT TTATGATAAA AAGTAATACT 
 2221 AGTTATTCAG ACAAGCCATG GTAACTTTAG ATGAGCAAAA ATCAATAAAT ATATTTTAGG 
 2281 CTCTGTTTTA ATTCTTTTTT TTCATGATTA TGTTGATTAA CAGATGTTAC TTTTATTTGA 
 2341 TGTAGTACAT TTCAGAATAA TATCAGTGCA AATGGTGCAT TAATTAAAAT GTCTGTTAGA 
 2401 TATAAGCTTT TTTTCAGTAT TGTGAAGAAA TGTTAATGAT TCTTATATAA TTTGCTCTTT 
 2461 CAAAGGCTTA GTTTATGTCC TGTTTTTGCT TTCTTACTCG CTTGTATTGA TATATGCGTA 
 2521 AAATAATGTG TATTATGTTA ATTTGTTTTT AATAAAATAA AAACATGTAA CAATAAACAT 
 2581 TTTACTTTTT TAAAGTCACT TTAATACAAT TAATAACAAT ATTAAAAGTT ATCTATTATG 
 2641 ATATATATGT GTGTGTATGT GTATATATGT GTGTGTGTAA TTTATTATGT AACTATTTTA 
 64
 2701 ACTGTCAATC TTTTCTAAAA TATTGCTAGT TTTGGTAGGT CTCAGTGATT AGGTTTAGAT 
 2761 TCCTTTTATC TTCTATTCTT ATTTTTATTA TCATTAAATA ATAAACATTT CTGTTAAAAC 
 2821 TTTTTTTTTT TGATTATTTA TATCCTCTAT ATAACGTTGT CATGTTTGTA ATTTGTATTT 
 2881 TATTATAAAC TATTAAAATT GTGATATTGA TTAAATTCTT TGCAAAATGC GTAAATGTAT 
 2941 TTATCCACTT TTAATAATTG CTTTATTTAC TTAGATTTTC TTAAGCAGAT TTGAGTTTTG 
 3001 TTAATATTGT AAAATGTATG GCAAAATAAA ACATAAATAT ATAAAGTCAT GATGAGGTGT 
 3061 CCGGTGTG ATGATGTGTGTAC AG TCGTCTC ATCCACGGCG TGTGCGTCTG AAGCCCTGGC 
 3121 TGGTCTCTCA GGTGGACAAC GCTACGTTTC CTGGGCTGGT CTGGCTGGAT AGAGACGCCA 
                       E2r 
 3181 AACGCTTCCA GATCCCCTGG AAACACGCAA CACGACACAC ACCGCAGCAG GAGGAGGAGA 
               E2f 
 3241 ACACCATCTT TAAGGTCAGA AAGTGGGTTT ACCTGGTGTG TGTGTTCAGT AAACGTGTGT 
 3301 TCAAAAACAA ATGTTTATGT GTGTGTGTGT GTATGTATTT GTGTGTTTTT AGAAAGAAAA 
 3361 TCTGCTTACT TGGTGTGTGT GTTCAGTATA TCAGTGTGTC CAGAAAGTGT GTGTGTGAGA 
 3421 AAGACAGTGT AACTGTGTGT GTTTCCAGAC CATAAGTGGG TCCAATGTGT GTGTGTGTGT 
 3481 GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GCGCGCGCGT 
 3541 GTGTGTGTGT GTGTGTGTGC GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GAGAGAGAGT 
 3601 GTGTGTGTGA GAGTGTGTGT GAGAGTGTGT GTGTGAGTGT GTGTGTGAGA GTGTGTGTGA 
 3661 GAGTGTGTGT GAGAGTGTGT GTGTGAGTGA GTGAGTGAGT GAGTGAGTGA GTGAGTGAGT 
 3721 GAGAGAGAGA GAGAGAGAGA GAGAGAGTGT GGATGTGTTA ACCCGGTGTG TGAGTGAGTG 
 3781 AGTGAGTGAG AGAGAGAGAG AGAGAGAGAG AGAGTGTGGA TGTGTTAACC CGGTGTGTCC 
 3841 AGTAAGTGTG TGTGTGTGTG AGTGAGTGAG TGAGTGAGAG AGAGAGAGAG AGAGAGAGAG 
 3901 AGAGAGAGTG TGGATGTTTA CCCTGTGTGT GTTCAGTATA TGTGTGTACC CAATAAGTGC 
 3961 CAACGAAAGA GAGTGTGAAT GCATTGTGTG TGTGTGTTCA TATATGTGAT TACACTGTGT 
 4021 TTATATATTT GTGTTTGTTT TTATCTTTGT GTGTGTTTGT TTGTGTGTAA GTGGGCTTAT 
 4081 TTATGTGTGT GCATGTAAGG TTTTGTCTCT GTGTGTTTGA GTGTGTTATA TCTGTGTGTT 
 4141 TACATTAGCC TTTATATATG TGTGCTTATA TCTGCGTTTT TTGTTTGTGT GTGTTTGTTT 
 4201 TTATCTGCAT GTGAACGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT GTGTGTGTGT 
 4261 GTGTGTGTTT AAACGCGTGT GTGTGTGTGT CTTTATCTGT TTCTGTTGTG TTTATATCTA 
 4321 TGTATTTGGT TGTGTTATCA CTGTCTACAC ACTTTTGTGT GTGTGTGTGT GTGTGTGTGT 
 4381 GTTTTGTCAG GCCTGGGCAG TGGAGACGGG GAAGTATCAG GAAGGAGTGG ATGAACCGGA 
 4441 TCCAGCTAAA TGGAAAGCGC AGCTCAGATG TGCTTTAAAC AAGAGTCGCG AGTTCAACCT 
              E3r 
 4501 CATCTACGAC GGCACGAAAG AGGTTCCCAT GAACCCGCTG AAGATCTATG ATGTGTGTGA 
                        E3f 
 4561 CATCCCACAG ACGCCCAGCA ACCCTGGTAA CACACACACA GCCACATACA CCTCCAAAAA 
 4621 ACAACATTAA TTTGTATAGA TAGATGGATA GATACACATT TAACTTAAAT ATGTTTTACA 
 4681 ATATCATACT TCAGATGTAA TATTTAATTG CTAAATGCTT AGTTGCACAT AATAAATTAA 
 4741 GTAAATGTGA TGCAATGCAA TTAAATCATT CATTAACGTT TCAAGTAATT GCTCCTAACA 
 4801 AGGTCACATG ACTTCAGTGC AAATATTAAA TTAAATTTAG CATGATTTTG TTTTCATTGA 
 4861 GATGCAGTTG CAGTTTTTTC ACTTTAATTT ATATATTTTT TGTTTTAATG TTGTTGTTAT 
 4921 TATTATTATT ATTATTTTAT TATTATTATT ATTTTATTTT TATTTTTTTC ATTTTAAGTT 
 4981 TTACAAACCT TTCTGTAGTT TTGCGTATTT TTGTTTCTGA TTAGTTGTTT TGTTACATTG 
 5041 TAAGTCAGTA AATAAGAAAA TTTTCTTGGC AGCTAGCTAA AATATAATTT TTTAATTAAT 
 5101 CATTTTTAAT GCTCTACTTC AGGTTCAGTT CCCACATACG AGACGGATGG AGATGAAGAC 
                                                      E4f 
 5161 GACATCCCAG ACACTCCTGA ACCTCCTCCA CCATATGCAT CACATGGTAT GGGAGATTAA 
              E4r 
 5221 TAGGCTCAGG CTCTAAAATA CTAAAATCAA AGTAAAAAGT TAGTTTTGAA GCTCATTTCA 
 5281 GGAGTTTAAA ACATTTGCTT CAGCTGCTAA ACATGGTCAA ACTCTCATTG GTCCA 
 
(B)  3’ of Intron 4 to Intron 7 
    1 GACCGGTAGT TTAGTTAGCT ATGTAAGTTT CAGTTGTAGT TTTAGTTTCA GTTTCAGTTT 
   61 GCTTAATACC CTGTGTGTGT TCAGGCATGA GTGCGTCTCC TCTGGCTGCG GTCTGGACTC 
  121 CTCCAGGCTC CGTGTCTCCT CTTCAGCCGT CCAGTTGTGC TCCTCCTCCT GCTCTTCCTC 
                          E5r 
  181 CTCCCCCTGC TCTTCCCCCT CCGGCCGCCA CCGTTCTTCC GGCCGCCGCC GCTCCTCCTG 
  241 CTAATGTTTG GCCCAAGAAG GAGCCGGAGG ACGTGGAGAT GCAGCCGCCC CCCATGGAGA 
  301 TACAGACGCC CACCGCTCTC GACAACCTGT TCATCACGCC GGAGACCTGG ATCAGCTCTC 
                          E5f 
  361 TGCCCAGTAT GGCGCACACA CACACACACA CACACACACG ACACATCTGT AGTCCACTAC 
  421 AACACTCAAA ATCCAGGCGT TCTTCAGAAT GACAAAACAT GATTTAGCAT GTTCAAAGCT 
  481 AGTTGCTAGT CATGGTTATG TAGCTTAAAT TTCTACTTAA GCTACATACC TGTAACTAGC 
  541 AACTAGGCTA GGACATGCTA GCAAAGTTAA ATCATGCAGC CACCATGGGG AAACATGCTA 
  601 CTAACATGTT AGAGCAAGTT AGAAATATGG AAAACATGCT AACATGTTTT AAAAACATGT 
  661 TATGAACGTG TGAATTCATG CTACCAATGT GTTAATTCGT ATTCGTAACA TGCTAATTCA 
 65
  721 TAAAAACATG CTAGCAATAT ACAAATCAAC AAAATGTTAA CCTTGTTAGC AAAATGCTAA 
  781 TTCACAGTAA CCTATTCTTA ATGTTTAAAA CTACCAAAGT ATGCTAAATA GTGTGTGAGC 
  841 AATGTTAAAG GTTTTTTGTT AATGCTAGCC ATATGGTAAT TCACAATAAC ACAGTGTAAT 
  901 CATGCTAGCA ACATGTTTAT TCATTTTAAG TGAATGTAAA CATAAGATAA ACCTTAGCAG 
  961 TGTGATTAAC AATGTAAGAA AAAATGTTAG CATCATGCTA ATTCACACTA ACAAGGTAAA 
 1021 CATTAGCTAG ATAACTCACG CTAACATAGT ATTATTGTAT TTTAGCTCTG GTGAACTATG 
 1081 CTAGAAATAT GTAAACATGC TAATTCATGC TATCACAGCC TAAAACATGC TAGCAAACAT 
 1141 GTTATCTTTA CCCTGAAATA TGCCAAATTC ATGCTACACA CGTAAAAACT AACATCAACT 
 1201 TAAACATGTT AGCAAAATAT GCTAACTGAT GTAATCATAA CATCAAAACA TGCTAGCAAA 
 1261 CATGTTAGAA GTGTTGACAA CGTGCTAGTT AGTTAACACT GTGTTTGTTA GCAAAACATG 
 1321 TCAGAAATGT GCTAAAGCAA CATGTAAATT CCTTTTGTGT GTGTGTGTGT GTGTGTGTGT 
 1381 TGACGG ATCTGGAGGT GCAGTTCTACGGGAGTGTGT CTCTCTCCGT GTATGTGTCT GCAG  
 1441 TACCGCGGTA AAGAGGTGTG TCCCCCATTG ACGGTCAGTA ACCCGCAGGG CTGTCGTCTG 
                          E6r 
 1501 TTTTACGGGG ACCTGGGCCC CATAGTGAAC CAAGAGGAGC TGTTCGGCCC CGTGAGCCTG 
 1561 GAGCAGGTGC GCTTCCCGCC CACAGAGCAC ATCGCTAACG ATAAGCAGCG CGTGTTCACT 
 1621 AGCCGGCTGC TGGACGTGAT GGACCGCGGG CTCATCCTGG AGGTCAGCGG GCACGACATC 
 1681 TACGCCGTGC GCCTCTGCCA GTGTAAGGTG TACTGGTCCG GTCCCTGCGC CCCCAACCCA 
 1741 AACGCTCCCA ACCTGATCGA GCGCCAGCAA AAGGTCAAGC TCTTCTGCCT CGAGTCCTTT 
             E6f 
 1801 CTCAGCGGTG AGAGACTCTC ATTATTCATA TGATATGAGG AGGCAGGGAT ACAGCCGCCT 
 1861 AGGTCGCCTC TATGGACGCG CCGGCCCTGA CTGTTGTTGG AGACCCTTAC AACCAAAATA 
 1921 TGACCCTATT TCATGTATAA TATGGGCTCT TTAAAACTAT TTGTTTAAAA TTGTAAAAGC 
 1981 AAAGTTTGCT GTTGTGTGTT TGTTATGTCT GTGTTTATTC TGTGGTGTGT GTTTATTCTG 
 2041 TGGTGTGTGT TTATTCTAAT ATGTGCTGTT GTGTGTGTGT GTGTGCAGGG GTGATCACTC 
 2101 ATCAGCGTGG TCAGTCTTCT GATGCTCCTC TTTATGATAT TCACTTGTGT TTTGGAGAGG 
                  E7f          
 2161 AGTGGCCCGA CGGTCGACCC CGAGAGCGCA AACTCATCAT GGTGCAGGTC GGCCCACACA 
                                            E7r 
 2221 AACACAATGC ATTATGGGTC ACTGAGGCTA AAATCACCTA CTACTCCAGT AGGTACTACA 
 2281 TTTGAATCTG AAATGTGCTT ATTGTTGTTT ATT 
 
 
(C) 3’ of intron 7 to exon 8 
    1 AAGCGCACAG TTGCTGACAT TGCGATTATA ATATGATTAA TCCTGCAGCA CTGAGGTCAA 
   61 GTGGTTCC AGTAGTGGCT CGTATGATCATACGAGTACA CTTGAATTGT TTGTGTGTTC AG  
  121 GCGAGATGTT CTCCGGCGAC TGCACACGTT CCTTCGACAG CGGCAGTGTG CGTCTGCAGA 
                              E8r 
  181 TCTCCATCCC GGATATTAAA GACAACATCG TGACGCACCT GAAGCAGCTG TACCGGCTCC 
  241 TGCAGACGCA CCAGGGGCCC GAGAACTGGC CGCTGCCACC CGGGGCCGCC CTGCAGCTCT 
  301 CCTCCGCCCT GCACACGCAG TAACGCTCAT CACACACACG CTTTTATACA CACTTCTGTG 
  361 TGTGTGTGTG TTTAGTAGAG TGTCGGTTTA TGTTTGAGTA AGTGTGTGTT TTGTGTATGC 
  421 GTTTGTGTGT GTGTGTGTGT TTGTATGTTT GTTTATGTGT GTTGGTTTTT GTCTGTGTAT 
  481 GTGTGTGTGT TGTGTATGCA TTTGTGTAAG TTCGTGTTTG TAAATTTGTG TGTGTGTGTT 
  541 TTGTGTGTGT AAGTTTGTGG GTGTGTTTTG TTTGTGTGTG TTTGTGTGTG TTGGTTTTTG 
  601 TCTGTTTATG TGTGCATGTG TGTGTTTTGT GTATGCATTT GTGTAAGTTT GTAAATTTGT 
  661 GTGTGTGTGT GTGTGTGTGT GTGTGTATGT AAGTTTGATT ATGTGTGTGT TTGGTTTTTG 
  721 TCTGTTTGTT TTGTGTGTGT GTATGTGTGT GTGTGTGTTT ATGTGTCTGC TTGAGTGTGT 
  781 ATGTTTGTGT GTGTGTGTCT GCTTGATTTT TGGTTTGTGT GTATGTTTGT GTGTGCGTGC 
  841 GTGTGAGTGT CTGTTTTGTT TTGTCTGTGT GTGCGTGTTT TGTGAATGAT TTGTGCTTGT 
  901 GTATATGTGT GTCTCTGTGT TTGTGTCTGA GTTCATTTGA GTGTTGGTTT GTGTGTGTGT 
  961 GTGTGTGTTT TGTATGCGTT TGCTTGCTTG TGTGTGTGCG TGTGTGTGTA TATACTGTAT 
 1021 GTGTGTGTTT TGTGCATGCA TTACTTTGTG TGTGTGTGTG TGTCTATTTG AGTTGTGTGT 
 1081 GTTACTTTTA TACACGCTTT TGTGTTTTTA CTGCAGACGT ATGTTACGCC ATTATTATCC 
 1141 TCCGCCACTT CTGTTTATTC TCCTGCTTCC GCTGTGAAGA TCTCGTCGTT CGTTTGTGTT 
 1201 TGTCTTTATT TTATAGCGTG TTCCTGTGTT TGATGTGCTA GTGTGTAGAT TTGTCCCGTA 
                                                            FL-IRFr 
 1261 ATGTATGG
 
Figure 3.5.  Assembled sequences of irf6 genomic fragments. (A) promoter region to 
5’ of  exon 4. (B) 3’ of intron 4 to 5’ of intron 7. (C) 3’ of intron 7 to exon 8. 
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A sequence of a gene promoter contains interesting information on cis-elements. 
These cis-elements implicate the genetic regulation pathway upstream of the gene. 
Therefore, one of aims of this project is to isolate the promoter of irf6. Using a 
genome walking strategy, a 1546 bp fragment upstream of the transcription start site 
of irf6 was isolated from zebrafish genomic DNA (AY725803).  A TATA box was 
observed within this putative promoter fragment.  This sequence and the adjoining 5’ 
UTR sequence of irf6 was used for linkage group (LG) mapping on the Goodfellow 
T51 radiation hybrid panel.  Using a pair of primers that amplified a fragment around 
the 5’ UTR, irf6 was mapped ~59 cR from the top of LG22 closest to markers 
unp1375 (LOD score 11.513) and z7662 (LOD scores 9.909).  A very similar result 
was obtained using a second pair of primers that amplified an overlapping fragment 
including part of the 5’ UTR, with LOD scores of 12.950 and 10.929 for markers 
unp1375 and z7662, respectively (Figure 3.6A). The result has been confirmed by 
Ensembl database version ZV6, where zebrafish irf6 is placed on LG 22 at location 
1.37-1.40 Mb. The chromosome segment of irf6 was compared with that of human 
and mouse IRF6 genes to look for the syntenic relationship. The result is summarized 
in Figure 3.6B. Five genes, camk1g, ripk5, btg2, rbbp5 and irf6, are syntenic to the 
region of human and mouse loci. This is another evidence that zebrafish irf6 is an 
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trimm44        (19p13.3; 8A1.1)
trif (19p13.3; 18A2)
uhrf1             (19p13.3; 17D)
trh1 (19p13.3; 8A1.2)
rbbp5            (1q32.1; 1E4)
btg2              (1q32.1; 1F)1.25
btc (4q13.3; 5E3)
capzb (1p36.13; 4D3)
1.10 hpse (4q21.23; 5E4)
trfp (6p21.1; 17C)
bysl (6p21.1; 17C)
ripk5             (1q32.1; 1E5)
sfrs3             (6p21.3; 17B1)











Figure 3.6.  The irf6 gene locus on LG22 in the T51 RH panel (A) and in the 
Ensembl zebrafish version 6 (ZV6) (B). The loci of other genes on the same 
chromosome are marked along the chromosome. The loci of the homologous genes of 
human and mouse are blanketed.  Loci of mouse are underlined. The genes syntenic to 
irf6 homologs are in boxes. 
 
3. Developmental expression pattern of irf6 
The knowledge of expression pattern is the first step to understand gene function. 
Using a probe specific to the 5’ UTR and part of the coding region of irf6 mRNA, 
whole mount in situ hybridization analysis was performed to determine the 
developmental expression pattern of irf6 in the zebrafish.  Abundant irf6 transcript 
was ubiquitously detected during the cleavage and blastulation stages, indicating that 
it is a maternally deposited transcript (Fig. 3.7A-C).  During the gastrulation period 
(~7-9 hpf), irf6 expression was concentrated in the forerunner cells (Fig. 3.7D).  The 
position of forerunner cells was confirmed by the two-color hybridization with ntl, 
which marks the dorsal midline in the gastrula (shown in small picture of Fig. 3.7D).  
From the bud stage to the 3-somite stage (~10-11 hpf), strong irf6 expression was 
observed in the Kupffer’s vesicle (Fig. 3.7E).  No irf6 transcript could be detected at 
the 6-somite (12 hpf) and 10-somite (14 hpf) stages of the segmentation period (data 
not shown). 
 
At the 10-somite stage, the otic placode is visible.  However, only at the 14-somite 
(16 hpf) was distinct irf6 expression observed in the otic placode (Fig. 3.7F).  At the 
22-somite stage (20 hpf), irf6 expression was also detected in the cloaca (Fig. 3.7G).  
During the pharyngula period (26 hpf), in addition to strong expression in otic vesicle 
and cloaca, new expression was also observed in the olfactory placode and gut (Fig. 
3.7H-L).  From 2 to 5 dpf, irf6 transcripts could be detected in more anterior segments 
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of the alimentary canal, including the esophagus, pharynx, and mouth, as well as in 
the pharyngeal arches (Fig. 3.8).   
 
Analysis of flat-mounts suggest that irf6 expression in the pharyngeal arches is 
confined to the ceratohyal and the ceratobranchials 1-5 (Fig. 3.8D-H), with no 
expression observed in the basihyal, basibranchials and hypobranchials nor in the 
Meckel’s cartilage, palatoquadrate, and hyosymplectic. Expression in the mouth, 
pharynx, gut, olfactory vesicle/naris and otic vesicle appear to occur predominantly in 
the epithelial layers (Fig. 3.8H-L). The flat-mount preparations also revealed irf6 
expression in the exocrine pancreas, a digestive organ of endodermal origin, but not in 
the insulin-secreting endocrine pancreas, as shown by two-color hybridization with 
insulin (Fig. 3.8M-O).  In addition, irf6 expression was also observed in two other 
organs of endodermal origin, the liver and swim bladder, as well as the hepatic and 
pancreatic ducts.  The anatomical analysis of digestive endodermal organs is based on 
previous studies (Field et al., 2003a; Field et al., 2003b).  The irf6 expression in liver 











































Figure 3.7.  Whole-mount (A-I) and sagittal section (J-L) analysis of irf6 expression in early zebrafish embryos.  Ubiquitous expression is 
observed in 1-cell (A) and 16-cell (B) cleavage stage embryos, and in the 40% epiboly stage blastula (C).  At the 80% epiboly stage (D) and bud 
stage (E), expression is concentrated in the forerunner cells (ntl expression in red indicates the midline) and kupffer’s vesicle, respectively.  No 
expression was observed in 6-somite and 10-somite stage embryos.  At the 14-somite stage, irf6 begins to be expressed in the otic placode (F).  
At the 22-somite stage, additional expression in the cloaca is observed (G).  At 26 hpf, lateral (H) and dorsal (I) views of whole-mounts show 
expression in olfactory placode, otic vesicle, and gut.  Sagittal tissue sections of 26 hpf stained embryos confirm irf6 expression in the olfactory 
placode (J), otic vesicle (K) and gut (L).  No staining signal was observed when embryos and larvae were hybridized with sense RNA probe 
























































Figure 3.8.  Expression of irf6 transcript in the developing zebrafish during pharyngula, hatching and larval stages.  Whole-mounts of 2 dpf (A) 
and 3 dpf (B) embryos show strong irf6 expression in the mouth and pharyngeal arch region, with increased expression intensity in 5 dpf larvae 
(C). Flat-mount lateral (D,E) and ventral (F,G) views, and sagittal section view (H), shows expression in pharyngeal arches at 35 hpf (D), 2 dpf 
(E), 3 dpf (F), 4 dpf (G), and 5 dpf (H).  Sagittal (I,J) and transverse (K,L) tissue sections of stained 2 dpf (I,K), 3 dpf (J), and 5 dpf (H,L) 
embryos and larvae show localization of irf6 expression in the mouth, pharynx, and gut. Flat-mount dorsal views of digestive system at 35 hpf 
(M), 2 dpf (N), and 3 dpf (O, P, Q) reveal irf6 expression in the prox1 expressed liver and exocrine pancreas in addition to the esophagus and 
intestinal bulb (gut), but not in insulin expressed endocrine pancreas.  e, eye; es, esophagus; g, gut; li, liver; m, mouth; nc, notochord; of, 






To analyze the function of irf6 during embryogenesis, we performed morpholino 
knockdown and dominant negative perturbation analyses to investigate the effects of 
down-regulation of irf6 on zebrafish embryos. 
 
4. Effectiveness of morpholino knockdowns and dominant negative 
perturbation 
Western blot analysis can be utilized to detect the effectiveness of morpholino 
knockdown. The Irf6 protein sequence was sent to the IMGENEX Corp. to design a 
peptide and prepare a rabbit polyclonal antibody. The antibody targeting to the 
epitope G124SVPTYETDGDEDDI138 was used to detect Irf6 protein (55 kDa) in the 
Western blot. Three proteins of different sizes, one between 50 to 75 kDa, one at 37 
kDa and one between 25 to 37 kDa, reacted with this antibody. There was no amount 
difference of detected proteins between morphant and wildtype embryos, suggesting 





Figure 3.9. The antibody targeting to the Irf6 epitope G124SVPTYETDGDEDDI138 is 







-irf6    WT 
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Alternative methods were utilized to detect the knockdown effectiveness of 
translation block morpholinos. The effectiveness detection of translation-blocking 
morpholinos was performed by co-injecting the expression plasmid pCMV-5’irf6-
EGFP and either of the translation-block morpholinos X, Y and Z (Fig.3.10A). The 
inhibition of expression of the fusion protein 5’Irf6-EGFP was observed from 
gastrulation stage on. It shows that the three morpholinos did effectively knockdown 
the translation of irf6 transcripts (Fig. 3.10B-G).  
 
In addition to the inhibition of translation initiation complex, we also applied two 
splicing-modified morpholinos E3I3 and E4I4 to block the proper post-transcriptional 
processing (Fig. 3.11A). The morpholino E3I3 shows high toxicity, leading to 100% 
lethal effects before segmentation period. E4I4 splicing interfered transcript was 
identified with RT-PCR. This variant of transcript was detected from 1 dpf stage on, 
accompanying with the decreasing amount of wildtype transcripts. The knockdown 
was most effective at 2 dpf stage. Afterward, the amount of wildtype transcript 
exceeded the variant again (Fig. 3.11B). DNA sequencing shows that a transcript 
variant fails to splice 398 bp of the 5’ Intron 4 that is included into Exon 4 and 
therefore introduces a premature stop codon following the 155th amino acid (aa) (Fig. 
3.11C). The result implies that E4I4 may have a delayed and milder inhibition 







Figure 3.10. Effectiveness of irf6 translation-block morpholinos. (A) Diagram of plasmid pCMV-5’Irf6-EGFP. Morpholinos X, Y and Z are 
denoted in thin lines, respectively referring to the morpholino oligos designed for the 5' UTR and coding sequences of the zebrafish irf6 gene. 
The plasmid was constructed by in frame insertion the 267 bp 5’UTR and the first 235 bp coding region into BamHI linearized pCMV-EGFP 
vector, resulting in a cDNA encoding a fused protein that includes the first 78 animo acids (aa) of Irf6, 5 aa of linker and the entire EGFP.  
Approximately 2 ng of plasmid was co-injected with morpholinos at various concentrations into the 1-4 cell stage embryo. (B) embryos injected 
with plasmid only. (C-G) embryos injected with plasmid and 4 ng of different morpholinos including negative control STD (C), 4-base 
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Figure 3.11. Effectiveness of irf6 splicing-modified morpholino E4I4. (A) Diagram of partial genomic structure of zebrafish irf6. Exons are 
shown in box and introns in thick line. The splice site targeted by E4I4 is indicated with thin line. The splice variation detected in E4I4 
morphants is indicated with dotted line and the extended Exon 4 in dotted box. A pair of primers E2f and E5r, which locations are indicated by 
arrows, are designed to amplify the transcript variant resulting from injection of E4I4. (B) RT-PCR analysis of irf6 mRNA in wildtype and E4I4 
morphants. (C) Comparison of cDNA sequences and their open reading frames indicate that the morpholino injection results in an alternative 
splicing at the downstream splice donor in Intron 4, so that Exon 4 is extended with additional 398 bp and a pre-mature stop codon is introduced. 










Dominant negative perturbation was carried out with the capped mRNA carrying a 
point mutation that replaces Arg84 with Cys. This mutation in human IRF6 was found 
to cause the oral cleft Popliteal Pterygium syndrome (Kondo et al., 2002). Cys84 
disrupts the hydrogen bond between Irf6 protein and the nucleotide of target cis-
element and therefore disables the DNA-binding ability of Irf6, although the protein-
protein interaction ability is intact. The mutated protein binds to its wildtype co-
activator or co-repressor however fails to regulate the targeted genes, perturbing the 
function of wild-type endogenous partners within the same cell. The translation ability 
of the in vitro synthesized capped mRNAs was detected with TNT® Quick Coupled 
Transcription/Translation System. The FluoroTectlys Green labeled proteins were 
visualized at the Irf6/R84CIrf6 estimated size (55K Da) on the SDS-denatured PAGE 




Figure 3.12. in vitro translation of capped 
mRNAs for the expression of wildtype 
Irf6 and R84C Irf6 (dominant negative 
mutation). The effective translation of 
capped transcripts from pT7TS-gene 
plasmids was detected by labeling the 
encoded protein with the TNT® Quick 
Coupled Transcription/Translation System 
and FluoroTect GreenLys in vitro 
Translation Labeling System (Promega), 
separating the protein on a 15% SDS 
PAGE gel and reading the gel with 
Typhoon 9200 at the 488 nm excitation. 
The proteins translated from wild type irf6 
and R84C irf6 were present at the 
expected size of 55 KDa, respectively. 
pT7TS-EGFP is applied as the positive 
control to express a 27 KDa EGFP protein 
and pT7TS as the negative control. 
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5. Phenotypes of irf6 morpholino knockdown and dominant negative 
perturbation. 
The specificity of knockdown was initially assayed using mRNA rescue. This analysis 
was performed by injection of X and Y morpholinos then followed by injection of irf6 
capped mRNA. The result is summaried in Table 3.2. In rescue experiment for X 
morpholino, 76.4% comparison groups were rescued (n = 34). For Y morpholino, 
only 33.3% comparison groups were rescued (n = 15). The rescue effect using mRNA 
for morphilino knockdown was uncertain. To determine the specific phenotypes of 
knockdown, alternative strategy was taken according to the suggestion of GeneTools 
(www.gene-tools.com). I designed three different translating-block morpholinos X, Y 
and Z. X and Z have a 12 nt overlap. Y is against the 5’ UTR without overlap with X 
and Z. Xi was designed as a 4-base mis-pairing control morpholino for X. The 
severity of defects is morpholino dosage-dependent. The lower volume or 
concentration of morpholinos led to a decreasing severity and decreasing proportion 
of morphants having bloated abdomen. The injection of high dosage of morpholinos 
gave rise to the most severe morphants having global defects and ventrally curled 
body at larvae period (Fig. 3.13). Those morphants with curled bodies caused by the 
injection of high amount of Xi, X, Y and Z were considered as non-specific, while the 
phenotypes commonly produced by the X, Y and Z but few affected by Xi were 
thought to be specific.  
 
Table 3.2. Summary of rescue experiments for morpholino knockdown. 
 



















X (6 ng) + capped mRNA (500 pg) 
versus X (6 ng) 




Y (6 ng) + capped mRNA (500 pg) 
versus Y (6 ng) 
33.3 53.3 13.3 15 13 
 
X and Y are anti-sense morpholinos to block ATG translation. X is targeted to 
junction of irf6 5’ UTR and coding region, while Y is targeted to 5’ UTR region. A 
dosage of 6-8 ng of either X or Y morpholino resulted in a phenotype with reduced 
eyes and head and bubble-like abdomen. To determine the specificity of knockdown 
effects, around 6 ng of either morpholino was injected into 1 to 2 cell embryos. The 2-
4 embryos injected with equal amount of morpholino were considered as a 
comparison group and were divided into two subgroups. One subgroup was followed 
by injection of the 500 pg of irf6 capped mRNA transcripts. After 3 dpf, the severities 
of two subgroups were compared and recorded. Injection of mRNA caused milder 
severity was considered as rescued. In contrast, injection of mRNA caused increased 
or equal severity was considered as non-rescued.  
 
As shown in Figure 3.14A-C, the 5 and 6 dpf morphants have a plump yolk, showing 
slower yolk resorption compared to wildtype. The somite trunk of morphants no 
longer kept the tight contact with yolk as those of wildtype. Trunk and yolk were 
separated by a transparent bubble-like space. The swimming bladder was not 
visualized. The morphants died within 10 days, probably because the morphants lost 
the predatory and digestive ability. 
 
The injection of the splicing-modified morpholino E4I4 gave rise to two defective 
phenotypes. The severe one was the phenocopy to the X, Y and Z morphants (Fig. 
3.14B); while the mild phenotype has a normal size of eyes, head and body shape 
however with a reddish intestine (Figure 3.14D). The reddish intestine appears due to 
the congestion of red blood cells inside the intestine lumen. To test this possibility, o-
dianisidine staining was used to detect red blood cells circulating inside the embryos. 
A transverse cryosection of intestine was treated with Wright’s staining to detect 
blood cells. The results indicated that the reddish color is not caused by the leak of red 




R84Cirf6 injected embryos show phenotypes identical to the E4I4 morphants, further 
confirming the knockdown specificity (Fig. 3.14B and D). The injection of either 
capped or non-capped mRNA of wildtype irf6 (R84) did not result in the defects 
observed in the dominant negative perturbation and knockdown analyses. The 
reduced eyes and head as well as the accumulation of blood cells near the anus were 
observed in the 2 dpf morphants (Fig. 3.14F). 
 













 Figure 3.13. Non-specific phenotypes caused by over-dosage of morpholinos. The morphants show the ventrally curled body. (A) 5 dpf old Xi 
morphants. (B) 5 dpf old X morphants. (C) 3 dpf old Y morphants. (D) 3 dpf old Z morphants. (E-G)  Head cartilages of curled body morphants. 
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Figure 3.14.  Loss of irf6 function phenotypes. (A and B) X, Y, Z and E4I4 morphants and R84C dominant negative perturbation at 5 dpf stage 
show the similar phenotype, reduced eyes and head and bubble-like abdomen. (C) 6 dpf old X and Z morphants. (D) E4I4 morphants and R84C 
dominant negative perturbation result in normal body shape with a milder defective phenotype, reddish intestine lumen. (E) o-dianisidine 
staining shows the reddish coloration in intestine lumen is not due to the red blood cells. (F) 2 dpf old morphants, showing the accumulation of 
blood cells near the anus. The negative control for irf6 morphants: MO-STD injected embryos. The negative controls for R84C dominant 

























Percentage of phenotypes (%) 
Severity (LowÆ High) 
Embryo 
No. 
Percentage of head cartilage phenotypes (%) 
Severity (LowÆ High) 
Embryo 
No. 






 Wildtype Kinked pharyngeal 
arches,  misplaced, 
reduced or absent 
P3-7 
Non-specific 




Uninjected 0 100.0 0 0 0 995 99.4 0.6 880 
STD 16 100.0 0 0 0 66 100.0 0 66 
Xi 12 45.1 0 4.9 35.7 182 92.9 7.1 170 
 10 79.5 0 16.4 4.1 122 96.7 3.3 122 
X 16 22.6 0 19.4 58.1 62 0 21.1 78.9 38 
 12 32.2 0 26.1 41.7 115 29.0 51.0 20.0 45 
 10 46.7 0 42.2 11.1 135 59.5 40.5 0 163 
 8 62.2 0 33.1 4.7 127 - - - - 
Y 16 2.1 0 9.7 88.2 144 0 0 100.0 98 
 12 4.5 0 38.6 56.8 88 12.5 45.0 42.5 40 
 10 14.0 0 39.5 25.6 43 42.1 57.9 30.1 44 
 8 26.8 0 44.6 28.6 56 - - - - 
Z 12 6.0 0 48.0 46.0 100 0 16.7 83.3 48 
 10 18.2 0 54.5 27.3 44 11.4 59.1 29.5 44 
 8 37.9 0 60.0 2.1 95 16.0 66.0 18.0 50 
E4I4 32 34.7 57.8 7.4 0 121 92.5 7.5 0 120 
WT irf6 
mRNA 
0.5 100.0 0 0 0 78 100.0 0 0 78 
R84C irf6 
mRNA 
0.5 60.5 29.8 9.8 0 215 90.1 9.9 0 215 
 
STD, Xi, X, Y, Z, and E4I4 are morpholinos used in knockdown analysis. X, Y, and Z are translating-block morpholinos. STD is the negative control. Xi is a 
4-base mis-pairing control in contrast to X.  E4I4 is a splicing-modified morpholino. Injected embryos were raised to 5 dpf. Head cartilages were detected 
using alcian blue staining. Phenotypes were observed using a dissecting microscope. Wildtype, reddish intestine and bloated abdomen phenotypes are shown 
in Figure 4. Head cartilage phenotypes (wildtype, kinked pharyngeal arches) are shown in Figure 7. Defective viscericranium as well as neurocranium is 
generally present in the larvae of ventrally curled body. Curled body and defective both craniums belong to the global defects, considered as non-specific 
phenotypes (not shown). 
 
6. The expression of molecular markers shows the organogenesis affected by Irf6 
irf6 was reported to be expressed in the epithelial cells of naris, otic vesicle and 
alimentary canal. The liver, exocrine pancreas and pharyngeal arches are also the 
organs expressing irf6. To investigate the function of Irf6 during zebrafish 
development, the organogenesis variations were analyzed with molecular markers in 
whole mount in situ hybridization analysis.   
 
As shown in Figure 3.15A, in the wildtype embryos at 26 hrs, dlx3 is expressed in the 
otic vesicle, olfactory placode and ventral postmigratory neural crest (Miller et al., 
2000; Piotrowski and Nusslein-Volhard, 2000). In irf6 morphants, the dlx3b 
expression in the neural crest stream 3 was down-regulated or completely absent, 
while expression in stream 1 and 2 as well as olfactory placode and otic vesicle 
remained unaffected (85%, n = 46). In 3 dpf wild-type embryos, the endoderm marker 
nkx2.3 was expressed in the intestine and foxA1/fkd7 was in the alimentary canal, liver 
and pancreas (Lee et al., 1996; Odenthal and Nusslein-Volhard, 1998). In irf6 
morphants, expression of nkx2.3 and foxA1 showed the reduced outlines of intestine, 
liver and pancreas (71%, n = 75; Fig. 3.15B and C). The molecular markers for liver, 
exocrine pancreas and endocrine pancreas are L-fabp, trypsin and insulin, respectively. 
We compared their expression in the three organs of the larvae from 3 to 5 dpf stages. 
In contrast to wildtype, irf6 morphants had significantly reduced or split liver and 
exocrine pancreas (93%, n = 131; Fig. 3.15D and E), while endocrine pancreas kept 
the same size as wildtype (81%, n = 89; Fig. 3.15F and G). However, endocrine 
pancreases of some morphants were split into two or more than two parts (16%, n = 
73). The percentage of reduced liver and pancreas present in MO-Xi injected larvae 
(8%, n = 59) was significantly lower than that in MO-X injected larvae (85%, n = 62). 
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The left-right asymmetry of liver and pancreas distribution was investigated. Majority 
of wildtype embryos had left liver and right pancreas. In the examined wildtype 
control group, 10% of embryos (n = 92) have an opposite asymmetry, with right liver 
and left pancreas. In the embryos inected with Xi, the mis-matched control, 10% of 
embryos have right liver and left pancreas (n = 29).  The percentages of opposite 
asymmetry in X, Y and Z morphants were 16% (n = 56), 14% (n = 37) and 12% (n = 
76), repectively. This result did not show the asymmetry of liver and pancreas 
distribution was affected with the down-regulation of irf6. 
 
The accumulation of blood cells near the anus was observed in some morphants. The 
gata-1 and βE-globin expression in the 1 dpf old embryos showed the red blood cells 
were accumulated inside the expanded intermediate cell mass (ICM) (79%, n = 43; 
Figure 3.15H and I). As irf6 was not expressed in vascular system, the defect present 
in the ICM should be due to an indirect effect by knockdown. 
 
Hematoxylin and eosin staining of transverse histological sections of 5 dpf larvae 
shows the intestine structure. The 5 dpf wildtype has a well-folded intestinal 
epithelium. The cells are in columnar shape. The nuclei are polarized to the base of 
the cells (Ng et al., 2005); Fig. 3.16A, H and J). Nevertheless, the guts of morphants 
show a reduced lumen size. The intestinal walls are thin and the epithelium lacks 
folds (Fig. 3.16B, C, G, I and K). The epitheliel cells are cuboidal. The situation of 
nuclei is at the center of cells and not polarized (Fig. 3.16G and I).  Hence, the 




 Figure 3.15. Comparison of expression of molecular markers in irf6 morphants and wildtype. (A) dlx3b expression in the stream 3 (S3) of neural 
crest is absent in irf6 morphant. (B) foxA1 expression in liver (li), gut (g) and pancreas (p) of irf6 morphant indicates that these organs are 
reduced in size. (C) nkx2.3 expression shows the narrower expansion of intestine bulb (ib) and gut in irf6 morphant. (D and E) L-fabp expression 
in liver and trypsin expression in exocrine pancreas (xp) show the remarkably reduced or split liver and pancreas in irf6 morphants. (F and G) 
trypsin (try) expression is reduced in exocrine pancreas in irf6 morphants, in contrast to the consistent insulin (ins) expression in endocrine 
pancreas (np). Endocrine pancreas of some morphants distribute in multiple patches. ot, otic vesicle. (H and I) gata-1 and βE-globin expression 













Figure 3.16. Hematoxylin and eosin 
staining of intestines sections of irf6 
morphants and wildtype. Scale bar: 50 
μm.  (A-C) Esophagus (e) and liver (li) 
of 5 dpf larvae. Esophagus of irf6 
morphants shows the narrower lumen, 
reduced folding, whereas the muscularis 
(m) appears unaffected. Livers are 
reduced as well. (D-G) Intestine bulbs 
(ib) of wildtype larvae at 3 dpf (D), 4 
dpf (E) and 5 dpf (F) stages and irf6 
morphant at 5 dpf stage (G). The 
intesinal lumen is reduced. The intestinal 
wall is thinner, lack of folds and 
polarization. p, pancreas; sb, swimming 
bladder. (H-K) Posterior intestines (pi) 
of the 5 dpf old wildtype larvae and irf6. 





7. Defective pharyngeal arches in loss of irf6 function larvae 
The head cartilages of the 5 dpf irf6 morphants and embryos treated with dominant 
negative perturbation were examined with alcian blue staining. Their phenotypic 
responses are summarized in Table 3.2. In those bloated abdomen larvae, the 
neurocranial cartilages appear normal in size and morphology. Among the pharyngeal 
skeletons, the palatoquadrate, hyosymplectic and basihyal are not affected. The first 
arch, meckel’s cartilage, is kinked and points ventrally (Fig. 3.17B-D). In some 
embryos, the second arches - ceratohyals extend anteriorly (Fig. 3.16C). The 
alignment of the ceratobranchials (P3-P7) is disturbed. The arches are variably 
reduced and absent (Fig. 3.17B and C). Some embryos treated with dominant negative 
perturbation have forked distribution of P5-P7, due to the absence of hypobranchial 3 
and posterior basibranchial (Fig. 3.17D). Some embryos have half part of 
ceratobranchials (Fig. 3.17D). The ectopic expression of irf6 does not lead to the 
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Figure 3.17. Alcian blue staining analysis of the effects of loss of irf6 function on zebrafish head cartilages.  (A) Wildtype 5 dpf old larvae, 
injected with MO-STD. (B-D) Loss of irf6 function larvae. The defective severities of phenotypes are dosage-dependent. The Meckel’s 
cartilages point ventrally. Pharyngeal arches (P1-7) appear kinked in various levels. (B) Mildly defective moprhants show the kinked 
ceratobranchials. (C) The alignment of kinked pharyngeal arches from 1 to 7 is messy in some irf6 morphants. Various ceratobranchial cartilages 
(P4-6) are in weaker intensity. The basibranchials can not be observed. (D) Head cartilages by dominant negative perturbation (bloated abdomen 
larvae). Because of the absence of the posterior basibranchial, both sides of ceratobranchials P5-7 can not be jointed together. The one side of 
ceratohyal and ceratobranchials together with basihyal and basicbranchials are absent in some larvae. bb, basibranchial; cb, ceratobranchial; m, 










8. Expression of EGFP driven by the 4 kb irf6 promoter 
Perturbation of irf6 is to reflect the developmental program regulated by irf6. It is not 
able to investigate the genetic pathway upstream of irf6. What are the genes that 
regulate the expression of irf6? The promoter analysis can reveal the cis-elements 
targeted by those upstream genes.  
 
Using the GenomeWalker kit (Clontech), a 1.5-kb fragment upstream of the irf6 
transcription start was cloned. To analyze the regulatory elements in the region 
upstream of irf6 ATG translation start site, primers IRF-Pf4 
(5’GAACTGCGATCTTAAGTTGTTG) and 5’E2r 
(5’CGTGGATGAGACGACATCAC) were utilized to amplify the fragment covering 
the 1.5 kb putative promoter, 5’UTR and intron 1. Based on the assembled sequence 
in previous genomic structure data, a 3061 bp fragment was supposed to be amplified. 
However, a 3919 bp fragment was amplified when using the genomic DNA extracted 
from a different male adult fish as the template (Fig. 3.18A; EF028081). The 
sequencing results show that this 3919 bp fragment has a 2196 bp long intron 1. The 
alignment of the new 2196 bp Intron 1 with the previous 1289 bp Intron 1 indicates 
that two Introns are little conserved (Fig. 3.18B).   
 
The PCR was then performed on genomic DNA of seven individual fish using 
primers E1f and E2r, one fish (A) carried the homozygous 1289 bp intron 1 and four 
fish (B, C, E, F) carried the homozygous 2196 bp intron 1, two fish (D and G) carried 
heterozygous introns, both 2196 bp and 1289 bp ones (Fig. 3.18C).  
(A) 
    1 GAACTGCGAT CTTAAGTTGT TGTTAGAGTA GTTCACTTTT GTGATTAAAC TAACTAATCT 
   61 AATATATGCA CAAATATATT ACTGTAAAGC ATCCTGTGGA AATATCTTTA AGGGGTGAAC 
  121 TCATTTGTGC TTAGCACTTT ATAAAGCTGT TCTTGAAAGC ATTGTGAGGT ATGGTATCAC 
  181 ATTGTGGTTT GGCAGCCTAT CTGTACATTC ATTCATTCAT TCATTTTCTT TTCAGCTTAG 
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  241 TCCCTTTATT AATTAGGGGT TGCCACAGCG GAATGAGCCG CCAATTTATC CAGCATACGT 
  301 TTTACACAGC GGATGCCCTT CCAGCTGCAA CCCAACACTG GGAAACACCC ATACATTCTT 
  361 GCATTTACAC TCATACAGCC AATTTAGTTC ATCAATTCCC CTATAGGGCA TGTGTTTTGA 
  421 CTCAAATCAG CGACCTTCTT GCTATGAGGC GATCGTGCTA CTCACTGCGC CACTGTGACG 
  481 CTCCCTATCT GTACACTGTA AGTCTGTACA GTATGATAAA ATGTTTGGCA TGATGAATAT 
  541 TTTAATTCTC AAGTTTTATA TGAGAATTGT GTCCTTAATC AGGTGGCAAA GATTCTGAAT 
  601 GATCCAACTC ATTTTTTGTA TTCACACTTC CCTCTGGTGG TAGGGGATAT GGAGTGTAGG 
  661 TTGAACCGTT ATAAGAAACC TTTGTAGCCA TTAAAGTAGG TTTATTTAAC AAGAGTTTAT 
  721 CTTAATTAGC ATTATAATTA TTGTAACTAC TGTATTTTTA TTGTTTTTAT TGTTTGTATT 
  781 TATGGAATGT CTGCAGCAAT ATGGTGATGC CAATAACAAA TTTTCTGTCA TGGACAATAA 
  841 AGTGTTCTAC TACTACACTG TATGTCCAAT CATTTATAAT TTGGTCTGTG TGCTACTCAT 
  901 GATGGAAACA AATCTGCAAT TAGCTTATAA AATGTAAAAT TGTTAATTAA ACAAAGATAT 
  961 ATATTGAATG AGTGAGTGGT TGAAAAAGGC AGTAAGGAAT GTGTGTGAGA AACTGAAAAA 
 1021 CTTACAGAAA ATTATTTCAG AATTTAGAGA ATTTATTTTA GTCAGTTGTC ATTAACATTT 
 1081 CTAATTTAAG TAAATATGCT ACATTAGCAT ATTTAGCTAT TTTAAATGTT ATTGAAATTA 
 1141 GTTTAAATAA TATATACGTT TTAACAATTA AATCTTGTAG AAATAAAAAA AAACTTAAAA 
 1201 TCATTTTACA TTTTAATTAA ACGTTTAGTG TTGGATTCTT TCATTACATA TAGGCTGCAG 
 1261 GGTTTGATTA ACCCTGCAAA CAATATAATC AGCTTATGAA ATTGGACATG AATGTGTAGC 
 1321 ATGACCTAAT TGTATTTAAC CGAGTAGCAT TGCTAAAAAG AGAATGTATA TATATTTCTT 
 1381 ACTTGAGGGC CCGTGAGTGT GCGCGCGCCC GTGCCTGTTT GTGTGCGCGT GATTCAGAGA 
 1441 AATGCTCGTG ACGTCACCGC TGTACCTGAG TTTCGGCGGA GGGTGAAACT CTCGAGCAGA 
 1501 GATTCAGATA CACATGAAAC TCAGTTCATA CCCTTTCACA CGGACACACG GATATTCTGC 
 1561 GAGTGTTTTT TCCTACCTGT TACCGAAACA CACCGACATT AAACACGTTT ATTCATAAAA 
 1621 ACCGTTCGTT TTGGCGGCAA AGGCCTCAGG AGTGCTGCTT TTTCCTGCTT TGACGCGAGC 
                                    E1f 
 1681 GCTTCCTGAA ACCCTCAGGT GAGACTCATT AATATTTATA TCGCGTTAAT ATTTCATGTT 
 1741 TATAGTCTTT TACAAGCATT CCAGCTGTAT ATAACGCTTT CATGTGATTT AGTGTCGGGA 
 1801 TTTCAGCGTT TTAATCGACG GCGAGGATGT TTTCTCAAAG TCAGATGCTC TTTATTTGCT 
 1861 CTTTATATTG CTTTTTCTTT TTAAATTGTG CATTAAATTA CTGTTTTTGA CAACATATGA 
 1921 GCTTTATCTG TCCTGTCCGG TGTTTTAAGT TGTTAAAAAT CAATCGAAAC TTTATATATA 
 1981 TTCAATAAAA GTGCAGTTTC AACTGCTGAT ATTGGTAATG TTTTACTAAT AACATAATAT 
 2041 TTGCAGATTA AATAATACAA AATTTGTAGT GTCAGTTTGT TTTTGTTTAG TTATAATAAC 
 2101 AATAATATAA TTTGATAGTA TGTTTTATAA TTAACATAAT ATAATAGCTA TTCAGACAAC 
 2161 ACATGTTGAC CTTAGATGAC CAAAATCAAT ATTTTAGATT TAGTTTCATT AATGKTTTTT 
 2221 TTTTATTCTT TACAGTAAGT CTGTCATCAT GATTATGGTA GCTGATGTTA CTTGTATATA 
 2281 GTGTAGCTAT TGTAATACAT TTTAGAATAA TGTTAGTTCA AATGTTGCAT TCATTATAAA 
 2341 TTCTGTTAGG TATTTTAAGT GTTTTAGGCT TGATTTGCTC ATTTCTCTCT ATATTGTGAA 
 2401 GTAATGCTAA TGATTCTTAT ATTTATTAAG TATTATTAGT GTTTAAATGA AATGGTTTGT 
 2461 CTATTTATTT CTGCTTTCTC ATTGATATTG TGCAATACAT GAAATTTGCA TGAAGAAATA 
 2521 TTCATTCTTT TTGTGCATTT GTTAGCTCAG TTTGTGTTAT TTAAAGTGTT TGTTATGTTT 
 2581 TAATTGTAAT TTATTTTAAT CAAATTGATA ACATTTATGT GGTGACCTCT TGTAAAACAA 
 2641 AAGTTACAAT TTTAAAGTCA CAATTAATAT GATTAATAAC AATAGTAAAA GTAATCAGTT 
 2701 TACCATAAAA TATATTTAAT TTATTATTAT CAGKATTTTA ATTGKATTTY CTTTCTAAAA 
 2761 TATTGTTATT TTTGGCAGGC GTTAGTGATT AGTTTYAGAT TTGTTTTTAA TTTTCTATTT 
 2821 TKGTGTTCTA GTAGGTATTA TTAATAAAAT ACTTCAAAGT AATATACAAA TTTATATTAA 
 2881 TAATTAATAT AATTAATTTA TGTTTTCTTT AAGTTKGTAA TGTTTTAATT GTAATTTGCA 
 2941 TTTTATTATA AACACTATTT TAGTTTTATT AGTTGTATTT TATTTGTAAT TTTAGTATGT 
 3001 ATTTCAGGCA GTTGTCAATA TTTTCAAATT TTCTTTTCTT TTTAAAGTGT GTGCATATAT 
 3061 ATATATATAT ACACACATTG TTATTTTAAT ATTTATAAGT TATTAATATC TTCTATAGGT 
 3121 TTTCATGTTT TATTTGTAAC TTTCATTTTT TCTATTTTTT TTTCACTATT TTAGTTTTAT 
 3181 TATTTTTTGT ATTTCAGACA GTTAATAAGA ACATTTATTA TAATAATTAA CAGCTCTTCT 
 3241 TAATTTCTTT TCTTTTGGTT TTTCAGGCAA ACTTGAGTTA TTTTAATTTA ATAAAATTTG 
 3301 AGTAACATGA TAATGTAAAC AATATAAAGT AAGTTTCTAT CAGTATGATA ACCTTGGATA 
 3361 AAAGTATCAC GTTATCCTCT AAAATAAGTT CTTTTTAAAT GTCTGGGTAA AAAACAACAA 
 3421 TCCCCCCCCC CCCTATATTT TATTTTAAGA CACATTTAAG GTATTCTGAA ACAGTAAACA 
 3481 TGTCCTACTA CATAATTATA ATAAATCATT GCCTTCTGCT GTCTTCATTA GCTTCAAACA 
 3541 CAGATTTCTG TACATCTTAA AAAGGCATCT GTGGAGATCT GTCTGTTCTG TGAATATAAG 
 3601 GTAAAGCCGC TGCACTGTTC AGCTCTACAG CAGGCTGGAT GTTGCCTTAG AACACATTTG 
 3661 TTTCTTACAT ATTTGCTGGA TCATCGGCTG ATCAGTAGCT TTTTATCTGG TACTGTTACC 
 3721 CTAAAAACTT AATAAAACAA TTGTAAAAAC ACGTTAAAAA GAAAAACAAC TTGTATATAC 
 3781 ATTGGGAACA GCATAACAGA ACATTTGTGG TTTTAAAACT CTGACTTTTC CTAACAGTGG 
 3841 TGATCTTTAA AACCAGTTAT CATCACATGT CTAATGTTAA GTGTGTGTGT ACAGCCGGTG
 3901 TGATGTCGTC TCATCCACG
                      5’E2r 
(B) 
                        1                                               50 
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A irf6 Intron 1     (1) GTGAGACTCATTAATATTTATATCGCGTTTATATTTAATGTTTATAGTCT 
B irf6 Intron 1     (1) GTGAGACTCATTAATATTTATATCGCGTTAATATTTCATGTTTATAGTCT 
      Consensus     (1) GTGAGACTCATTAATATTTATATCGCGTT ATATTT ATGTTTATAGTCT 
                        51                                             100 
A irf6 Intron 1    (51) TTTACAATCATTCCAGCAGTATAAAACGCTTTCATGTGATTTAGTGTCGG 
B irf6 Intron 1    (51) TTTACAAGCATTCCAGCTGTATATAACGCTTTCATGTGATTTAGTGTCGG 
      Consensus    (51) TTTACAA CATTCCAGC GTATA AACGCTTTCATGTGATTTAGTGTCGG 
                        101                                            150 
A irf6 Intron 1   (101) ATTTTCAGCGTTTTAATCGACGACGAGGATATTTTCTTGCTTTAGAATCA 
B irf6 Intron 1   (101) GATTTCAGCGTTTTAATCGACGGCGAGGATGTTTTCT------------- 
      Consensus   (101)   TTTCAGCGTTTTAATCGACG CGAGGAT TTTTCT              
                        151                                            200 
A irf6 Intron 1   (151) AATATCAAAGTCAG--GCTCTTTATTTACCCTTTATTTACTGTATTATGT 
B irf6 Intron 1   (138) -----CAAAGTCAGATGCTCTTTATTTGCTCTTTAT-------ATT---- 
      Consensus   (151)      CAAAGTCAG  GCTCTTTATTT C CTTTAT       ATT     
                        201                                            250 
A irf6 Intron 1   (199) GGCTTTTTCTTTTCAAACTACCCATTGAATCAATGTTTT-GACCATACAT 
B irf6 Intron 1   (172) -GCTTTTTCTTTTTAAATTGTGCATTAAATTACTGTTTTTGACAACATAT 
      Consensus   (201)  GCTTTTTCTTTT AAA T   CATT AAT A TGTTTT GAC A A AT 
                        251                                            300 
A irf6 Intron 1   (248) GAGCTTTTTCTGTGTTGTACATTTAGTCAATTTGTTTATAATCAATGGAA 
B irf6 Intron 1   (221) GAGCTTTATCTGTCCTGTCCGGTGTTTTAAGTTGTTAAAAATCAATCGAA 
      Consensus   (251) GAGCTTT TCTGT  TGT C  T   T AA TTGTT A AATCAAT GAA 
                        301                                            350 
A irf6 Intron 1   (298) ACTT---AAATGTTCAATAAAGTTGCTGTTTCA------GA-ATTGTTTA 
B irf6 Intron 1   (271) ACTTTATATATATTCAATAAAAGTGCAGTTTCAACTGCTGATATTGGTAA 
      Consensus   (301) ACTT   A AT TTCAATAAA  TGC GTTTCA      GA ATTG T A 
                        351                                            400 
A irf6 Intron 1   (338) TATTTTG-TAATATTGCAATATTTGCGCATTTTAATGTTAGAGCGGTTGT 
B irf6 Intron 1   (321) TGTTTTACTAATAACATAATATTTGCAGATTA-AATAATACAAAATTTGT 
      Consensus   (351) T TTTT  TAATA    AATATTTGC  ATT  AAT  TA A    TTGT 
                        401                                            450 
A irf6 Intron 1   (387) --TATCAGTTTGTTTAT--TGTGTT---A-------AATAAA-------- 
B irf6 Intron 1   (370) AGTGTCAGTTTGTTTTTGTTTAGTTATAATAACAATAATATAATTTGATA 
      Consensus   (401)   T TCAGTTTGTTT T  T  GTT   A       AATA A         
                        451                                            500 
A irf6 Intron 1   (415) ----GTTTTATGATAAAAAGTA-ATACTAGTTATTCAGACAAGCCATGGT 
B irf6 Intron 1   (420) GTATGTTTTATAATTAACATAATATAATAGCTATTCAGACAACACATGTT 
      Consensus   (451)     GTTTTAT AT AA A  A ATA TAG TATTCAGACAA  CATG T 
                        501                                            550 
A irf6 Intron 1   (460) AACTTTAGATGAGCAAAAATCAAT-----AAATATATTTT-----AGGCT 
B irf6 Intron 1   (470) GACCTTAGATGACCAAAA-TCAATATTTTAGATTTAGTTTCATTAATGKT 
      Consensus   (501)  AC TTAGATGA CAAAA TCAAT     A AT TA TTT     A G T 
                        551                                            600 
A irf6 Intron 1   (500) CTGTTTTAATTCTTT--------TTTTTCATGATTATGTTGATTAACAGA 
B irf6 Intron 1   (519) TTTTTTTTATTCTTTACAGTAAGTCTGTCATCATGATTATGGT-AGCTGA 
      Consensus   (551)  T TTTT ATTCTTT        T T TCAT AT AT  TG T A C GA 
                        601                                            650 
A irf6 Intron 1   (542) TGTTACTTTTATTTGATGTAG---------TACATTTCAGAATAATATCA 
B irf6 Intron 1   (568) TGTTACTTGTATATAGTGTAGCTATTGTAATACATTTTAGAATAATGTTA 
      Consensus   (601) TGTTACTT TAT T  TGTAG         TACATTT AGAATAAT T A 
                        651                                            700 
A irf6 Intron 1   (583) GTGCAAATGGTGCATTAATTAAAATGTCTGTTAGATAT------------ 
B irf6 Intron 1   (618) GTTCAAATGTTGCATTCATTATAAATTCTGTTAGGTATTTTAAGTGTTTT 
      Consensus   (651) GT CAAATG TGCATT ATTA AA  TCTGTTAG TAT             
                        701                                            750 
A irf6 Intron 1   (621) AAGCTT------------TTTTTCAGTATTGTGAAGAAATGTTAATGATT 
B irf6 Intron 1   (668) AGGCTTGATTTGCTCATTTCTCTCTATATTGTGAAGTAATGCTAATGATT 
      Consensus   (701) A GCTT            T T TC  TATTGTGAAG AATG TAATGATT 
                        751                                            800 
A irf6 Intron 1   (659) CTTATATA-AT---------TTGCTCTTTCAAAGGCTTAGTTTATGTCCT 
B irf6 Intron 1   (718) CTTATATTTATTAAGTATTATTAGTGTTTAAATGAAATGGTTTGTCTATT 
      Consensus   (751) CTTATAT  AT         TT  T TTT AA G   T GTTT T T  T 
                        801                                            850 
A irf6 Intron 1   (699) G-TTTTTGCTTTCTTACTCGC-TTGT---AT---TGATATATGCGTAAAA 
B irf6 Intron 1   (768) TATTTCTGCTTTCTCATTGATATTGTGCAATACATGAAATTTGCATGAAG 
      Consensus   (801)   TTT TGCTTTCT A T    TTGT   AT   TGA AT TGC T AA  
                        851                                            900 
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A irf6 Intron 1   (741) TAATGTGTAT----TATGTTAATTTGTT-------TTTAATAAAATAAAA 
B irf6 Intron 1   (818) AAATATTCATTCTTTTTGTGCATTTGTTAGCTCAGTTTGTGTTATTTAAA 
      Consensus   (851)  AAT T  AT    T TGT  ATTTGTT       TTT     A T AAA 
                        901                                            950 
A irf6 Intron 1   (780) ACATGTAACAA-TAAACATTTTACTTTTTTAAAGTCACTTTAATACAATT 
B irf6 Intron 1   (868) GTGTTTGTTATGTTTTAATTGTAATTTATTTTAATCAAATTGATAACATT 
      Consensus   (901)    T T   A  T    ATT TA TTT TT  A TCA  TT ATA  ATT 
                        951                                           1000 
A irf6 Intron 1   (829) AAT------A--------A---CAATA--------TTAAAAGTTATC--T 
B irf6 Intron 1   (918) TATGTGGTGACCTCTTGTAAAACAAAAGTTACAATTTTAAAGTCACAATT 
      Consensus   (951)  AT      A        A   CAA A        TT AAAGT A    T 
                        1001                                          1050 
A irf6 Intron 1   (852) ATTATGATATATA-----TGTGTGTGTA---TGTGTATATATGTGTGTGT 
B irf6 Intron 1   (968) AATATGATTAATAACAATAGTAAAAGTAATCAGTTTACCATAAAATATAT 
      Consensus  (1001) A TATGAT  ATA      GT    GTA    GT TA        T T T 
                        1051                                          1100 
A irf6 Intron 1   (894) GTAATTTATTATG-TAACTATTTTAACTGTCAATCTTTTCTAAAATATTG 
B irf6 Intron 1  (1018) TTAATTTATTATTATCAGKATTTTAATTGKATTTYCTTTCTAAAATATTG 
      Consensus  (1051)  TAATTTATTAT  T A  ATTTTAA TG    T  TTTCTAAAATATTG 
                        1101                                          1150 
A irf6 Intron 1   (943) CTAGTTTTGGTAGGTCTCAGTGATTAGGTTTAGATTCCTTTT--ATCTTC 
B irf6 Intron 1  (1068) TTATTTTTGGCAGGCGTTAGTGATTAGTTTYAGATTTGTTTTTAATTTTC 
      Consensus  (1101)  TA TTTTGG AGG  T AGTGATTAG TT AGATT  TTTT  AT TTC 
                        1151                                          1200 
A irf6 Intron 1   (991) TATTCTTATTTT--------TATTATCATTAAA-TAATAAACATTTCTGT 
B irf6 Intron 1  (1118) TATTTTKGTGTTCTAGTAGGTATTATTAATAAAATACTTCAAAGTAATAT 
      Consensus  (1151) TATT T  T TT        TATTAT A TAAA TA T  A A T  T T 
                        1201                                          1250 
A irf6 Intron 1  (1032) TAAAACTTTTTTT----TTTTG-ATTATTTA--TATCCTCTATATAACGT 
B irf6 Intron 1  (1168) ACAAATTTATATTAATAATTAATATAATTAATTTATGTTTTCTTTAAGTT 
      Consensus  (1201)   AAA TT T TT     TT   AT ATT A  TAT  T T T TAA  T 
                        1251                                          1300 
A irf6 Intron 1  (1075) TGTCATGTTT-----GTAATTTGTATTTTATTATAAACTATTAAAATTGT 
B irf6 Intron 1  (1218) KGTAATGTTTTAATTGTAATTTGCATTTTATTATAAAC-ACTATTTTAGT 
      Consensus  (1251)  GT ATGTTT     GTAATTTG ATTTTATTATAAAC A TA   T GT 
                        1301                                          1350 
A irf6 Intron 1  (1120) GATATTGATTAAATTCTTTGCAAAATGCGTAAATGTATTT-ATCCACTTT 
B irf6 Intron 1  (1267) TTTATTAGTTGTATTTTATTTGTAATTTTAGTATGTATTTCAGGCAGTTG 
      Consensus  (1301)   TATT  TT  ATT T T    AAT      ATGTATTT A  CA TT  
                        1351                                          1400 
A irf6 Intron 1  (1169) TAATAATTGCTTTATTTACTTAGATTTTCTTAAGCAGATTTGAGTTTTGT 
B irf6 Intron 1  (1317) TCAATATTTTCAAATTTTCTTTTCTTTT--TAAAGTGTGTGCATATATAT 
      Consensus  (1351) T A  ATT     ATTT CTT   TTTT  TAA   G  T  A  T T T 
                        1401                                          1450 
A irf6 Intron 1  (1219) TAATATTGTAAAATGTATGGCAAAATAAAA--CATAAATATATAAAGTCA 
B irf6 Intron 1  (1365) ATATATATACACACAT-TGTTATTTTAATATTTATAAGTTATTAATATCT 
      Consensus  (1401)   ATAT    A A  T TG  A   TAA A   ATAA T   TAA  TC  
                        1451                                          1500 
A irf6 Intron 1  (1267) TGATGAGGTGTA-------------------------------------- 
B irf6 Intron 1  (1414) TCTATAGGTTTTCATGTTTTATTTGTAACTTTCATTTTTTCTATTTTTTT 
      Consensus  (1451) T    AGGT T   TGT T                                
                        1501                                          1550 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1464) TTCACTATTTTAGTTTTATTATTTTTTGTATTTCAGACAGTTAATAAGAA 
      Consensus  (1501)                                                    
                        1551                                          1600 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1514) CATTTATTATAATAATTAACAGCTCTTCTTAATTTCTTTTCTTTTGGTTT 
      Consensus  (1551)                                                    
                        1601                                          1650 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1564) TTCAGGCAAACTTGAGTTATTTTAATTTAATAAAATTTGAGTAACATGAT 
      Consensus  (1601)                                                    
                        1651                                          1700 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1614) AATGTAAACAATATAAAGTAAGTTTCTATCAGTATGATAACCTTGGATAA 
      Consensus  (1651)                                                    
                        1701                                          1750 
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A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1664) AAGTATCACGTTATCCTCTAAAATAAGTTCTTTTTAAATGTCTGGGTAAA 
      Consensus  (1701)                                                    
                        1751                                          1800 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1714) AAACAACAATCCCCCCCCCCCCTATATTTTATTTTAAGACACATTTAAGG 
      Consensus  (1751)                                                    
                        1801                                          1850 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1764) TATTCTGAAACAGTAAACATGTCCTACTACATAATTATAATAAATCATTG 
      Consensus  (1801)                                                    
                        1851                                          1900 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1814) CCTTCTGCTGTCTTCATTAGCTTCAAACACAGATTTCTGTACATCTTAAA 
      Consensus  (1851)                                                    
                        1901                                          1950 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1864) AAGGCATCTGTGGAGATCTGTCTGTTCTGTGAATATAAGGTAAAGCCGCT 
      Consensus  (1901)                                                    
                        1951                                          2000 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1914) GCACTGTTCAGCTCTACAGCAGGCTGGATGTTGCCTTAGAACACATTTGT 
      Consensus  (1951)                                                    
                        2001                                          2050 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (1964) TTCTTACATATTTGCTGGATCATCGGCTGATCAGTAGCTTTTTATCTGGT 
      Consensus  (2001)                                                    
                        2051                                          2100 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (2014) ACTGTTACCCTAAAAACTTAATAAAACAATTGTAAAAACACGTTAAAAAG 
      Consensus  (2051)                                                    
                        2101                                          2150 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (2064) AAAAACAACTTGTATATACATTGGGAACAGCATAACAGAACATTTGTGGT 
      Consensus  (2101)                                                    
                        2151                                          2200 
A irf6 Intron 1  (1290) -------------------------------------------------- 
B irf6 Intron 1  (2114) TTTAAAACTCTGACTTTTCCTAACAGTGGTGATCTTTAAAACCAGTTATC 
      Consensus  (2151)                                                    
                        2201                         2233 
A irf6 Intron 1  (1290) ----------------------TGTGTGTACAG 
B irf6 Intron 1  (2164) ATCACATGTCTAATGTTAAGTGTGTGTGTACAG 
















Figure 3.18. (A) The sequence of putative irf6 promoter fragment amplified with 
IRF-Pf4 and 5’E2r. The sequences of exon 1 and exon 2 are in bold letter. (B) The 
alignment of two alternative Intron 1 of irf6. (C) Two sizes of PCR products, 1431 bp 
and 2338 bp, were amplified from seven fish individuals (fish A to G) using primers 
E1f and E2r. 
 
The 3919 bp fragment was cloned into an expression vector pXD-Ef1α-EGFPpA. 
This plasmid was injected into embryos to determine the cis-element specificity. As 
shown in Fig 3.19, the EGFP expression was in the yolk and in cells without specific 
pattern. The expression does not recapitulate the pattern of in situ hybridization. To 
study the regulatory elements of irf6 gene, a longer promoter that can drive the 













Figure 3.19.  The EGFP expression in embryos injected with the expression vector pXD-Ef1α-4kbirf6-EGFPpA. The EGFP expression does not 














CHAPTER 4   DISCUSSION AND CONCLUSION 
 
1. Zebrafish Irf6 and its cDNA  
This study has identified the zebrafish ortholog of the human IRF6 gene and 
determined its full-length cDNA, gene structure, and chromosomal location. The 
predicted zebrafish IRF6 peptide contains the typical functional domains found in 
other members of the IRF family, a winged-helix DNA-binding motif and a protein-
binding motif.  Both motifs of IRF6 are highly conserved among the different species 
(Fig. 3.1; Table 3.1). It is interesting that 3’UTR of the cDNA is unusually GT-rich, a 
feature which is not observed in the orthologous human, mouse and Xenopus cDNAs. 
UTRs control the stability, cytoplasmic localization and translational efficiency of 
mRNAs. However, the functional significance of this GT-rich sequence is not clear.  
A possible role is that GT repeats facilitate the alternative splicing, resulting in irf6 
transcripts in various 3’ UTR. In future study, RT-PCR amplified with primers 
targeting to 3’ coding region and 3’ UTR can help identify these transcript varients. 
The function of this 3’UTR can be studied by observation of the fate of mRNA of a 
reporter gene with a GU-rich 3’UTR in fish embryos.  
 
2. IRF6 orthologs of various organisms have conserved genomic structures and 
conserved syntenic arrangement. 
A comparison of the genomic organization of zebrafish irf6 with its orthologs in 
human, mouse, and Fugu revealed strong structural conservation among these species, 
especially in the seven coding exons.  Four exon-exon junctions are conserved among 
the four organisms (Fig. 3.4).  In addition, the exons containing the protein-interaction 
domain are identical in size in all four species.  Although the other exons are different 
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in size between species, the arrangement and order of the highly conserved DNA-
binding domain and the protein interaction domains are very similar.  
 
Another interesting finding is the syntenic loci on the LG 22 chromosome. According 
to Ensembl database ZV6, LG 22 has a length about 48 Mb. In this thesis, the known 
genes that distribute in the first 5.4 Mb were analyzed. The gene loci of their 
orthologs of human and mouse were compared (Figure 3.6B). Four different 
conserved syntenic groups were observed: (1) pparb -- sfrs3 -- bysl – trfp (human 
chromosome 6 and mouse chromosome 17); (2) camk1g -- ripk5 – btg2 – rbbp5 – irf6 
(human chrosome 1 and mouse chromosome 1); (3) hpse – btc (human chromosome 4 
and mouse chromosome 5); (4) timm44 – trif – uhrf1 – trh1 (human chromosome 19 
and mouse chromosome 8).  The multiple syntenies in one zebrafish chromosome 
indicate that chromosomal rearrangement occurs among organisms during divergent 
evolution. However, it is unknown what the mechanism giving rise to the 
chromosome rearrangement is. In addition, the duplication of irf6 gene was not found. 
 
3. Comparison of IRF6 expression patterns 
A detailed in situ hybridization analysis of whole-mounts, flat-mounts and 
cryosections were performed to document zebrafish irf6 expression from the cleavage 
stage to the day 5 hatchling.  Zebrafish irf6 transcripts were detected in zygotic, 
cleavage and blastula stage embryos, indicative of maternal transcript deposition in 
the oocyte.  These observations are similar to the findings of (Hatada et al., 1997) in 
Xenopus, in which IRF6 transcripts were shown to be present in cleavage (32-cell) 
and blastula (stage 8) embryos, as well as in the ovaries of adult frogs.  Using 
northern blot analysis on whole embryos, they also detected IRF6 transcripts in early 
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gastrula (stage 10) through neural groove (stage18), embryos after which expression 
decreased sharply until it was undetectable.  Using whole-mount in situ hybridization, 
however, they were able to observe IRF6 expression in both neural groove (stage 18) 
and tail bud (stage 25) embryos, predominantly in the presumptive somitic mesoderm 
and the tailbud somitic mesoderm, respectively. 
 
In contrast, zygotic expression of zebrafish irf6 transcripts was observed to be 
concentrated in the forerunner cells of gastrula stage embryos, and later in the 
Kupffer’s vesicle after the 100% epiboly stage.  Thereafter, irf6 expression was 
undetectable at the 6-somite and 10-somite stages.  Beginning with the 14-somite 
stage, irf6 expression was again observed, this time in the ectodermally-derived otic 
placode, and then the endodermally-derived cloaca and gut.  By the 22-somite stage, 
irf6 expression was observed in another ectodermal organ, the olfactory placode.  
Therefore, although both Xenopus IRF6 and zebrafish irf6 are orthologous genes, 
their zygotic expression patterns appear quite different (Ben et al., 2005; Hatada et al., 
1997), suggesting that their functions may have diverged.  Nonetheless, we cannot 
exclude the possibility that there may be another copy of the irf6 gene, due to genome 
duplication events that occurred in the zebrafish, which may be expressed in a more 
similar pattern as the Xenopus IRF6 gene. 
 
The expression pattern of mouse and chick Irf6 has also been reported (Knight et al., 
2006; Kondo et al., 2002).  However, no expression data are available for the 
cleavage stages.  In mouse, the earliest stage of Irf6 expression reported was in the 
4.5-day embryo - the attaching blastocyst.  RT-PCR and Northern blot analyses 
indicate that mouse Irf6 is expressed in a broad range of embryonic stages (Kondo et 
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al., 2002).  Whole-mount in situ hybridization analysis revealed Irf6 expression in the 
epithelial cells of the facial processes during the period when the upper lip, primary 
palate and secondary palate in mouse are fusing. Higher Irf6 expression at the medial 
edges of palate, the tooth germ, thyroglossal duct, hair follicles, skin and external 
genitalia were reported (Knight et al., 2006; Kondo et al., 2002).  In addition, Irf6 
transcripts could also be detected by RT-PCR in multiple adult mouse tissues, 
including the eyes, heart, liver, lung, placenta, skin, testes and tongue (Kondo et al., 
2002).  Expression in the otic or olfactory vesicles was not reported. In the chick, 
where the primary palate fuses but the secondary palate is naturally cleft, Irf6 was 
expressed in the fusing epithelial cells of the primary palate but not in the medial edge 
epithelia of the secondary palate. In addition, Irf6 is expressed in the hair follicles of 
both mouse and chick (Knight et al., 2006).  
 
In the zebrafish embryo, irf6 is specifically expressed in the epithelial linings of the 
olfactory and otic vesicles, pharyngeal arches, as well as endodermally-derived tissues 
and organs of the alimentary system.  Therefore, although some of the sites of 
expression appear to be similar, there are obvious differences between the species. 
 
4. The association of irf6 expression pattern and human VWS and PPS disorders.  
In human, intragenic mutations and deletions of the IRF6 gene have been identified in 
two allelic human oral clefting disorders, Van der Woude syndrome (VWS) and 
poplitieal pterygium syndrome (PPS) (Kondo et al., 2002). Both disorders are 
characterized by pits and/or sinuses of the lower lip, cleft lip and/or cleft palate (CL/P, 
CP), and hypodontia, with PPS presenting additional features of webbing of the lower 
limbs, bands of mucous membrance between the jaws, syndactyly, and genital 
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anomalies.  Additionally, both otitis media and sensorineural deafness have recently 
been reported to be associated with VWS (Kantaputra et al., 2002; Salamone and 
Myer, 2004).  Furthermore, a PPS baby has been reported with additional unusual 
features including malformed alae nasi (Sasidharan and Ravi, 2004).  It is possible 
that these conditions are either isolated individual-specific presentations or are 
secondary manifestations of the palatal clefting.  Interestingly, however, we observed 
strong irf6 expression in the developing zebrafish otic and olfactory vesicles in 
addition to expression in the mouth, pharynx and pharyngeal arches.  These data 
suggest the possibility that the auditory and nasal problems observed in some VWS 
patients may be a primary effect of the IRF6 mutation itself.  Assuming conservation 
of gene function between man and fish, it is tempting to speculate that the lip pits, oral 
clefts, malformed alae nasi, otitis media and sensorineural hearing loss of VWS and 
PPS patients could be caused by the malformation of the epithelium lining the oral 
cavity, olfactory vesicles and/or otic vesicles during fetal developmental and that 
IRF6 is required for the normal morphogenesis of the epithelial lining of these 
organs/structures. 
 
5. Loss of function analysis 
This project shows the organogenesis affected by the loss of irf6 function analysis. 
Both transient knockdown and dominant negative perturbation respectively indicate 
that irf6 gene is involved in the development of endodermal digestive organs and 
pharyngeal arches.  
 
5.1 Phenotypes of morphants and dominant negative perturbation 
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5.1.1 Comparison of translating-block knockdown and splicing-modified knockdown 
The irf6 knockdown studies were performed at two different levels: 1. morpholinos X, 
Y and Z inhibit the ATG-translation of wildtype transcripts; 2. E4I4 inhibits the 
production of the wildtype transcripts. A severe defective phenotype showing bloated 
abdomen with reduced head and eyes is present in the majority of X/Y/Z morphants 
and minority of E4I4 morphants. A mild defective phenotype, appearing with the 
reddish intestine, is more frequently present in E4I4 morphants. irf6 was the maternal 
transcripts, abundantly expressed during the zygotic and cleavage periods. The 
injection of either morpholinos X, Y or Z immediately eliminates the translation of 
maternal transcripts, and then the translation of zygotic transcripts. In contrast, the 
injection of splicing-modified morpholino E4I4 at 1-4 cell stage can only target to the 
zygotic transcript while the translation of maternal transcripts is still normal. 
Therefore, the percentage of severe defective phenotype by the injection of either X, 
Y or Z is much higher than that by the E4I4 injection.  
 
The knockdown using splicing modified morpholino was first applied on fgf8 gene 
(Draper et al., 2001). This study revealed that splicing modified transcript by fgf8-
E3I3 was present from sphere stage, and was predominant at shield stage and later. 
However, we found that irf6-E4I4 has a different effectiveness pattern. In the injected 
embryos, irf6-E4I4 splice variant was not present before and during gastrulation 
period. It was first detected in the 1 dpf old injected embryos, and then exceeds the 
amount of wildtype transcript at 2 dpf old. After that, wildtype transcript amount 
exceeds the variant amount again (Figure 3.11B). Why has the irf6-E4I4 a delayed 
interference on the pre-mRNA splicing machinery? It is probably due to the long life 
of the wildtype irf6 maternal transcripts and the little amount of zygotic transcripts in 
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cells at early stages. Nevertheless, it provides a unique model to reveal the 
organogenesis problem when the reduced irf6 expression happens in later embryonic 
stage. The lethal effect of irf6-E3I3 morpholino is unspecific, probably due to the 
(GT)5 repeat sequence in the oligo. 
 
5.1.2 Dominant negative perturbation 
In human, the dominant negative mutations on IRF6 cause the Popliteal pterygium 
syndrome, an orofacial clefting disorder associated with skin and genital anomalies. 
Eight of 13 mutations convert the Arg84 to His or Cys (Kondo et al., 2002). To study 
the effects of dominant negative mutations on zebrafish, we introduced capped 
mRNA containing the point mutation leading to R84C into zebrafish embryos at the 
1-4 cell stage. Capped mRNA of EGFP was co-injected with irf6 mRNA as a control 
to test the protein translation time-point.  The protein encoded by capped mRNA was 
produced as early as blastulation period, according to the observation of green 
fluorescence. Hence, R84CIrf6 protein is supposed to be present from blastulation 
period and perturb the wildtype proteins translated from both maternal and zygotic 
transcripts. The embryos treated with this dominant negative perturbation have the 
defective phenotypes identical to the irf6-E4I4 morphants. E4I4 morpholino targeted 
to knockdown zygotic transcripts. Embryos injected with E4I4 produced a 155-aa 
truncated protein. This truncated protein has both the disrupted DNA binding and 
protein-protein interaction abilities. It is interesting that the effect of knockdown of 
zygotic transcripts is identical to that of dominant negative perturbation. 
 
5.2 Loss of irf6 function causes malformation of digestive organs under-develop  
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Irf6 was found to be expressed in the epithelial cells of intestine. Intestine is the first 
affected digestive organ by loss of irf6 function. Some of 5 dpf old larvae develop 
reddish coloration in the lumen of instestine. The Wright staining of cryosection 
sample and the whole mount o-dianisidine staining indicated that the reddish intestine 
was not caused by the accumulation of red blood cells. An explanation is that the 
intestine is filled with red pigments secreted by gallbladder and liver. The underlying 
pathological mechanism is unknown. The histological detection with hematoxylin and 
eosin however does not show any morphological changes in the intestinal lumen and 
wall. Their liver and pancreas develop in normal shape. In those larvae having severe 
phenotype of bloated abdomen, the gut has narrow lumen, the epithelium fails to 
properly fold and the nuclei fail to locate at the base of cells. Both liver and exocrine 
pancreas fail to grow while the size of endocrine is unaffected. The defects are 
corresponding to the expression pattern of irf6. Some larvae have a split liver and 
pancreas. Three possibilities can cause the reduced liver and exocrine pancreas: (1) 
the specification of organ development is blocked or delayed, (2) cell apoptosis is 
increased, or (3) cells fail to proliferate when Irf6 is down-regulated. In future study, 
expression of molecular markers prox1 (for primordial liver) and pdx1 (for primordial 
pancreas) will be detected to examine the organ specification. The genetically 
programmed cell death will be examined with TUNNEL staining. Cell proliferation 
will be assessed using 5-bromo-2V-deoxyuridine (BrdU)/5-fluoro-2V-deoxyuridine 
(FdU) staining. 
 
Although the growth of endocrine pancreas appeared unaffected, we found that some 
insulin-positive cells migrate to the outside of major islet. The multiple patches of 
endocrine pancreas suggest certain dependence of endocrine pancreas orientation on 
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exocrine pancreas, although the endocrine pancreas is budding as early as the 10-
somite stage, before the budding of the anterior exocrine pancreas by 40 hpf. 
 
5.3 Loss of irf6 function leads to deformations in pharyngeal arches 
irf6 was reported to be expressed in the zebrafish cartilages ceratohyal and 
ceratobranchials (Ben et al., 2005). At 5 dpf stage when the head cartilages have 
developed, the P3-7 are variably misplaced, reduced or absent in irf6 loss of function 
embryos. This is consistent with the absence of stream 3 of postmigratory neural crest 
in early stage morphants (1 dpf) when detected with dlx3 in whole-mount in situ 
hybridization, as the stream 3 of neural crest is the primordium of cartilages for 
pharyngeal arches 3-7.  Although irf6 is not expressed in Meckel’s cartilage, this first 
arch is normal in size but displaced. Thus, irf6 is essential to the proper alignment and 
formation of pharyngeal arches. Why down-regulation of irf6 gives rise to abnormal 
pharyngeal arch is unclear.  
 
5.4 Evaluation of zebrafish morphants, mouse Irf6 mutants to study VWS/PPS 
syndrome 
When irf6 is disrupted in zebrafish, the most predominant/evident defects occur on 
the digestive organs. The proliferation and differentiation of intestine epithelial cells 
into columnar and polarized cells appear to be inhibited. The liver and pancreas can 
not grow up to the normal size. In human, no cases were reported to have digestive 
problem. VWS or PPS occurs when IRF6 defective mutation happened on one 
chromosome. Evident defects show that the palatogenesis and skin morphogenesis are 
affected, consistent with the Irf6 expression in facial tissues and hair follicle of mouse 
and chick. In spite of this, the knowledge of IRF6 expression in endodermal organs of 
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human, mouse and chick are incomplete so far. Irf6 expression in mouse liver is 
detected with RT-PCR. One possibility to explain the various defects present in the 
different organisms by loss of IRF6 function is that VWS and PPS patients are 
heterozygous for a normal and a mutated copy of IRF6. Half dosage of defective IRF6 
protein may not be sufficient to cause severe functional problems in the alimentary 
system. It is possible that digestive functions, among others, may be severely affected 
when both copies of IRF6 are mutated.  Homozygosity or compound heterozygosity 
for IRF6 mutations may also be developmentally lethal, as homozygous affected 
individuals have never been documented. Our zebrafish irf6 knockdown experiments 
suggest that the abnormal development of the digestive endoderm is dosage-
dependent, lending support to this hypothesis.  
 
 A knockout mouse strain carrying a null mutation was constructed (Ingraham et al., 
2006). This null mutation was made by the insertion of the gene trap vector into intron 
1 (gt1). Meanwhile, a knockin mouse strain was developed by introducing the R84C 
dominant negative mutation (Richardson et al., 2006). In contrast to oral cleft VWS 
and PPS, mice that carry heterozygous gt1 mutation have wildtype appearance, while 
mice that are heterozygous in R84C mutation have intraoral adhesions between 
epithelia. In some mice, the oral epithelial adhesion is so severe that mice are not able 
to open mouth and breathe, leading to death.  However, oral cleft occurring in PPS 
patients was not observed in Irf6+/R84C mice.  Therefore, mice respond to heterozygous 
Irf6 mutations differently from human. 
 
The digestive tracts of both Irf6gt1/gt1 and Irf6R84C/R84C mice have adhesion between 
esophageal epithelium. The esophageal lumens fail to form. Reduced intestine, and 
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reduced and/or split liver and pancreas were not reported in two mouse mutants. 
Homozygous Irf6 mutations also affect the development of mouse head skeleton. 
Similar to zebrafish, Irf6gt1/gt1 indicated shorter snout and jaw and reduced skull, while 
the facial complex of Irf6R84C/R84C mice is foreshortened. Irf6gt1/gt1 mice do not have 
external ears. Oral clefts are present in mice when Irf6 mutations are homozygous. In 
addition, the zero dosage of normal Irf6 protein leads to truncated limbs and shortened 
tails, highly penetrated skin caused by the hyperproliferated and undifferentiated 
keratinocytes and unmatured hair follicles. Hindlimbs, tail and body are fused 
together by the adhesion of epidermis. Due to the severity, homozygous mutants are 
not able to survive after birth. This fact help explain why no human cases were found 
to have homozygous or compound IRF6 mutation. 
 
Both zebrafish and mouse models reveal that the abnormal development caused by 
mutated Irf6 is dosage-dependent. Zebrafish, mouse and human have various 
phenotypic responses to mutated IRF6 and its dosage. Different phenotypic responses 
may result from the physiological, anatomical and developmental divergences 
amongst organisms. For instance, fish do not have palatal fusion and hair follicle. 
Therefore, it is difficult to expect that fish can give an ideal phenocopy to human 
syndromes. 
 
Generally, zebrafish can be a suitable model to study the diseases occurring common 
vertebrate organs in embryonic stage. In this irf6 case, intestine and head skeleton of 
morphant fish are reminiscent of mouse esophageal epithelium, facial complex and 
skull defects, repectively. The comprehensive embryonic expression patterns of 
zebrafish genes are meaningful to understand disease phenotypes and mechanism as 
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well as gene function. For instance, the finding that irf6 is expressed in otic and naris 
epithelial cells helps explain deforms present in mouse and human ear and nose organ. 
However, to study human oral cleft, zebrafish is not a good animal model to study 
human oral cleft. For those disorders occurring on mammalian specific developmental 
process, mouse is a better choice. 
 
6. Two forms of irf6 Intron 1 
Two various forms of irf6 Intron 1 were isolated using primers targeting to regions 
from promoter to Exon 2 and from Exon 1 to Exon 2. Two possibities may explain the 
various forms of Intron. One possible explanation is that two forms may come from 
duplicated irf6 genes. If this hypothesis is correct, two sizes of bands representing two 
various forms of Intron 1 shall be amplified from all zebrafish individuals. However, 
the application of primers on 7 individual fish showed that one fish had the 1289 bp 
Intron 1 only, four fish had the 2196 bp Intron 1 only, and two fish had both forms of 
Intron 1. The results were against that the alternative forms of Intron 1 origin from 
duplicated gene copies, but supportive to the second possible explanation that two 
polymorphisms of Intron 1 exist in this single locus. 
 
7. Anti- G124SVPTYETDGDEDDI138 polyclonal antibody can not work in 
Western Blot analysis 
IMGENEX Corp. utilized the peptide G124SVPTYETDGDEDDI138 to inoculate rabbit 
for anti-IRF6 antibody preparation. The peptide is located in the region between DNA 
binding domain and protein interaction motif. This polyclonal antibody was applied in 
Western blot analysis. Identical intensities of multiple bands were detected in embryo 
lysate samples of both wildtype and irf6 morphant, showing the non-specificity of the 
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antibody. In contrast, a research article on mouse IRF6 reported a successful detection 
of mouse IRF6 in immunoassay analysis (Knight et al., 2006).  The anti-mouse IRF6 
antibody was prepared by inoculation of two peptides, 
E147DELEQSQHHVPIQDTFPF165  and S187PEASWPKTEPLEMEV202 (Fig.4.1.).  
 
 
                 71      *                                                          140 
    hIRF6   (71) VDDPDPAKWKAQLRCALNKSREFNLMYDGTKEVPMNPVKIYQVCDIPQPQGSIINPGS--TGSAPWDEKD 
    mIRF6   (71) VDDPDPAKWKAQLRCALNKSREFNLMYDGTKEVPMNPVKIYQVCDIPQTQGSVINPGS--TGSAPWDEKD 
    zIRF6   (71) VDEPDPAKWKAQLRCALNKSREFNLIYDGTKEVPMNPLKIYDVCDIPQTPS---NPGS-----VPTYETD 
    fIRF6   (71) MDEPDPAKWKAQLRCALNKSREFNLVYDGTKEVPMNPLKIYDVCEIPQPSS---NQGSSDAGSWTPHDDD 
    xIRF6   (71) ADEPDPAKWKAQLRCALNKSREFKLMYDGTKEVPMNPVKIYEVCDIPQSQGSIINPGS--TGSVPWDDDD 
Consensus   (71) VDEPDPAKWKAQLRCALNKSREFNLMYDGTKEVPMNPVKIYDVCDIPQTQGSIINPGS  TGS PWDE D 
 
                 141                                                                210 
    hIRF6  (139) NDVDEEDEEDELDQSQHHVPIQDTFPFLNINGSPMAP-ASVGNCSVGNCSPE------------------ 
    mIRF6  (139) NDVDEDEEEDELEQSQHHVPIQDTFPFLNINGSPMAP-ASVGNCSVGNCSPE------------------ 
    zIRF6  (133) GD-----EDDIPDTPEPPPPYASHGMSASPLAAVWTPPGSVSPLQPSSCAPPPALPPPPALPPPAATVLP 
    fIRF6  (138) GG-----EEDIPDTPESLPPYPSN---ES-------------SMQPSSCPPSNEGWP------------- 
    xIRF6  (139) ------FEADELNQSQNHVPISEPFNCLNINDSPIG------SSSTGSCTPE------------------ 
Consensus  (141)  D     EEDELDQSQ HVPI D F  LNINGSPMAP ASV   S GSCSPE                   
 
                 211                                                                280 
    hIRF6  (190) -------AVWPKTEPLEMEVPQAP-------------------IQPFYSSPELWISSLPMTDLDIKFQYR 
    mIRF6  (190) -------SVWPKTEPLEMEVPQAP-------------------IQPFYSSPELWISSLPMTDLDIKFQYR 
    zIRF6  (198) AAAAPPANVWPKKEPEDVEMQP-----------PPMEIQTPTALDNLFITPETWISSLPMTDLEVQFYYR 
    fIRF6  (174) --KEESVKIWPKEEPVDVEMHPTLMADMPPANLPDHPMQPPPLPDTLFATPEHWSS-LPMTDLEVQFLYR 
    xIRF6  (179) -------QTWPKTEPQEMEVPPTSG------------------PADFFSSPEMWISSLPMTDLEIQFYYR 
Consensus  (211)         VWPKTEPLEMEVPP                     I  FFSSPELWISSLPMTDLEIQF YR 
 
Figure 4.1.  The locations of peptides used for preparation of anti-IRF6 polyclonal 
antibodies. The epitope peptides are highlighted. 
 
8. Conclusion and Future studies 
8.1   Genomic and transcript information of irf6 and its expression pattern 
In conclusion, zebrafish irf6 is a gene located on linkage group 22 chromosome. It 
consists of eight exons and encoding a 492 aa protein which contains a Winged-helix 
DNA-binding domain and protein-interaction motif. Zebrafish irf6 is a maternal 
transcript. During gastrulation period, it is expressed in the endodermal progenitor, 
the forerunner cells. From the segmentation period, zebrafish irf6 transcript is present 
in the epithelial cells of otic vesicle, olfactory vesicle, and alimentary tube.  It is also 
expressed in the accessory organs of alimentary system and the pharyngeal arches. 
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 8.2   irf6 affects the digestive and pharyngeal arch organogenesis 
This study also reveals the irf6 knockdown and dominant negative perturbation 
phenotypes. The endodermally derived organs are evidently affected. The knockdown 
of irf6 causes various levels of reduced or split liver and exocrine pancreas and 
reduced intestine, dependent on the injected dosages of morpholinos. Although 
endocrine pancreas keeps the same size as wildtype, some morphants have endocrine 
pancreas split into two or more than two parts. The lumen of morphant intestine 
becomes narrower. The epithelial layer becomes thinner and the epithelium can not be 
normally folded. The differentiation of epithelial cells from esophageal to posterior 
intestine is affected, indicated by the cuboidal cells that can not be transformed into 
columnar shape and that the nuclei can not be polarized to the cell base. The splice-
modified knockdown and dominant negative perturbation also induce a phenotype 
with a reddish intestine present in the 5 dpf old larvae. The erythrocytes were not 
observed in the intestine lumen. The reddish matrix is probably caused by the red 
pigment secreted by the gallbladder and liver. Besides the digestive organs, the 
formation of pharyngeal arches is also affected, indicated by kinked, reduced or 
absent cartilages. The underlying pathological mechanisms are still unknown.  
 
8.3 Clinical significance of perturbation of zebrafish irf6  
The finding that irf6 is expressed in oral, otic and olfactory epithelia has clinical 
significance as it help explain why the defects are present in the corresponding organs 
of VWS and PPS patients in addition to oral clefts. VWS and PPS are autosomal 
dominant inherited disorders, reflecting the developmental effect when IRF6 is down-
regulated at the level of half of normal dosage. Human cases that carry homozygous 
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IRF6 mutation have not been found. In clinical research, it seems not able to know 
how human development will be when normal IRF6 is at the level of zero dosage.  In 
zebrafish, the severity of abnormal growth of intestine, liver, pancreas and pharyngeal 
arches is Irf6 dosage-dependent, providing a clue that homozygous or compound 
heterozygous mutations occurring on IRF6 may have lethal effects in human 
development. The analysis of Irf6 knockout and dominant negative mutation – 
knockin mice also support that Irf6 dosage is essential for the embryonic development. 
Zebrafish phenotype is complementary to the mouse mutants to explain the IRF6 
function and the pathological mechanism of VWS and PPS. 
 
8.4   Unknown interacting partners of Irf6 
Irf6 has a protein interaction motif, suggesting the proper regulation of Irf6-targeted 
transcription requires the synergetic interaction with a co-activator or co-repressor. 
This study does not reveal the transcription factor associated with Irf6. The proteins 
interacted with Irf6 can be baited using yeast two-hybrid system in future study.  
 
8.5  Is Irf6 an activator or repressor, and what are the genes regulated by Irf6 
The differentially expressed genes among the wildtype embryos, irf6 morphants and 
irf6 overexpression can be screened using microarray technology. These differentially 
expressed genes are candidates that are regulated by Irf6. On the other hand, the 
binding sites of Irf6 in the zebrafish genomes can be mapped using chromatin 
immunoprecipitation (ChIP) paired-end ditags strategy (Loh et al., 2006), and the cis-
acting elements mediates the Irf6 binding to genomes can be analyzed using de novo 
motif discovery algorithms. The microarray differential expression data is combined 
with ChIP mapping result to narrow the candidate target genes, of which 
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transcriptions are activated or suppressed by Irf6. The direct regulations would be 
further validated through the examination of in vivo expression of target genes in irf6 
variation embryos using whole mount in situ hybridization analysis and in vitro DNA-
protein interaction gel-shift assay to detect the binding of Irf6 and the promoter 
sequence of the candidate genes.  
 
8.6   What are those transcription factors regulating irf6 expression 
To study the cis-acting elements of irf6 gene, a longer promoter that can drive the 
reporter gene to express in an irf6-specific pattern needs be cloned through 
sequencing a Bac clone containing the irf6 gene. The promoter sequence can be 
aligned with the promoters of fugu, mouse and human IRF6 genes. The conserved 
elements in the promoters demonstrate the transcription factors regulating the irf6 
expression. The regulations can be validated through the examination of in vivo 
expression of irf6 in embryos that have defective expression of upstream genes using 
whole mount in situ hybridization analysis. The in vitro binding of upstream 
transcription factors with the promoter of irf6 can be examined using in vitro DNA-
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